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Summary 
Gene expression is highly regulated and interconnected to processes like mRNP 
processing, mRNA export as well as to DNA repair and replication. The first step of 
gene expression is the transcription of protein coding genes by RNA polymerase II. 
Transcription is controlled by general transcription factors, the phosphorylation of the 
C-terminal domain of Rpb1, the largest subunit of RNA polymerase II, and chromatin 
modifications that allow proper accessibility of the DNA. A major player in these 
coupling processes is the TREX complex, coupling transcription elongation to the 
nucleo-cytoplasmic export of the mRNP via the nuclear pore complex. Particularly, 
the THO subcomplex of TREX has functions in hyperrecombination, nucleotide 
excision repair and transcription coupled repair.  
A genetic screen with TREX components, performed to identify genes involved in 
these processes, lead to the identification of the cyclin dependent kinase Bur1. Bur1 
and its cyclin Bur2 are needed for efficient transcription elongation by RNA 
polymerase II by regulating the methylation of histone tails. Interestingly, Bur1 
interacts in vivo with RPA, a single strand DNA binding protein essential for genome 
stability. This biochemical interaction raised the idea of a novel interconnection 
between transcription, chromatin modification and genome maintenance. 
Mutations in the BUR1 as well as in the RFA1 gene lead to sensitivity to drugs that 
cause DNA damage and replication or transcription stress. Deletion of the C-terminus 
of Bur1, which is sufficient for the binding to RPA, also renders cells sensitive to 
those agents. This shows the functional significance of this protein-protein interaction 
in the cell upon stress induction.  
However, attempts to identify the DNA repair pathway Bur1 is involved in showed 
that mutations in BUR1 do not behave epistatic with deletions of specific pathways. 
This result points to a more general, maybe regulatory role of Bur1 in the response to 
DNA damage. It is interesting to note that mutations in BUR1 lead to increased 
genomic instability as they show the appearance of a higher amount and longer 
persistence of nuclear foci, DNA repair “factories” that contain, among other proteins, 
Rfa1 and Rad52.  
Furthermore, RFA1 mutants show decreased levels of histone H3 alone as well as 
lower levels of histone H3 Lysine 4 trimethylation, a mark for transcription elongation, 
when combined with a mutation in BUR1. The RFA1 mutant is also impaired in the 
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expression of a β-galactosidase reporter gene, pointing to a function of RPA in 
transcription.  
Interestingly, combining BUR1 and RFA1 mutants leads to a lower susceptibility of 
cells to stress than one of the mutations alone. On the one hand, this could be 
elucidated by better growth of the double mutant strains upon stress compared to the 
single mutants. On the other hand, whole genome expression analysis shows that 
the double mutant strain clusters with the bur1 mutant whereas the rfa1 mutant does 
not, showing that its expression pattern is closer to the bur1 mutant. Both results 
show that the protein complexes have antagonistic roles as the combination of both 
mutations leads to a suppression phenotype based on differential gene expression. 
Taken together, a function of Bur1 in genome maintenance could be established, as 
well as an effect of RPA on transcription elongation and chromatin modification. The 
results provide a possibility to speculate about a coupling of transcription and 
genome stability mediated by the interaction of Bur1-2 with RPA. 
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1. Introduction 
Many studies have revealed molecular details in the fields of transcription regulation 
and DNA repair over the last years. Both processes are regulated by a sophisticated 
network of factors that ensure the right timing and coordination. Especially, a tight 
interconnection of these processes with others, that were initially thought to be 
discrete, could be determined.  
1.1. Transcription  
All information needed by the cell to live is encoded in the DNA. The enzyme 
transcribing all protein coding genes is RNA Polymerase II (RNApolII).  
Transcription is regulated in several ways. First, the assembly and binding of general 
transcription factors as well as the Mediator complex control transcription initiation. 
The phosphorylation of the C-terminal domain (CTD) of the largest subunit of 
RNApolII, Rpb1, provides a second level of regulation. The C-terminal domain (CTD) 
of RNApolII is comprised of a number of tandem YSPTSPS repeats. (Svejstrup, 
2004) Those repeats are conserved through evolution but the number of repeats 
changes in different eukaryotic organisms ranging form 26-27 copies in yeast, 45 in 
flies to 52 copies in human (Corden, 1990). The tandem repeats of the CTD can be 
phosphorylated on Serine 2 (S2) and Serine 5 (S5). These phosphorylations are a 
major source of regulation. A third mechanism of transcription regulation is achieved 
by covalent histone modifications, mostly ubiquitination and methylation, and 
chromatin remodelling that leads to the necessary accessibility of the DNA. The great 
level of interconnectivity between those regulatory events will be discussed in greater 
detail below. 
1.1.2 Regulation of transcription initiation by general transcription 
factors 
Initiation of transcription in eukaryotes is achieved by the recognition of promoter 
elements that form a platform for the binding of general transcription factors. (Smale 
and Kadonaga, 2003). 
The first step is the binding of TBP, a subunit of TFIID to the TATA box, the best 
characterized element of the core promoter. This leads to DNA bending and serves 
as a nucleation site for the following factors. Afterwards, TFIIA binds and stabilizes 
the DNA/TBP complex. Subsequently, TFIIB contacts this complex and recruits hypo-
Introduction 
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phosphorylated RNApolII together with TFIIF. The final assembly of TFIIE and TFIIH 
forms the pre-initiation complex (PIC) (Van Dyke et al., 1988). TFIIH regulates the 
initiation of transcription in two ways. First, it unwinds the DNA using energy from the 
hydrolysis of ATP leading to the formation of the so called open complex. In this 
complex the DNA is melted forming a “transcription bubble”. Second, it 
phosphorylates the CTD of RNApolII on S5 with its kinase subunit Kin28 leading to 
the clearance of the promoter and transcription initiation. This subset of factors is 
required for the initiation of basal transcription in vitro from most promoters (Woychik 
and Hampsey, 2002). 
Another protein complex identified to be necessary is the Mediator, functioning in co-
activation as well as in co-repression. Mediator can bind to specific DNA sequences 
as well as to the unphosphorylated CTD and fulfils its function in transcription 
initiation, because it dissociates from RNApolII after the CTD is phosphorylated (Max 
et al., 2007).  The Mediator subunits Srb10/Srb11 can also phosphorylate S5 of the 
CTD already before the assembly of the PIC and thus hinders its formation. Due to 
this property it also has a repressive function (Hengartner et al., 1998).  
Some of the general transcription factors and the Mediator complex remain bound in 
a scaffold complex on the promoter to allow a rapid re-initiation of transcription on a 
given gene (Yudkovsky et al., 2000). An overview of these steps in transcription 
initiation is shown in Figure 1. 
 
 
Figure 1: Transcription initiation and re-initiation by RNApolII (Hahn, 2004) 
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1.1.3 Transcription elongation and termination 
The transition from initiation to productive elongation is facilitated by a shift from S5 
to S2 phosphorylation on the CTD (Marshall et al., 1996) and phosphorylation of Spt5 
(Wada et al., 1998), a component of the negative regulator DSIF. In human this is 
carried out by the positive transcription elongation factor b (P-TEFb), which consists 
of the cyclin dependent kinase Cdk9 and cyclin T.  
Two putative Cdk9 homologs exist in S. cerevisiae. On the one hand the Ctk1 
complex that is responsible for the S2 phosphorylation of RNApolII’s CTD (Cho et al., 
2001) and on the other hand the Bur1-2 complex, which is most likely not involved in 
CTD phosphorylation but in the phosphorylation of Spt5 and regulation of chromatin 
modification. The phosphorylation of Spt5 is speculative and results from indirect 
experiments showing that Cdk9 from S. pombe is able to phosphorylate Spt5 and 
complements for the deletion of BUR1 in S. cerevisiae (Pei and Shuman, 2003). The 
functions of the Bur1-2 complex will be discussed later in greater detail.  
Despite of these proteins, other factors like TFIIS or the PAF complex are recruited to 
the ORF during transcription elongation (Pokholok et al., 2002). 
After transcription is terminated (Gilmour and Fan, 2008) the CTD becomes 
dephosphorylated on S2 by Fcp1 (Cho et al., 2001; Hausmann and Shuman, 2002) 
and on S5 by Ssu72 (Dichtl et al., 2002; Krishnamurthy et al., 2004) and is recycled 
for another round of transcription. 
Figure 2 gives an overview about the whole “transcription cycle” from initiation to 
elongation and termination as reviewed in (Egloff and Murphy, 2008; Prelich, 2002).  
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Figure 2: The eukaryotic mRNA transcription cycle and interconnection to other processes. 
(Egloff and Murphy, 2008) 
1.1.4 Transcription associated chromatin modifications in yeast 
Transcription, especially transcription elongation, is regulated by a defined landscape 
of histone modifications. This is most likely a consequence of RNApolII moving 
through the gene and recruiting various chromatin modifying enzymes. An overview 
of these modifications is shown in Figure 3. 
Introduction 
 7
 
Figure 3: Distribution of histone modifications from a transcriptional point of view (Li et al., 
2007).  
The curves represent the distribution based on genome-wide approaches. Except for H3K9me, 
H3K27me and H2Aub1, most data were obtained in yeast.   
1.1.4.1 Histone H2B ubiquitination 
Histone H2B monoubiquitination (H2Bub) is facilitated by Rad6 in S. cerevisiae on 
Serine 123  of histone H2B (Robzyk et al., 2000). The E3 ubiquitin ligase Bre1, is 
associated with Rad6 to recruit it to the promoter of transcriptionally active genes. 
The deletion of BRE1 also leads to elimination of H2Bub (Wood et al., 2003). 
Additionally, the PAF complex, needed for transcription elongation, is important for 
the control of the ubiquitination. Deletions of RTF1 and PAF1 reduce the level of 
histone H2Bub, even though they are not needed for the recruitment of Rad6 (Wood 
et al., 2003). Thus, it seems to regulate its activity. Deletion of RTF1 leads to inability 
of Rad6 to travel with RNApolII into the open reading frame. Additional factors are 
also required, e.g. Bur1-2 when mutated, also reduce the level of ubiquitinated H2B 
(Laribee et al., 2005). It is unclear if this is a direct effect or a consequence of the 
inability to recruit PAF. Kin28 loss and thus loss of S5 phosphorylation eliminates 
H2Bub, whereas loss of Ctk1 and thus loss of S2 has no effect. These data indicate 
that Rad6 and H2Bub are important in the initiation and early steps of transcription 
elongation.  
The ubiquitination of histone H2B is a prerequisite for histone H3 methylation (Sun 
and Allis, 2002). Deletion of RAD6 as well as mutation of histone H2B prevent the 
methylation of histone H3 on Lysine 4 and 79, catalyzed by the histone 
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methyltransferases Set1 and Dot1, respectively. This phenomenon is unidirectional 
as mutations that affect H3 modification have no effect on the ubiquitination of 
histone H2B. The methylation of Lysine 36 on histone H3 is not dependent on H2Bub 
(Briggs et al., 2002).  
Interestingly, there is much more histone methylation than ubiquitination in the cell. A 
possible explanation might be the different stability of those modifications. 
Methylation is supposed to be a very stable mark, whereas the ubiquitination has a 
very high turnover rate. This means that methylated histones most likely have been 
ubiquitinated before.  
There are several possibilities how H2Bub facilitates the subsequent histone 
methylation. Either the ubiquitination leads to an unfolding of the chromatin making it 
possible for Set1 and Dot1 to bind, or the ubiquitination is directly recognized by 
these methyltransferases.  Another model is based on the fact, that the PAF 
complex, besides its need for H2Bub, is also needed for the methylation of H3K4 and 
H3K79 (Krogan et al., 2003a; Ng et al., 2003). PAF is required for the recruitment of 
Set1 to the promoter which in turn leads to the H3K4 methylation. Set1 is not active 
until PAF activates Rad6-Bre1 to ubiquitinate H2B. H2Bub might then regulate the 
activity of the methyltransferases. This model would explain the identical phenotypes 
of ∆paf1, ∆rad6 and htb1-K123R. In the ∆paf1 mutant H3K4 can not be methylated, 
because Set1 can not be recruited to chromatin, in ∆rad6 and htb1-K123R H3K4 can 
not be methylated because Set1 can not be activated. 
The deubiquitination on S. cerevisiae is carried out by Ubp8, a component of the 
SAGA co-activator complex (Daniel et al., 2004) Experiments have shown that a 
∆ubp8 mutant has elevated levels of H2Bub, both globally and at the GAL1 promoter 
upon galactose activation. Ubp8 is required for the recruitment of Ctk1, the S2 
phosphorylated CTD form of RNApolII and Set2 to the 5’ end of the ORF (Wyce et 
al., 2007). H2B monoubiquitination prevents Ctk1 recruitment to elongating RNApolII. 
This might indicate that the H2B ubiquitination serves as a checkpoint for early 
transcription elongation. The S2 phosphorylation also provides a binding site for 
Set2, the methyltransferase for H3K36, which is required for the subsequent steps in 
transcription elongation. As Rad6 and Ubp8 bind to elongating RNApolII there might 
be multiple rounds of H2B ubiquitination and deubiquitination occurring during 
transcription elongation (Fig. 4). 
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Besides the histone ubiquitination function, Rad6 has also acts in DNA repair and 
protein degradation pathways. Here, it makes use of different ubiquitin ligases like 
Rad18 (Jentsch et al., 1987).  
 
 
Figure 4: Histone H2B ubiquitination and deubiquitination in transcription elongation (Weake 
and Workman, 2008) 
I. Ubiquitination of histone H2B is important for early steps in transcription initiation and elongation. 
II. Deubiquitination of histone H2B is required for later steps in transcription elongation.  
1.1.4.2 Histone H3 Lysine 4 methylation 
One of the currently most studied histone modifications in transcription elongation is 
the methylation of histone H3 Lysine 4 (H3K4me). This reaction is accomplished by 
the Set1 (COMPASS in yeast, MLL in human) complex. The monomethylation 
(H3K4me) peaks to the end of the gene, the dimethylation (H3K4me2) in the middle 
and the trimethylation (H3K4me3) at the transcription start site (Pokholok et al., 
2005). Those three modifications depend on each other, meaning that the residue 
has to be monomethylated first before it can be di- and trimethylated. It seems like 
the monomethylation is achieved by the basal activity of Set1 and that the di- and 
trimethylation are depending on the recruitment of Set1 during transcription. 
Phosphorylation of S5 of RNApolII by Kin28 recruits Set1 to the 5’ region of a gene 
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(Zhang et al., 2005). As the Set1 complex is recruited mainly in the beginning of 
transcription the di- and trimethylation rise during early transcription elongation 
making monomethylation less frequent at this stage. Towards the end of the gene 
more monomethylation is present because it is not converted into di- or 
trimethylation. H2B ubiquitination specifically affects di- and trimethylation but does 
not eliminate monomethylation (Dehe et al., 2005). Additionally, H3K4me2 and 
H3K4me3 depend on the association of the PAF complex with RNApolII. In a ∆paf1 
strain H3K4me2 and me3 are not detectable whereas H3K4me is. Another factor 
important especially for H3K4me3 is the cyclin dependent kinase Bur1. Mutations in 
BUR1 reduce H2Bub but only affect H3K4me3 (Laribee et al., 2005). 
There are also indications that the Ccr4-Not mRNA processing complex has a 
function in the steps between H2B ubiquitination and H3 Lys4 methylation (Laribee et 
al., 2007a). This complex participates both in mRNA degradation and transcription 
regulation as a repressive factor. Mutations in some of the components reduce 
trimethylation of H3 Lys4 but do not affect mono- or dimethylation or H3K79 
methylation. The Not4 component has a RING domain that is required for H3K4me3 
and might thus be an E3 ubiquitin ligase (Laribee et al., 2007b). 
Interestingly, there seems to be no direct effect of the H3K4 methylation on 
transcription. In vitro, there is no measurable impact of this modification and Set1 
does not affect the processivity of RNApolII and is not essential. Thus, the function is 
most likely to recruit other chromatin remodelling factors but the mechanism will be a 
task for future research. 
1.1.4.3 Histone H3 Lysine 36 methylation 
The methylation of Lysine 36 on histone H3 (H3K36me) is mediated by the histone 
methyltransferase Set2. It associates with S2 phosphorylated RNApolII in the body of 
actively transcribed genes (Krogan et al., 2003b). This histone mark seems to serve 
as a binding site for the Rpd3 complex. Rpd3 is a histone deacetylase in S. 
cerevisiae that functions as a transcriptional co-repressor via interaction with the 
DNA binding factor UME6 (Kadosh and Struhl, 1997, , 1998). Acetylation and 
deacetylation of lysine residues on histones are linked to transcriptional activation 
and repression, respectively. Eaf3 is a subunit of the Rpd3 complex and deletion 
strains show an increase in acetylation in coding regions, sometimes with a bias to 
the 3’ end. This acetylation shows an inverted distribution to the H3K36 methylation 
levels. Deletions EAF3 and SET2 have strikingly similar phenotypes, leading to the 
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conclusion that H3K36 dictates the global levels of histone acetylation related to Eaf3 
(Joshi and Struhl, 2005). 
1.1.4.4 Histone H3 Lysine 79 methylation 
Methylation of Lysine 79 is mediated by Dot1 and important for the regulation of  
transcriptional silencing (Ng et al., 2002). On telomeres and other heterochromatin-
like regions H3K79 is hypomethylated whereas it is hypermethylated in actively 
transcribed regions.  
1.1.5 Interconnection of transcription with other processes 
The process of transcription is intimately coupled to other processes in gene 
expression like mRNA processing and export as well as to DNA replication, 
recombination and repair (Orphanides and Reinberg, 2002). These processes, 
except for the DNA repair associated ones, are controlled by the recruitment of 
different factors dependent on the phosphorylation pattern of the CTD. The CTD 
stimulates capping, splicing and 3’-processing which is facilitated by different regions 
of the CTD (Fong and Bentley, 2001). The phosphorylation of S5 is required for 
recruiting the capping apparatus whereas 3’-end processing and splicing depend on 
phosphorylation of S2 (Ahn et al., 2004).  
Components of the TREX complex couple TRanscription to mRNA EXport (Strasser 
et al., 2002). The TREX complex is needed for efficient transcription elongation 
(Chavez and Aguilera, 1997; Chavez et al., 2000) (Rondon et al., 2003), splicing (Kim 
et al., 1997), and genome stability (Jimeno et al., 2002). The coupling of transcription 
and mRNA export is mediated by the interaction of THO and Yra1 which in turn binds 
to the mRNA export factor Mex67-Mtr2 to transport the mature mRNP to the 
cytoplasm via interaction with nuclear pore proteins (Strasser and Hurt, 2000). Yra1 
has also been shown to be required for S-phase entry (Swaminathan et al., 2007). 
THO components were shown to be defective in NER (Gonzalez-Barrera et al., 2002) 
and TCR (Gaillard et al., 2007) and cause the formation of R-loops, DNA:RNA 
hybrids, that lead to transcription impairment and transcription associated 
recombination (Huertas and Aguilera, 2003; Piruat and Aguilera, 1998) (Fig. 5).  
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Figure 5: Interconnections and functions of TREX, BUR and RPA 
The TREX complex couples transcription to mRNA export. Mutations in TREX components show 
phenotypes in various cellular processes like transcription elongation, mRNA export, splicing, 
nucleotide excision repair (NER) and transcription associated recombination. The cyclin dependent 
kinase/cyclin complex Bur1-2 was found to interact genetically (SL; synthetic lethality) as well as 
biochemically (BI; biochemical interaction) with TREX (Sträßer, unpublished data). The major function 
of the BUR complex is regulation of transcription elongation, most likely due to histone modification. A 
biochemical interaction of Bur1-2 and RPA could be established in our lab. RPA, consisting of Rfa1, 
Rfa2 and Rfa3, is a single strand DNA binding protein with functions in DNA repair, recombination and 
replication. BUR1 and RFA1 additionally interact genetically (SUP; suppression) pointing to 
antagonistic roles in the process they are involved in. These Interactions might provide a molecular 
explanation how these processes are coupled. 
1.2. The function of Bur1-Bur2 
1.2.1 Identification of Bur1-Bur2 
BUR1 was first identified as a protein with an unspecific function in the release from 
α-factor induced G1 arrest where it suppresses the supersensitivity of a GPA1 
mutation, a heterotrimeric G-protein that binds to pheromone receptors. Due to the 
suppression it was called SGV1 (suppressor of GPA1v50). A mutation rendering the 
G1 cyclin Cln3 hyperactive was able to rescue the deletion of BUR1 indicating that it 
may act downstream of BUR1 (Irie et al., 1991). 
The now commonly used name BUR1 comes from a screen performed in the Prelich 
lab using SUC2 deleted of its upstream activating sequence (UAS) as a reporter 
gene. This mutation causes cells to die on sucrose as a carbon source. Mutations 
able to rescue the phenotype were called the BUR genes (bypass UAS requirement).  
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The genes identified here are involved transcription. For example RNAPolII, general 
transcription factors like TBP and chromatin genes like histone H3. 
Later, Bur1 was shown to be a cyclin dependent kinase and Bur2 as the 
corresponding cyclin (Yao et al., 2000) 
1.2.2 Function of Bur1-Bur2 in transcription elongation 
Bur1 was shown to phosphorylate the CTD of RNApolII in vitro (Murray et al., 2001) 
but in vivo the CTD phosphorylation does not change dependent on BUR1, still it is 
needed for efficient transcription elongation (Keogh et al., 2003). It was shown that 
Bur1 copurifies with Ser5 phosphorylated RNApolII indicating that it binds to initiating 
RNApolII.  It is synthetic lethal with CTK1, SPT4 and SPT5, temperature sensitive 
with DST1 and 6’-AU sensitive. All these data point to a function in transcription 
(Lindstrom and Hartzog, 2001; Murray et al., 2001).  
Bur1 itself is phosphorylated by CAK1 (Yao and Prelich, 2002) as it is the case for 
other transcription associated kinases like Kin28 (Espinoza et al., 1998) or Ctk1 
(Ostapenko and Solomon, 2005). 
Deeper insight into the function of BUR in transcription elongation comes from more 
recent publications showing that ∆bur2 shows a specific impairment in histone H3 
Lys4 trimethylation (H3K4me3) and histone H2B ubiquitination (H2Bub) but had no 
effect on histone H3 Lys79 methylation (Laribee et al., 2005). (This paper was the 
first one showing an uncoupling of the histone H3 Lys4 from the Lys79 methylation.) 
Rad6, an E2-ubiquitin conjugating enzyme needed for the ubiquitination of histone 
H2B, was identified as an in vitro substrate of Bur1. Mutation of the phosphorylated 
site on Rad6 impairs H2Bub to the same extend as deletion of BUR2 (Wood et al., 
2005). 
As Rad6 is not fully inactivated by this mutation, the phosphorylation might just 
enhance its catalytic activity. Rad6 is still recruited to the promoter without BUR2 
whereas the PAF complex, which is needed for the activity of Rad6, is not. It is thus 
not completely clear if the impairment in H2Bub and H3K4me3 comes directly from 
the Bur1 complex and its phosphorylation of Rad6 or indirectly due to a failure in 
recruiting the PAF complex (Wood et al., 2005).   
The deletion of BUR1 is suppressed by the deletion of the methyltransferase activity 
of Set2 or by mutation of Serine 36 on histone H3. Set2 deletion did not rescue all 
BUR1 phenotypes pointing to Set2 and Bur1 having partly antagonistic but non 
overlapping roles. Bur1-2 is needed for transcription associated histone H3 Lys36 
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trimethylation. Deletions of CHD1, a chromodomain containing chromatin remodeler, 
and EAF3, a component of the Rpd3S deacetylation complex also containing a 
chromodomain, suppress the growth defect of ∆bur1 but act downstream of the 
H3K36 methylation showing a new connection of Bur1 and histone methylation. It 
seems as ifs the complete abolishment of H3K36 methylation is less harmful for the 
cell than a missregulation (Chu et al., 2006). Also ∆rtf1 appears to suppress ∆bur1 
and it was also shown that deletion of those factors restored the recruitment of 
RNApolII to the gene that is lowered in ∆bur2 (Keogh et al., 2005). The suppression 
of ∆bur1 by deletion of CHD1 and EAF3 as well as other genes involved in this 
pathway was also pointed out in this publication. 
Proteins containing a JmjC domain are able to reverse the di- and trimethylation of 
histone H3K36 and act as transcriptional repressors. H3K36 methylation in yeast acts 
as a docking site for Eaf3, a subunit of Rpd3S. This histone deacetylation inhibits 
transcription initiation on cryptic start sites within the gene. Set2/Rpd3S inhibits PolII 
elongation and counteracts Bur1. Jhd1 and Rph1, both containing a JmjC domain, 
have been shown to specifically demethylate Lys36. Both promote PolII transcription 
through repressive chromatin generated by Set2/Rpd3S. Overexpression of both of 
these proteins suppress ∆bur1 thus bypassing the requirement for Bur1 by removing 
the repressive Lys36 methylation. Rph1 was originally isolated as a transcriptional 
repressor of photolyase and is phosphorylated by Rad53 upon DNA damage 
suggesting that histone methylation/demethylation might somehow be linked to DNA 
repair (Kim and Buratowski, 2007). 
1.4. DNA repair 
Cells are constantly challenged with agents that lead to DNA damage. This can either 
be extrinsic factors, like UV irradiation, or intrinsic factors, like reactive oxygen 
species. It is estimated that a human cell repairs about 10000 DNA damages per cell 
per day. Compared to this, the actual mutation frequency is extremely low due to 
highly sophisticated and interconnected DNA repair mechanisms. The pathway 
choice is dependent on the specific kind of DNA damage.   
DNA repair pathways can be divided into two major classes. The excision repair 
pathways and the double strand break repair pathways.  
All excision repair pathways share the same principle. The first step is the recognition 
of the damage followed by a dual incision of the DNA backbone. The damaged site is 
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excised from the DNA and a new strain is synthesized on the basis of the non-
damaged strand by a DNA polymerase which is then ligated again.  
The nucleotide excision repair (NER) pathway is needed for the removal of damages 
that distort the DNA helix, e.g. CPDs. The NER pathway is not essential for survival 
but leads to several illnesses like Cockayne’s  syndrome or xeroderma pigmentosum 
(Thoma, 1999). It can be subdivided into global genomic repair (GGR) which is 
responsible for generally repairing the genome and transcription coupled repair 
(TCR), specifically repairing damage in the transcribed strand of a gene. It has been 
shown that UV damage is repaired faster in the transcribed strand than in the non-
transcribed one (Sweder and Hanawalt, 1992). Most of the proteins needed for both 
of the pathways are the same just the recognition is facilitated by different proteins. 
Damage recognition in GGR is fulfilled by the Rad16-Rad7 complex (Guzder et al., 
1997) whereas Rad26 and the RNApolII subunit Rpb9 are responsible for TCR (Li 
and Smerdon, 2002).  
Damaged bases that do not distort the DNA structure like oxidation and alkylation are 
repaired by the base excision repair pathway (BER). The damage is recognized by 
specific glycosylases like Mag1 and processed by AP endonucleases like Apn1 
(Memisoglu and Samson, 2000). The glycosylase cleaves the N-glycosylic bond 
between the base and the sugar, producing an abasic site. Here, the backbone is 
cleaved and the correct base is inserted by a DNA polymerase. One can distinguish 
between short-path BER when only one base is excited and long-path BER where 
usually two to six bases are excited.  
Mismatch repair (MMR) targets mismatches that either come from DNA replication, 
homologous recombination or alkylating agents. It is thus considered as a damage 
avoidance and replication fidelity pathway (Marra and Schar, 1999).  
The most hazardous DNA damages for the cell are DNA double strand breaks (DBS). 
Two different pathways exist to repair this kind of damage: homologous 
recombination (HR), which is the major DSB repair pathway in yeast and non-
homologous end joining (NHEJ), which is the more important one in human. The HR 
branch is always preferred by the cell as it always leads to error free repair. NHEJ 
just uses short homologies for guiding repair and joins DNA ends, which might in turn 
result in loss of nucleotides. 
HR requires the genes of the RAD52 epistasis group (Krogh and Symington, 2004). 
The first event upon a DSB is phosphorylation of histone H2A (metazoan histone 
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H2AX) (Fillingham et al., 2006). The broken ends are recognized and processed by 
the Mre11/Rad50/Xrs2 exonuclease complex producing a 3’ ssDNA overhang which 
is subsequently bound by RPA. Rad52 facilitates the displacement of RPA by Rad51 
which leads to a filament searching for homologous sequences. Rad55 and Rad57 
initiate the strand exchange, which leads to replication of the homologous strand by a 
DNA polymerase and subsequent ligation.  
NHEJ in yeast requires the DNA end binding proteins Ku70/Ku80 and the MRX 
complex. These two complexes recruit Lig4/Lif1 which in turn ligates the broken DNA 
ends (Shrivastav et al., 2008). 
1.5 Replication Protein A (RPA) 
RPA has been discovered 20 years ago and the multiple functions and domains have 
been extensively studied until today (Iftode et al., 1999; Wold, 1997).  
RPA is a heterotrimeric protein complex. The subunits are named RPA1, 2, 3 or 
RPA70, RPA32 (sometimes also RPA34 which might be due to different migration 
behaviour of the middle subunit due to phosphorylation) and RPA14 in higher 
eukaryotes. (The yeast counterparts are called Rfa1, 2 and 3 because the 
abbreviation RPA was already assigned to the subunits of RNA Polymerase I). RPA 
binds single stranded DNA (ssDNA) with high affinity but is also able to bind double 
stranded DNA (dsDNA) and RNA but with approximately three orders of magnitude 
lower affinity. Homologous heterotrimeric ssDNA binding proteins have been found in 
all eukaryotes that were examined. RPA was originally shown to be essential for 
SV40 virus replication (Wold and Kelly, 1988) and was subsequently called 
“Replication Protein A” even though it has functions in DNA replication, 
recombination and repair and thus the “R” could also stand for recombination or 
repair. RPA becomes phosphorylated in the cell on its middle subunit when bound to 
ssDNA. It was also shown for RPA that it might have a function in transcription by 
binding to specific dsDNA regulatory sequences (Luche et al., 1993; Singh and 
Samson, 1995; Tang et al., 1996). The complex is very abundant and seems to be 
the most abundant ssDNA binding protein (estimated 3 x 104 – 5 x 105 molecules per 
human cell). Additionally, this protein complex is very stable, e.g. in urea up to 6 M or 
guanidinium-HCL up to 2 M. The subunits are only soluble when expressed together. 
RPA1 alone is insoluble, RPA2 and RPA3 are soluble when expressed together. 
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They might form a pre-complex that is necessary for the folding of the complete 
complex.  
1.5.1 Expression and localization 
The mRNA expression of RPA peaks at the G1/S transition but the protein half-life is 
very long (>12 h in human cells). The cellular localization changes during the cell 
cycle: During G1 and G2 phase RPA is diffusely localized to the nucleus with RPA3 
also detectable in the nucleolus. RPA70 seems to be associated with dsDNA in G1. 
During S-phase, chromosomal DNA replication occurs in a punctuate pattern, also 
termed replication foci or replication centers, in which 300-1000 DNA molecules and 
multiple proteins are aggregating to form replication factories. RPA becomes 
recruited to those foci before the initiation of replication and stays there also during 
DNA synthesis. After the completion it dissociates from chromosomes. During M-
phase only RPA2 is found to associate with chromosomes, RPA3 is selectively 
localized to the cytoplasm. The overall ratio of all subunits stays constant during the 
cell cycle.   
1.5.2 DNA binding 
Binding of RPA to DNA under physiological conditions needs a length of 30 
nucleotides. However, an 8 nucleotide binding mode has also been observed. 
According to the current model RPA binds first to 8 nucleotides with DNA binding 
domains A and B (Fig. 5) and has a more globular shape. Using additional contacts 
with the secondary binding domains C and D it forms an elongated conformation and 
binds 30 nucleotides. RPA can bind to bubbles of dsDNA as small as 4 nucleotides 
and yeast RPA was shown to bind up to 90-100 nucleotides building nucleosome like 
structures. Probably due to those two binding modes, RPA confers a helicase activity 
that is independent of ATP. It has been found to bind to damaged DNA, most likely 
due to the helix disturbance, and prefers polypyrimidines (T/C) over polypurines 
(A/G).  
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Figure 6: RPA domains and interactions with other proteins (Iftode et al., 1999). 
1.5.3 The RPA subunits 
The biggest subunit, RPA70, has several functions. It has an intrinsic DNA binding 
activity, binds to numerous proteins and is essential for DNA replication, 
recombination and repair. Studies in yeast have shown that all residues except of the 
N-terminal 10 amino acids are essential. RPA70 undergoes a conformational change 
upon DNA binding. In the human protein the center domain contains the DNA binding 
domains, the N-terminal domain is needed for complex formation and the C-terminal 
domain is needed for protein-protein interactions (Fig. 6). The DNA binding domains 
are interchangeable in yeast and the domains of the human protein can substitute for 
the yeast counterpart, showing a high level of conservation. RPA70 contains a Zink 
finger domain, but its function is unknown and it is also unknown if it really binds Zink.  
The middle subunit, RPA32, has three domains. A secondary DNA binding domain, 
located in the center, phosphorylation sites that become phosphorylated in a cell 
cycle dependent manner but are not essential, and the C-terminus, needed for 
protein-protein interactions and complex assembly (Fig. 6). The phosphorylation 
Introduction 
 19
occurs from the G1/S transition to late mitosis. Human RPA is phosphorylated by the 
cyclin dependent kinase cdk2 when it is in complex with the G1 cyclins A and B but 
not with the G2 cyclin E. It becomes additionally hyperphosphorylated in vivo in 
response to DNA damage. Another kinase, DNA-PK, needs DNA for phosphorylating 
RPA32. Phosphorylation can also be achieved by the checkpoint kinase ATM and 
the yeast counterpart Mec1. Thus, at sites of DNA damage, recombination and 
during DNA repair the phosphorylation might serve to recruit other factors needed for 
the respective process.  
The function of RPA14, besides RPA complex formation, is still mostly unknown but it 
seems to be important for efficient DNA binding and correct positioning of the 
complex (Weisshart et al., 2004). Cells with a deletion of the N-terminal 70 (of 122) 
amino acids are still viable but temperature sensitive.  
1.5.4 Functions in replication, recombination and repair 
The RPA complex has roles in several DNA associated cellular processes. In DNA 
replication it could be involved in polymerase switching because it is involved in the 
synthesis of a small primer by DNA polymerase α (Pol α) before the switch to DNA 
polymerase δ (Pol δ). In viral DNA replication it binds to the viral origin and helps in 
denaturation together with the T antigen. Those factors then recruit Pol α. The 
stimulatory role of RPA on Pol α requires the ssDNA binding activity of RPA. 
In DNA recombination and DSB repair RPA might have a function due to the binding 
of Rad51 and Rad52 to the RPA32 subunit. In yeast the interaction with Rad52 
seems to be mediated via the whole protein with the strongest affinity to Rfa1. This 
function was deeply analysed and lead to a model in which a DNA DSB is first 
recessed to generate a 3‘-ssDNA tail that is subsequently bound by RPA. Rad52 
then acts to displace RPA and facilitates binding of Rad51, leading to the formation 
of a filament that is able to search for homologous sequences for recombination. In 
vivo, this is thought to be much more complex because of the need for numerous 
other factors for foci formation (Lisby et al., 2004).  
In addition, DNA repair pathways require RPA. Mismatch repair can be stopped by 
adding antibodies directed against RPA and adding back RPA restores it. The 
mechanism is still unknown (Guo et al., 2006). 
A function in base excision repair  (BER) has been established due to the interaction 
with UNG (uracil-DNA-glycosylase). RPA has been shown to be stimulatory for long 
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patch BER by facilitating gap filling by DNA polymerase (DeMott et al., 1998). 
Additionally, a lot of RPA mutants are MMS sensitive.  
RPA is essential for nucleotide excision repair (NER). In the early stage it interacts 
with XPA (Rad14 in yeast), a DNA damage recognition factor, and stimulates its 
activity to bind to the damaged DNA. Afterwards the XPG ERCC1-XPF (Rad2, Rad10 
and Rad1 in yeast) endonuclease complex is recruited to the damaged site. RPA 
also interacts with XPG. Finally, RPA participates in the gap filling reaction together 
with PCNA and DNA polymerases δ and ε.  
RPA has moreover been shown to act in transcription-coupled repair. A mutant of 
rfa1, that was completely defective in GG-NER was still able to repair the transcribed 
strand, even though with reduced activity (Teng et al., 1998). 
Additionally, RPA functions in cell cycle and checkpoint regulation due to interaction 
with p53.  
1.5.5 Function in transcription 
RPA might also have a role in regulating transcription. It has been published to bind 
to the URS1 sequence in yeast, a sequence that negatively regulates the activity of 
several metabolically regulated genes (Luche et al., 1993), as well as the MAG locus, 
which has a repressive effect on DNA repair and metabolism genes (Singh and 
Samson, 1995). In other organism like sea urchin or human RPA was found to bind 
to the P10 site, regulating expression in early development, and the promoter of 
metallothionein, respectively. In the case of the metallothionein promoter it was 
demonstrated that higher expression of RPA inhibits its expression (Tang et al., 
1996). 
Two recent publications (Elmayan et al., 2005; Kapoor et al., 2005) highlight that 
mutations in RPA2 release the silencing induced by mutations in the DNA 
glucosylase/lyase ROS1. RPA and ROS1 interact both genetically and physically. 
This RPA mutation furthermore leads to enhanced expression of some transposons. 
Neither DNA methylation nor siRNA expression is blocked by this mutation but 
histone H3 Lys4 trimethylation is increased whereas the Lys9 methylation is 
decreased in the double mutant in comparison to the ros1 mutant, depicting a role for 
RPA in the maintenance of gene silencing at specific loci.  
Thus, a possible role of RPA in transcription could be revealed, even though a 
mechanism remains elusive. 
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1.6. Aim of this work 
Genome expression and maintenance are among the most important processes in 
the cell. A key player in gene expression is the TREX complex, important for 
transcription and the coupling to the transport of the mature mRNP to the cytoplasm. 
Furthermore, subunits of TREX, HPR1 and THO2, function in genome maintenance. 
A synthetic lethal screen with TREX lead to the identification of the cyclin dependent 
kinase Bur1, indicating a functional overlap with the TREX complex. Bur1 is an 
essential protein regulating transcription by the methylation of histone tails. This 
kinase interacts with RPA, a protein that is essential for DNA repair, replication and 
recombination. This interaction might provide a molecular explanation how these 
processes are coupled. 
Therefore, the aim of this work was the analysis of the interaction of the Bur1-2 
complex with RPA and the functional characterization of both protein complexes in 
the cellular processes mentioned before. First, the genetic and biochemical 
interaction of both complexes should be investigated. One of the aims, in addition to 
the characterisation of the complex, was to create a Bur1 mutant unable to bind to 
RPA without changing the other properties of the protein, like the ability to fulfil its 
kinase function and to interact with other proteins. Second, a function of Bur1 in DNA 
repair, replication and recombination events should be identified, specifically with the 
aim to find the DNA repair pathway BUR1 might be involved in. Additionally, finding a 
phosphorylation target of Bur1 kinase was a matter of particular interest. Third, a 
putative role for the RPA complex in transcription and histone methylation should be 
determined.  
The results of this study should allow deeper insight into new functions of the Bur1-2 
and RPA complexes as well as a speculation about a coupling of transcription 
elongation, chromatin modification and genome maintenance by a previously 
unknown mechanism. 
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2. Results 
2.1. The kinase Bur1 interacts genetically with TREX 
The TREX complex was shown to couple transcription to mRNA export (Strasser et 
al., 2002). In order to identify genes with overlapping functions to TREX, a synthetic 
lethal (SL) screen was performed (Sträßer, unpublished data). One of the candidates 
indentified in the screen was the cyclin dependent kinase BUR1. It was found in 
screens with ∆hpr1 and ∆mft1, both deletions of components of the THO complex. 
As the genetic interactions of BUR and TREX were not focus of this work only an 
example of the synthetic lethality is shown here. For testing the SL relationship of 
BUR1 and YRA1 strains that were deleted of both genes and transformed with 
plasmids coding for the wild type genes with addition of promoter and terminator 
sequences and containing a URA3 marker. As both, BUR1 and YRA1, are essential 
genes, this strain was subsequently transformed with plasmids carrying mutations in 
both, or only one of the genes as control, respectively. The wild type URA3-
containing plasmids can be shuffled out of the cells by restreaking them on plates 
containing 5’-FOA and the growth behaviour caused by the mutant alleles is 
subsequently determined. If strains containing either wild type copies of the genes 
examined or single mutations grow but cells containing mutations in both of the 
genes die they are synthetic lethal. This phenotype can hint to a physical or 
functional interaction of the genes examined as the cell can compensate for mutation 
in one of the genes but not in both. Combination of bur1 temperature sensitive (ts) 
mutants with ts mutants of yra1 showed a SL phenotype (Fig. 7). Thus, the SL 
relationship of BUR1 could be extended to another component of the TREX complex.    
 
Figure 7: BUR1 is synthetic lethal with YRA1 
The BUR1 YRA1 shuffle strain was transformed with plasmids coding for either wild type copies of 
BUR1 or YRA1 or mutations in one of the genes or both. Transformants were restreaked on plates 
containing 5’-FOA and grown for 4 days. No growth in the double mutant strains shows a synthetic 
lethal interaction of these bur1 and yra1 alleles.  
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2.2. Bur1-2 and RPA interact biochemically 
To obtain deeper insight of the function of the Bur1-2 cyclin dependent kinase/cyclin 
complex, tandem affinity purifications (TAP) of Bur1-TAP and Bur2-TAP were 
performed to find in vivo interaction partners. 
2.2.1 Interaction of Bur1-2 with RPA 
Eluates of TAP purifications of Bur1-TAP and Bur2-TAP were analyzed by SDS 
PAGE, stained with Coomassie and the copurifying bands were analyzed by mass 
spectrometry. A stoichiometric Bur1 and Bur2 complex was obtained in both 
purifications. Substoichiometrically Rfa1, Rfa2 and Rfa3 as well as Rad52 could be 
identified as major interactors (Fig. 8 A and Sträßer, unpublished data) indicating that 
the Bur1-2 complex might also have a function in processes RPA is involved in. 
These processes could be DNA replication, recombination or repair. To also test if 
RPA is able to bind the BUR complex, Rfa1-TAP was purified. The untagged wt 
strain serves as a control for unspecific binding. Prt1 is a protein with a function in an 
unrelated process. It is part of the translation initiation factor eIF3 and as well serves 
as a control for unspecific protein binding. As the relative amount of RPA in the cell is 
much higher than the amount of BUR (about ten fold based on microscopy 
fluorescence intensity data, data not shown), only a small fraction of bound BUR 
complex was expected in the Rfa1-TAP purification. The BUR complex is not visible 
in the Coomassie staining but Western blot analysis using an antibody specific for 
Bur1 shows that it binds specifically to Rfa1 but is not detectable in control 
purifications. The second higher molecular weight band in the Rfa1- and Prt1-TAP 
cell extracts corresponds to the cross reaction of the secondary antibody with protein 
A from the TAP tag which is cleaved of for elution (Fig. 8 B).  
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Figure 8: Bur1-2 interact biochemically with RPA 
(A) Tandem affinity purifications of Bur1 and Bur2 from S. cerevisiae. Eluates were separated by 10% 
SDS PAGE and co-purifying proteins were analyzed by mass spectrometry. Bur1 and Bur2 bands are 
shifted to a higher molecular weight in the respective purification due to the tag. Rfa1 and Rfa2 were 
identified to interact with the BUR complex.  
(B) TAP purification of an untagged wt strain, Rfa1-TAP and Prt1-TAP. Cell extracts and eluates were 
separated by 12% SDS-PAGE, blotted and probed with an antibody directed against Bur1. Bur1 
copurifies specifically with Rfa1 but not with control purifications. (* The higher molecular weigh band 
in the cell extracts corresponds to the cross reaction of the secondary antibody with the TAP tag.)  
2.2.2 The C-terminus of Bur1 is unstructured and sufficient for binding to 
RPA 
Being interested in the interaction of the Bur1-2 and RPA complexes, the interaction 
was investigated in more detail. Secondary structure predictions of the Bur1 C-
terminus using PSIPRED (McGuffin et al., 2000) show that there is no predictable 
secondary structure in this part of Bur1 (Fig. 9 B). The N-terminal part of Bur1 shows 
homology to kinases, especially with cyclin dependent kinases (amino acids 1-365). 
This fragment of the protein will be referred to Bur1 kinase domain, whereas amino 
acids 365-657 will be referred to as Bur1 C-terminus. TAP purifications of the Bur1 
kinase domain did not result in Coomassie stainable amounts of protein and Western 
blot analysis shows that this part of the protein is much less expressed than the C-
terminal construct or full length Bur1 (data not shown). However, the C-terminus was 
TAP tagged, purified and shows interaction with Rfa1 and thus probably with the 
whole RPA complex, which was confirmed by mass spectrometry (Fig. 9 C). As 
expected the C-terminus did not bind to Bur2 which is consistent with other studies 
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showing that in cyclin dependent kinases the cyclin binds to the kinase domain to 
activate it (Baumli et al., 2008).  
 
 
 
Figure 9: Analysis of the Bur1 C-terminus. 
(A) Schematic showing the domain structure of Bur1. The N-terminal part shows homology to cyclin 
dependent kinases, the C-terminus does not show any significant homology. (B) Secondary structure 
prediction using PSIPRED. Starting form amino acid 400 no secondary structure can be predicted. (C) 
TAP purifications of full length Bur1 and the Bur1 C-terminus. The Bur1 C-terminus is sufficient for 
binding to Rfa1 and does not bind to Bur2.  
2.2.3 Mapping of the Bur1 and Rfa1 interaction site  
The aim of these experiments was to map the Bur1-RPA interaction site to generate 
a full length protein just containing a point mutation which inhibits the binding to RPA. 
This construct could then be used for further characterizing the functional significance 
of the interaction of both protein complexes in vivo. 
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2.2.3.1 Interaction site mapping using a GST Pulldown approach 
As no secondary structure for the C-terminus of Bur1 was predictable, a GST 
pulldown approach to identify possible binding sites was performed. To obtain first 
indications of the position of this binding sites, GST-tagged truncations of the Bur1 C-
terminus were expressed recombinantly in E. coli, purified with GSH sepharose and 
subjected to a binding assay using high salt washed TAP purified RPA from 
S.cerevisiea (Fig. 10). GST was used as a negative control for unspecific binding.  
 
 
Figure 10: Example of the GST Pulldown based Bur1-RPA binding assay 
Coomassie stained SDS-PAGE gel of the Bur1-RPA binding assay. GST tagged truncations of the 
Bur1 C-terminus were expressed in E. coli and purified using GSH sepharose. RPA was purified from 
S. cerevisiae using TAP tagged Rfa1 (lane 2). RPA was added (lane 4 and 6) or not, as negative 
control (lane 3 and 5), to the GST-bound Bur1 truncations. This figure shows fragments form amino 
acids 500-630 and 500-650. Both fragments were able to bind RPA. The asterisk (*) marks an 
unspecific protein originating from the E. coli expression.  
 
The first constructs (Fig. 11) expressed were truncated 50 amino acids from the C-
terminus (365-657, 365-600, 365-550, 365-500, 365-450, 365-400). The longest 
constructs bound RPA. The last construct that was still able to bind was ranging from 
amino acids 365-500 and the first construct not able to bind anymore was spanning 
amino acids 365-450. Thus, the binding site should be between amino acids 450 and 
500. To further narrow down this region new constructs were generated that were 
shortened by 10 amino acids in this region (365-490, 480, 470, 460). The longest one 
was able to bind weakly, the other ones were not able to bind, leading to the 
conclusion that the binding site is between amino acids 480 and 500. In addition, as 
control experiments, also N-terminal truncations were generated starting at amino 
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acids 460, 470, 480, 490 and 500 until 657. Surprisingly, all those constructs were 
still able to bind to RPA indicating that there is a second binding site in the more C-
terminal half of this domain.  
 
 
 
Figure 11: Summary of the binding abilities of fragments of the Bur1 C-terminus to RPA 
Shown is a schematic of the Bur1 C-terminus from amino acids 365-657. The lines below depict the 
recombinantly expressed parts of the Bur1 C-terminus from E. coli and their ability to bind to TAP 
purified RPA from S.cerevisiea. Two putative binding sites could be identified in initial experiments 
ranging from amino acids 480 to 500 as well as from amino acids 540-560. But when those sites were 
deleted the fragments were still able to bind. The smallest fragments sufficient for binding to RPA 
reach from amino acids 413-500 and from 500-570.   
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This second binding site could then also be narrowed down to 20 amino acids 
spanning an area between amino acids 540 and 560. Those two binding sites should 
then be verified using constructs to express only one part of the protein where one of 
the binding sites mapped and this binding site was deleted. For the first binding site 
the construct was ranging from amino acids 365-530 and either amino acids 480-490 
or 490-500 were deleted. Surprisingly, those constructs were again able to bind to 
RPA. The same approach was used for the second binding site. Constructs spanning 
from amino acids 510-657 missing either amino acids 540-550, 550-560 or 550-570 
were tested for the binding ability and were also able to bind. The smallest constructs 
that were still able to bind were ranging from amino acids 413-500 and from amino 
acids 500-570. There might thus be weaker binding sites or a specific folding of the 
C-terminal domain of Bur1 induced by the binding to RPA that are sufficient for the 
binding to RPA (Fig. 11). The results of this study were part of the Diploma thesis of 
Barbara Müller. 
2.2.3.2 Interaction site mapping using a peptide mapping approach 
As a second approach for detecting the interaction site of the Bur1 C-terminus with 
RPA, a peptide array was generated. Here, fifteen amino acid long peptides 
spanning the Bur1 C-terminus from amino acids 365-657 were synthesized, in 
collaboration with Georg Arnold, with an overlap of 12 amino acids so there was a 
shift of three amino acids between each peptide. Those peptides were immobilized 
on a cellulose membrane using the SPOT approach (Frank, 2002; Hilpert et al., 
2007).  
Purified RPA from S. cerevisiae could then be used to bind to this membrane and 
can subsequently be detected with an antibody to indentify the peptides necessary 
for binding.   
To have a detectable epitope for antibody binding after the purification, a TAP tag 
was generated consisting of Protein A and a Flag tag with a TEV cleavage site in 
between. Using this tag it is possible to purify a protein with those tags and detect the 
eluted protein afterwards using an α-Flag antibody (Fig. 12). (It can also be used to 
natively elute the protein after the two step purification natively by competition with 
the Flag peptide in a smaller volume than with the usual TAP protocol and thus 
achieving a higher concentration.)  
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Figure 12: Rfa1 TAP purification using a TAP tag consisting of Protein A and Flag. 
Rfa1 was C-terminally tagged with Protein A, a TEV cleavage site and a Flag epitope for eluting the 
native protein with a small tag for detection when bound to a peptide mapping membrane. The single 
purification steps were separated by SDS PAGE and stained with Coomassie. Additionally, they were 
subjected to Western blot analysis to test the detection with the α-Flag antibody. (* unspecific band, x 
Rfa1-FLAG-Protein A) 
 
The purified, Flag-tagged RPA complex from S. cerevisiae (high salt washed TEV 
eluate) was incubated for binding on the peptide array, detected with an antibody 
against the Flag-tag and a secondary antibody carrying a HRPO enzyme for 
detection using ECL. This approach lead to a low signal to noise ratio, indicating that 
the interaction of the Bur1 C-terminus with RPA is relatively weak (Fig.13 B). The 
possible binding sites ranged from amino acids 396-443, 498-524 and 594-650 
(Fig.14 D). 
A second approach that is normally used for the detection of discontinuous epitopes 
when mapping a binding site for an antibody with the peptide array was also used. 
Here, the purified RPA complex was first incubated with the peptide mapping 
membrane, washed and immobilized on a PVDF membrane by three subsequent 
blotting steps. The advantage of the immobilization is that also lower amounts of the 
protein can be detected by a Western blot like approach afterwards because Rfa1 
bound to the cellulose membrane is efficiently transferred and tightly bound to the 
PVDF membrane. This lead to a better signal to noise ratio than the “Far Western 
approach” (Fig.13 C). Here RPA bound almost the whole C-terminus of Bur1 (Fig.14 
E). The possible binding sites are ranging from amino acids 383-473 and 501-650.     
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Figure 13: Peptide mapping for Bur1--Cterminus/RPA interaction site mapping 
A peptide mapping approach was performed to map the interaction site of the Bur1 C-terminus with 
RPA. (A) Schematic representation of the peptides spotted onto the membrane. Peptides with a size 
of 15 amino acids were synthesized with a shift of 3 amino acids and spotted onto a cellulose 
membrane. (B) The membrane was incubated with Protein A-TEV purified, flag-tagged RPA directly 
and detected afterwards using antibodies against the Flag epitope and a secondary HRPO conaining 
antibody. The signal-to-noise ratio is relatively low. (C) For obtaining a better signal-to-noise ratio and 
detection of weaker interactions, the peptide mapping membrane was first incubated with RPA and 
blotted several times afterwards to transfer the bound protein to a PVDF membrane and immobilize it 
there. Detection with the corresponding antibodies is stronger and thus it is possible to detect weaker 
interactions. The two blots were done after each other. The fist one contains more protein but might 
also have more unspecific binding, the second one shows a more stringent representation.  
2.2.3.2 Comparison of the interaction site mapping approaches 
A comparison of the two methods used for the mapping of the Bur1 and RPA 
interaction sites was performed (Fig. 14). The smallest constructs that were still able 
to bind were ranging from amino acids 413-500 and from amino acids 500-570 
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(Fig.14 B). The GST pulldown based assay identified two binding sites ranging from 
amino acids 480 to 490 and from amino acids 540 to 560 (Fig.14 C). However, 
deletions of those sites in the Bur1 C-terminus were still able to bind to RPA. It 
seems likely that there are more, and probably weaker, binding sites that could not 
be detected using this assay. Using a peptide array approach most of the C-terminus 
was able to bind to RPA. The possible binding sites were ranging from amino acids 
396-443, 498-524 and 594-650 (Fig. 14 D), in the case of the direct “Far Western” 
approach and from amino acids 383-473 and 501-650 after blotting (Fig. 14 E). 
These results hint to the existence of several short binding sites that cooperate in 
binding. Surprisingly, those sites do not overlap in the different approaches. Thus, it 
is not possible to generate a non RPA-binding mutant of Bur1 that just contains a 
point mutation or small deletion without deleting the whole C-terminus.  
 
 
 
Figure 14: Comparison of the Bur1-RPA binding sites identified using the two approaches 
(A) Schematic representation of the Bur1 C-terminus ranging from amino acid 365-657. 
(B) The smallest fragments found in the GST pulldown approach that were sufficient for binding to 
RPA (amino acids 410-500 and 500-570). 
(C) Binding sites indentified in the GST pulldown (amino acids 480-500 and 540-560). 
(D) Binding sites indentified in the “Far Western” peptide mapping approach without blotting (amino 
acids 396-443, 498-524 and 594-650). 
(E) Binding sites indentified in the blot based peptide mapping approach (amino acids 383-473 and 
501-650). 
2.2.4 Deletion of the Bur1 C-terminus leads to sensitivity to DNA damage 
as well as to replication and transcription stress 
The C-terminus of Bur1 does not show homology to any other protein and is sufficient 
for binding to RPA. To further investigate the in vivo function of this domain, the Bur1 
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N-terminus, containing the kinase domain and the C-terminus were expressed in S. 
cerevisiae.  
The ability to complement for the Bur1 knock-out was tested using these constructs. 
The N-terminus alone carrying the kinase domain was sufficient for complementing 
∆bur1 with negligible growth impairment. The unstructured C-terminus was not able 
to rescue the deletion of BUR1 and is lethal, as well as the complete knock-out (Fig. 
15 A). However, it is interesting that deletion of the C-terminus and thus non-binding 
of RPA results in sensitivity of the cells to HU, 6’AU an MMS (Fig. 15 B), showing that 
the interaction of the BUR complex with RPA is needed for stress response.  
 
Figure 15: Deletion of the Bur1 C-terminus can complement for ∆bur1 but leads to sensitivity to 
stress.  
(A) Complementation studies of the deletion of BUR1. Full length plasmid encoded BUR1 as well as 
the kinase domain lacking the C-terminus can complement for ∆bur1. The Bur1 C-terminus alone as 
well as an empty plasmid can not. (B) Deletion of the Bur1 C-terminus leads to sensitivity of the cells 
to HU (100 mM), 6’AU (100 µg/ml) and MMS (0.035%). 
2.3. The interaction of Bur1 and RPA is most likely not conserved in 
human 
2.3.1 Cdk9 and RPA do not co-immunoprecipitate 
As S. cerevisiae Bur1 and RPA interact, experiments were performed to test if the 
human homolog, Cdk9, interacts with RPA. As a fist experiment, stably integrated, 
GFP-tagged Cdk9 (Röther, unpublished data) was purified from HeLa cells using a 
GFP binder matrix (Rothbauer et al., 2008). The eluate was subjected to SDS-PAGE 
and stained with Coomassie. Copurifying bands were analysed by mass 
spectrometry (Fig.16 A). Cdk9 was identified, showing that the purification worked. 
Most of the other proteins copurifying were heat shock proteins (HS90A, HS90B, 
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HSP7C). Neither RPA nor the corresponding cyclins could be identified. To have a 
more sensitive method to examine the interaction, Cdk9-GFP was purified and the 
fractions of the purification were subjected to Western analysis using antibodies 
directed against Cdk9 as control and against RPA32 to elucidate a putative 
interaction. Mock purification of wild type cells serves as a control for unspecific 
binding. Both proteins could be detected in the cell extracts and the flow-through of 
the purifications. However, in the Cdk9-GFP eluate only Cdk9 was detected and not 
RPA32 showing that the proteins most likely do not interact (Fig.16 B). This could be 
either due to non binding of the proteins or because RPA32 binds to a different 
isoform of Cdk9, Cdk9-55 (Shore et al., 2003). To test this, a reverse tagging strategy 
was used by purifying RPA32-GFP.  
 
Figure 16: Human Cdk9 and Cdk9-55 do not interact biochemically with RPA 
(A) Purification of GFP tagged Cdk9 from HeLa cells using GFP binder. Coomassie stained gel of the 
purification. Co-purifying bands were analyzed by mass spectrometry. Cdk9 itself could be indentified 
but not the corresponding cyclins. The other copurifiers are either heat shock proteins or unknown. (B) 
Pulldown of Cdk9-GFP using GFP binder. The different steps of the purification, whole cell extracts 
(WCE), Flow through (FT) and eluates (IP) were separated by SDS-PAGE and either Coomassie 
stained or subjected to western blotting and detection with a α-Cdk9 or an α-Rpa32 antibody. A clear 
enrichment of Cdk9 can be seen in the purification but Rpa32 can not be detected in the purification 
done under the same conditions as the yeast TAP purifications, in which Bur1 and RPA interact. (C) 
Purification of transiently expressed Rpa32-GFP using GFP binder. Here, also the insoluble fraction is 
shown (P). Rpa32 can be significantly enriched in the purification but no interaction with either Cdk9-
55 or Cdk9 can be detected by Western blotting.  
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It was shown that when RPA is immunoprecipitated with a α-RPA32 antibody the 
complex shows a constant ratio of the three subunits (Din SU and Stillman, Gendev 
1990). According to this, an affinity purification strategy using transiently expressed 
GFP tagged RPA32 was used to purify human RPA and test the association with 
Cdk9 or the Cdk9-55 isoform. The different steps of the purification, whole cell 
extracts (WCE), the insoluble pellet (P), flow-through (FT) and the eluate (IP) were 
subjected to SDS-PAGE and either Coomassie stained or analyzed by Western 
blotting. The Coomassie stain shows an enrichment of RPA32 in the eluate. Western 
blots, using antibodies directed against Cdk9-55 or Cdk9 show that the proteins are 
present in the different purification steps but not in the eluate (Fig. 16 C). Thus, 
neither Cdk9 nor Cdk9-55 was able to bind to human RPA.  
2.3.2 Cdk9 and RPA do not colocalize 
Another, independent approach, to test if Cdk9 and RPA bind was to examine the 
proteins by fluorescence microscopy in collaboration with Oliver Mortusewicz from 
the Leonhardt lab. It has been shown that hRPA forms foci in S-Phase (Coverley and 
Laskey, 1994) as well as after induction of DNA damage. HeLa cells expressing 
GFP-Cdk9 were treated with NCS or HU for four hours. The cells were fixed and co-
localisation of Cdk9 with RPA examined. RPA forms foci after the treatment whereas 
GFP-Cdk9 stays diffuse in the nucleus and thus does not colocalize. Colocalisation of 
Cdk9 with the repair histone variant γ-H2AX as well as with microirradiation sites of 
DNA damage was also not detectable (data not shown).  
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Figure 17: Cdk9-GFP and Rpa32-RFP do not colocalize after DNA damage or replication stress 
HeLa cells expressing stably integrated Cdk9-GFP were treated with Neokarzinostatin to induce DSBs 
or with HU for inducing single or double strand breaks during DNA replication. Fixed cells were 
analyzed by fluorescence microscopy. RPA shows a punctuate staining after the treatment whereas 
Cdk9 stays diffuse showing no specific interaction of both proteins.  
2.4. BUR1 and RFA1 interact genetically 
2.4.1 Generation of BUR1 and RFA1 temperature sensitive mutants 
To have a tool for a conditional knockout and for allele specific genetics, temperature 
sensitive mutants of BUR1 (Sträßer, unpublished data) and RFA1 were generated by 
hydroxylamine mutagenesis. As can be seen in Fig.18, those mutants grow like wild 
type when incubated at 30°C just bur1-24 and rfa1-249 are already slightly impaired 
in growth. When grown at 37°C the mutations become lethal.  
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Figure 18: BUR1 and RFA1 temperature sensitive mutants 
Growth of temperature sensitive mutants of BUR1 and RFA1 generated by random mutagenesis. The 
growth of those mutants is not or only slightly impaired at 30°C. Upon shift to the restrictive 
temperature of 37°C mutants show no growth anymore.  
 
To see if the stability and expression of the mutants generated was still comparable 
to the wild type, Western blots of whole cell extracts from either wild type cells or 
cells that contain the mutant allele were performed using an antibody generated 
against the C-terminus of Bur1. The expression of the bur1-1, bur1-4 and bur1-7 
mutants is the same compared to the wild type, just bur1-24 that contains a 
premature stop codon, is expressed at lower levels or has a size of about 15 kDa that 
is not resolved on this gel. This protein would be non functional as the kinase domain 
is only partly expressed. Still, it seems to have basal activity as the cells survive at 
30°C. The wild type protein shows a double band most likely corresponding to the 
phosphorylated form of the protein modified by CAK1 (Yao and Prelich, 2002) that is 
absent in the temperature sensitive mutants. The expression levels do not change 
upon shift to 37°C for 3 hours. Pgk1 serves as the loading control (Fig. 19).  
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Figure 19: Expression and stability of Bur1 non- and TAP tagged temperature sensitive 
mutants  
Expression of the bur1 ts mutants was determined with western blots using an antibody directed 
against Bur1. The ts mutants are expressed to the same level as wt expression, except for bur1-24 
which is expressed in much lower amounts or much smaller. The temperature shift to 37°C was 
performed for 3 hours. Notably, the bur1 mutants do not show the second higher molecular weight 
band which most likely corresponds to the phosphorylated form of Bur1 modified by CAK1 (Yao and 
Prelich, 2002). Pgk1 is used as a loading control. 
 
Also the expression of the rfa1-249 mutant was tested by Western blotting, using an 
antibody against Rfa1 (Brill and Stillman, 1991). It is the same as in the wild type 
(Fig. 20). Expression at 37°C was not determined, but the expression does not 
change upon treatment with MMS (data not shown).  
 
Figure 20: Expression and stability of the rfa1-249 temperature sensitive mutant 
Expression of the rfa1-249 mutant was assayed by Western blotting using an antibody directed 
against Rfa1 (Brill and Stillman, 1991).The expression and stability is comparable to the wild type 
level. Pgk1 serves as the loading control. 
2.4.2 bur1 mutants are sensitive to DNA damage and to replication and 
transcription stress 
Knowing that BUR and RPA interact biochemically lead to the idea of a function of 
the BUR complex in DNA replication, recombination and repair. To further investigate 
a function in one of these processes bur1 mutants were subjected to drugs inducing 
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DNA damage (MMS) or replication stress (HU) or to an agent impairing transcription 
elongation (6’AU) (Fig. 21). Mutations in BUR1 lead to sensitivity to replication stress 
induced by hydroxyurea when grown at semi permissive temperature of 33°C. The 
bur1-1 and bur1-4 mutations are only slightly sensitive whereas the bur1-7 and bur1-
24 can not survive at a concentration of 100 mM and thus show a strong phenotype. 
The same phenotype can be seen for MMS at a concentration of 0.035%, a drug that 
causes DNA damage, indicating that BUR1 might have a function in DNA repair. 
Other transcription elongation factors like DST1 do not show this phenotype (data not 
shown). It is interesting to note that these BUR1 mutants, except for bur1-24, are only 
slightly sensitive to 100 µg/ml 6’-Azauracil, a drug that impairs transcription 
elongation (Fig.21 6’AU).  
 
Figure 21: BUR1 mutants are sensitive to replication stress, DNA damage and impairment of 
transcription elongation.  
 BUR1 mutants are sensitive to drugs that induce replication stress (100 mM HU) or DNA damage 
(0.035% MMS) as well as transcription impairment (100 µg/ml 6’AU). The bur1-1 and bur1-4 mutations 
show only a slight impairment. The bur1-7 and bur1-24 are strongly impaired by HU and MMS and can 
not compensate for replication stress and DNA damage. The bur1-24 mutation is also strongly 
sensitive to 6’AU. It is interesting to note that the other three BUR1 mutant are not or only slightly 
sensitive to the transcription elongation impairment. 
2.4.3 A rfa1 mutant is sensitive to drugs impairing transcription 
elongation 
The interaction of Bur1 and RPA also suggests a function of RPA in transcription.  To 
get first indications for this, RFA1 mutants were subjected to drugs inducing DNA 
damage (MMS) or replication stress (HU) or to an agent impairing transcription 
elongation (6’AU). A mutation, rfa1-249,  in the RFA1 gene, the biggest subunit of 
RPA, shows growth impairment on replication stress (100mM HU) and DNA damage 
(0.01% MMS) as well as on transcription impairment (100 µg/ml) showing that this 
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mutant might have a function in DNA replication, DNA repair and most interestingly in 
transcription elongation (Fig.22). 
 
 
 
Figure 22: A rfa1 mutant is sensitive to replication stress, DNA damage and impairment of 
transcription elongation.  
 The rfa1-249 mutant is sensitive to drugs that induce replication stress (100 mM HU) or DNA damage 
(0.01% MMS) and most interestingly to transcription impairment (100 µg/ml 6’AU).  
2.4.4 Mutations in bur1 suppress the sensitivity of rfa1 mutants 
Bur1 and RPA interact biochemically and mutations in both of the genes lead to 
sensitivity of the cells to replication stress, DNA damage and impairment of 
transcription elongation. Due to these findings the genetic interaction of bur1 mutants 
and rfa1 mutants was examined. A BUR1 RFA1 shuffle strain was created and 
transformed with plasmids that encode for either, BUR1 wild type or a bur1 mutation 
as well as a RFA1 wild type or a rfa1 mutation, respectively, to create strains having 
either wild type genes, mutations in one gene or double mutants. The URA3 wt 
plasmids were shuffled out by restreaking transformants on plates containing 5’-FOA. 
The resulting yeast strains were spotted on plates with full media or full media 
containing Hydroxyurea (50 mM HU), Methylmethanesulfonate (0.005% MMS) or 6’-
Azauracil (10 µg/ml 6’AU). Growth was analyzed after three days at 30°C. The single 
mutant strains show sensitivity to these drugs but interestingly, strains that had both 
mutations were growing better showing that the mutants suppress each other and 
hinting to antagonistic roles of the BUR1 and RFA1 genes (Fig. 23).  
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Figure 23: Suppression of rfa1 mutant phenotype by mutation of bur1  
Growth impairment of both, the rfa1 and the bur1 mutant is detectable on plates containing drugs that 
induce replication stress (50 mM HU) or DNA damage (0.005% MMS) as well as to transcription stress 
(10 µg/ml 6’AU). The rfa1 mutant shows a stronger sensitivity than the bur1 mutant. Noteworthy, 
combination of both mutants leads to better growth, showing that these cells can compensate for the 
stress and indicating a specific in vivo interaction of both proteins. As mutations compensate for each 
other we conclude that BUR1 and RFA1 might have antagonistic functions.  
2.5 Role of BUR1 in DNA repair 
2.5.1 Epistasis and SL of BUR1 with mutants in DNA repair pathways 
As there were indications for Bur1-2 having a role in DNA repair, an epistasis 
analysis was performed, with the aim to identify the pathway the BUR complex is 
involved in.  
Epistasis is an interaction between two genes. In the case of DNA repair, one would 
expect that upon the knockout of a specific pathway, deletion or mutation of an 
additional gene in the same pathway would not lead to an increased sensitivity to 
DNA damage as this pathway is already not functioning. If an additional impairment is 
visible, the conclusion is that another DNA repair pathway is affected and the 
sensitivities add up from the first and the second pathway. 
For this analysis, double shuffle strains with deletions of distinct non-essential DNA 
repair pathway genes and BUR1 were created. These strains were transformed with 
bur1 mutants and either the repair pathway deletion was covered with the wild type 
plasmid as control experiment or not. The cells carrying combinations of a bur1 
mutation and a repair pathway deletion were subjected to DNA damage, for example 
by UV irradiation or MMS. UV irradiation leads to CC dimers, a bulky lesion, and 
MMS alkylates DNA. The sensitivity of these strains to DNA damage was determined 
either by 10-fold serial dilutions of cells on plates containing the damage inducing 
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compound or quantified by counting cells which were plated out in a defined amount 
and subjected to different concentrations of MMS or different doses of UV irradiation.  
If BUR1 had a function in a specific pathway one would expect to see that the double 
mutant grows like the deletion of this pathway as this specific pathway is not 
functional anymore and thus the bur1 mutation can not have an additional effect. If 
the double mutant strain grows worse than the deletion of the specific DNA repair 
pathway one can conclude that the additive effect of this specific pathway deletion 
and bur1 argues for an additional effect of bur1 from a different pathway than the one 
examined.  
Several non essential deletions of DNA repair pathways have been chosen for the 
analysis: RAD52, needed for homologous recombination (Krogh and Symington, 
2004), MSH6 functions in MMR and is involved in the recognition of mismatches 
(Bowers et al., 1999), POL4 is involved in DSB break repair via NHEJ (Tseng and 
Tomkinson, 2004), RAD16 forms a complex with RAD7 and is involved in the DNA 
damage recognition in NER (Guzder et al., 1997), RAD26 is responsible for TCR (Li 
and Smerdon, 2002). RAD16 and RAD26 functions partly overlap in both pathways, 
NER and TCR (Verhage et al., 1996). XRS2 is part of the MRX complex needed for 
DSB break repair (Assenmacher and Hopfner, 2004), MAG1 is a glycosylase needed 
for damage recognition in BER and APN1 an endunclease also functioning in BER 
(Memisoglu and Samson, 2000). RNR1 is a subunit of ribonucleotide-diphosphate 
reductase, catalyzing dNTP synthesis and regulating DNA replication and damage 
checkpoint pathways (Yao et al., 2003). 
2.5.1.1 BUR1 is synthetic sick with RAD52 but not epistatic 
Epistasis of bur1 mutants was tested with RAD52. RAD52 is known to have a 
function in double strand break (DSB) repair by homologous recombination (Fig.23).  
The analysis of BUR1 and RAD52 shows two phenomena. On the one hand bur1 
mutants are already impaired in growth with the additional deletion of RAD52 without 
the subjection to DNA damage. This can be seen slightly at 30°C and becomes 
stronger at 33°C. This synthetic sickness leads to the conclusion that BUR1 and 
RAD52 have a functional overlap without DNA damage and thus might act in the 
same pathway, e.g. in telomere maintenance. On the other hand as soon as the cells 
are challenged with DNA damage the double mutant strains grow significantly slower 
excluding the homologous recombination branch of DSB repair as the pathway BUR1 
functions in (Fig. 24).  
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Figure 24: BUR1 is not epistatic with RAD52 but synthetic sick 
(A) Ten-fold serial dilutions of strains carrying bur1 mutations and a deletion of RAD52 either covered 
with a wild type or empty plasmid were spotted on plates containing no drug or MMS. The bur1 
mutants are only slightly sensitive when subjected to MMS at 30°C and show higher sensitivity at 
33°C. Interestingly, the bur1 mutants are synthetic sick with ∆rad52 without DNA damage. After 
induction of damage by MMS the double mutants are much sicker than the single ones, excluding 
DSB repair by homologous recombination as the pathway BUR1 acts in. (B) Quantification of the MMS 
sensitivity. At 0.05% MMS the double mutants becomes more sensitive than the deletion of RAD52. 
(C) Ten-fold serial dilutions of the strains also show higher sensitivity of the double mutant strains to 
UV irradiation. This can be seen especially with the bur1-7 mutation at 33°C. (D) Quantification of the 
UV survival rates also shows that combination of bur1-7 or bur1-24 with the deletion of RAD52 leads 
to a stronger sensitivity than deletion of RAD52 alone. This indicates that BUR1 does not have a 
specific function in DSB repair but in another DNA repair pathway and thus gives an additive effect to 
the deletion of RAD52.  
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2.5.1.2 BUR1 is not epistatic with MSH6 
To investigate the function of BUR1 in mismatch repair (MMR) epistasis was tested 
between BUR1 and MSH6 (Fig. 25). The bur1 mutants, especially bur1-7 and bur1-
24 are more sensitive that the deletion of MSH6. Also the double mutants grow worse 
than ∆msh6, giving an additional effect of bur1 mutations to the deletion of MSH6.  
Consequently, a function of BUR1 in mismatch repair was excluded. 
 
Figure 25: BUR1 is not epistatic with MSH6 
(A) Ten-fold serial dilutions of strains carrying a bur1 mutation and a deletion of MSH6 were spotted 
on plates containing no drug or MMS. After induction of damage by MMS the double mutants and the 
bur1 mutants are sicker than the deletion of MSH6. Thus bur1 mutants are more sensitive to DNA 
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damage than the deletion of the mismatch repair component MSH6 excluding a function of BUR1 in 
mismatch repair. (B) Quantification of the MMS sensitivity. At 0.2% MMS the double mutants becomes 
more sensitive than the deletion of MSH6 alone. This effect is only slightly visible and is more 
pronounced at higher concentrations of MMS. (C) Ten-fold serial dilutions of the strains also show 
higher sensitivity of the double mutant and bur1 mutant strains to UV irradiation. This can be seen 
especially with the bur1-7 mutation at 33°C. (D) Quantification of this effect also shows that the 
combination of bur1-7 with the deletion of MSH6 is much more sensitive than deletion of MSH6. This 
indicates that BUR1 does not have a specific function in mismatch repair but in another DNA repair 
pathway and thus gives an additive effect to the deletion of MSH6. 
2.5.1.3 BUR1 is not epistatic with POL4 
The genetic interaction of BUR1 mutants with POL4 was also determined. POL4 
mediates DSB repair by the non-homologous end joining (NHEJ) pathway (Fig. 26).  
The sensitivity of the BUR1 mutants, especially of the bur1-7 mutant, as well as the 
bur1-7 ∆pol4 double mutant show stronger sensitivity than the deletion of POL4, 
indicating that the effect of BUR1 is different from the one from POL4 and thus 
excludes NHEJ as the process the BUR complex functions in.  
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Figure 26: BUR1 is not epistatic with POL4 
(A) Ten-fold serial dilutions of strains carrying bur1 mutants and a deletion of POL4 that was 
transformed either with a plasmid coding for the wild type gene or an empty plasmid, were spotted on 
plates containing no drug, MMS or were irradiated with UV. After induction of damage by MMS or UV 
the double mutants and the bur1 mutants are much sicker than the deletion of POL4. Thus bur1 
mutants are more sensitive to DNA damage than the deletion of the non-homologous end joining 
deletion POL4 excluding a function of BUR1 in NHEJ. (B) Quantification of the UV sensitivity. Already 
at 3J/m2 the double mutants becomes more sensitive than the deletion of POL4. The strongest 
phenotype is visible in the bur1-7 mutant. (C) Quantification of the MMS sensitivity also shows that the 
combination of the bur1 mutants with the deletion of POL4 are more sensitive than deletion of POL4 at 
0.2% MMS. This indicates that BUR1 does not have a specific function in DSB repair b NHEJ but in 
another DNA repair pathway and thus gives an additive effect to the deletion of POL4. 
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2.5.1.4 BUR1 is not epistatic with RAD16 
To examine a possible function of BUR1 in nucleotide excision repair (NER) strains 
were created with a deletion of BUR1 and RAD16 (Fig. 27). 
Mutations in the BUR1 gene are as sensitive as deletion of the RAD16 gene upon 
treatment with MMS or HU at 30°C. When grown at 33°C the bur1-7 mutant and also 
the double mutants become more sensitive than ∆rad16. The same phenotype can 
be seen when cells are UV irradiated. The bur1-7 mutation is more sensitive than the 
deletion of RAD16. In the quantification only bur1-7 shows high sensitivity but not the 
bur1-7 ∆rad16 mutation. This is not expected and most likely due to revertants in this 
strain that are then behave like the wild type. The results from the dot spot analysis 
shows that the function of BUR1 is in a pathway different from NER. Additionally, as 
the bur1-7 mutant is more sensitive to UV irradiation than ∆rad16 the same 
conclusion can be drawn from the quantification. 
 
Figure 27: BUR1 is not epistatic with RAD16 
(A) Ten-fold serial dilutions of strains containing bur1 mutations and a deletion of RAD16 either 
covered with a wild type RAD16 containing or empty plasmid were spotted on plates containing no 
drug, MMS or HU. The bur1 mutants are sensitive when subjected to MMS at 30°C and show higher 
sensitivity at 33°C. Especially on 33°C the bur1 mutants and the double mutants show a stronger 
sensitivity that the deletion of RAD16. After induction of damage by MMS or HU the double mutants 
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are much sicker than the single ones thus excluding NER as the pathway BUR1 acts in specifically. 
(B) Ten-fold serial dilutions of the strains also show higher sensitivity of the BUR1 and double mutant 
strains to UV irradiation. (C) Quantification of this effect also shows that especially the bur1-7 mutant 
is very sensitive to UV irradiation. As it is more sensitive than the deletion of RAD16 a specific function 
of BUR1 in NER was excluded. 
2.5.1.5 BUR1 is not epistatic with RAD26 
The RAD26 gene was identified in yeast for having a role in transcription coupled 
repair (TCR). To elucidate a possible function of BUR1 in this process, double 
mutants were generated and tested for their epistatic behaviour (Fig. 28).  
The deletion of RAD26 is not sensitive to MMS or HU. Compared to this the bur1-7 
and bur1-24 mutants used in this assay, are far more sensitive than the deletion of 
RAD26. Also the double mutant strain behaves as the bur1 mutant. No or only slight 
differences in strains carrying those mutations were detected after UV irradiation. As 
the bur1 mutations show a higher sensitivity than the deletion of RAD26, BUR1 is 
most likely not involved in TCR.  
 
Figure 28: BUR1 is not epistatic with RAD26 
Ten-fold serial dilutions of strains containing bur1 mutations and a deletion of RAD26 either covered 
with a wild type RAD26 containing or empty plasmid were spotted on plates containing no drug, HU, 
MMS or were irradiated with different doses of UV. Here, only bur1-7 and bur1-24 were tested as they 
show the strongest sensitivity. The bur1 mutants are sensitive when subjected to HU and show only 
slight sensitivity to MMS and UV irradiation at 30°C but it is enhanced at 33°C. Especially on 33°C the 
bur1 mutants and the double mutants show a stronger sensitivity that the deletion of RAD26. As the 
bur1 mutants and the double mutants are sicker than the deletion of RAD26, TCR was excluded as 
the pathway BUR1 acts in.  
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2.5.1.6 BUR1 is not epistatic with RAD16 and RAD26 double mutants 
It has also been shown that additional deletion of RAD16 to the deletion of RAD26 
makes cells more sensitive to UV irradiation when the TCR pathway is knocked-out 
in addition to the NER pathway (Verhage et al., 1996). To see the impact of a 
deletion of both pathways also ∆rad16 ∆rad26 cells were tested for their epistatic 
behaviour with BUR1 (Fig. 29).  
 
Figure 29: BUR1 is not epistatic with a RAD16 RAD26 double deletion 
Ten-fold serial dilutions of strains that were deleted of BUR1, RAD16 and RAD26 and transformed 
with combinations of plasmids encoding either wild type BUR1 of bur1-7, RAD16, RAD26 to cover the 
deletion or an empty plasmid to see the phenotype of the knockout, were subjected to UV irradiation. 
The additional deletion of a NER component in the RAD26 deletion strain is supposed to show a 
stronger phenotype than the deletion of RAD26 alone. Here both strains do not show sensitivity to UV 
irradiation but the combination of those deletions with bur1-7, especially at 33°C, shows a stronger 
sensitivity to UV damage. We conclude that BUR1 does not act specifically in TCR because it gives an 
additive effect to the RAD16 and RAD26 knockouts pointing to an additional impairment in a different 
DNA repair pathway.  
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No additional UV sensitivity could be observed in the ∆rad16 ∆rad26 double mutant 
strains compared to the wild type in dot spot analysis, even though it was shown in 
quantifications of the UV survival (Verhage et al., 1996). At 30 °C all strains behave 
the same way in regard to the survival upon UV irradiation. When grown at 33°, 
semipermissive temperature, a clear impairment is visible when the bur1-7 mutation 
is introduced. Cells grow already slower without irradiation but there is no difference 
in growth when either plasmid encoded RAD16 of RAD26 or both were reintroduced 
into the cells. Those strains also show sensitivity to UV irradiation compared to the 
untreated cells. As the bur1 mutant shows a stronger sensitivity to UV irradiation than 
the ∆rad16, ∆rad26 single and double mutation, a function of BUR1 in TCR was 
excluded also when NER is impaired. 
2.5.1.7 BUR1 is not epistatic with XRS2 
XRS2 is a component of the Mre11-Rad50-Xrs2 complex needed for DSB repair. 
MMS sensitivities of genomically integrated bur1-7 and ∆xrs2 as well as the double 
mutant were compared (Fig. 30). The deletion of XRS2 has a strong impairment in 
compensation of DNA damage. Compared to this the bur1-7 mutation is much less 
sensitive. But the double mutants are more sensitive than the deletion of XRS2 alone 
showing that BUR1 is not involved in DSB repair. It shows a stronger sensitivity and 
thus an additive effect arguing for impairment in a different repair pathway that is hit 
by the bur1-7 mutation. 
 
Figure 30: BUR1 is not epistatic with XRS2 
Ten-fold serial dilutions of strains carrying the bur1-7 allele genomically integrated and a deletion of 
XRS2, either covered with a wild type XRS2 encoding or empty plasmid were spotted on plates 
containing no drug or different concentrations of MMS. Here only bur1-7 was tested because it shows 
the strongest sensitivity. The bur1-7 mutant is sensitive when subjected to MMS already at 30°C and 
more severely affected at 33°C. The bur1-7 ∆xrs2 double mutant is clearly more sensitive than the 
single mutants showing that BUR1 does not function in DSB repair.   
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2.5.1.8 BUR1 is not epistatic with APN1 
To elucidate a possible function of BUR1 in base excision repair (BER), strains were 
created with a deletion of BUR1 and APN1 (Fig. 31). 
The bur1 mutants and APN1 deletion showed no sensitivity upon MMS treatment at 
30°C. However, as soon as the cells were grown at semipermissive temperature the 
bur1-7 mutant and slightly also the bur1-1 mutant as well as the corresponding 
double mutant strains are more sensitive than the deletion of APN1 (Fig. 31 A). No 
sensitivity of the strains was visible in the quantification upon UV irradiation (Fig. 31 
B). This is most likely due to a too low irradiation dose. At a higher dose the 
differences should be visible. The bur1-7 and bur1-24 mutants also show a higher 
sensitivity to HU at 30°C and 33°C than the APN1 deletion. Additionally, bur1-7 
shows a slight sensitivity to Camptothecin, a drug that inhibits nucleic acid synthesis 
and induces DNA strand breaks, (Hsiang et al., 1985) at 33°C (Fig. 31 C). 
Quantification of the MMS sensitivity also shows that bur1-7 ∆apn1 double mutants 
are more sensitive then the deletion of APN1 (Fig. 31 D). This additive phenotype 
excludes a function of BUR1 in BER.  
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Figure 31: BUR1 is not epistatic with APN1 
(A) Ten-fold serial dilutions of strains carrying bur1 mutations and a deletion of APN1 were spotted on 
plates containing no drug or MMS. After induction of damage by MMS the double mutants and the 
bur1 mutants are sicker than the deletion of APN1. Thus, bur1 mutants are more sensitive to DNA 
damage than the deletion of the base excision repair gene APN1, excluding a function of BUR1 in 
BER. (B) Quantification of the UV sensitivity. No difference could be observed in the sensitivity to UV 
irradiation between bur1 ∆apn1 and ∆apn1. This is most likely due to a too low UV dose. Phenotypes 
could thus only be observed at higher doses. (C) Ten-fold serial dilutions of the bur1-7 and bur1-24 
mutants with deletion of APN1. The bur1 mutants, as well as the double mutants are more sensitive 
than the deletion of APN1. (D) Quantification of the MMS sensitivity. At 0.2% MMS the bur1-7 ∆apn1 
double mutant becomes more sensitive than the deletion of APN1. These additive sensitivities exclude 
a function of BUR1 in BER. 
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2.5.1.9 BUR1 is not epistatic with MAG1 
To investigate a function of BUR1 in direct reversal of the alkylated site, strains were 
created with a deletion of BUR1 and MAG1. 
Growth of those strains on plates containing MMS shows that the bur1-7 mutant and 
the bur1-7 ∆mag1 double mutant show a stronger sensitivity than the deletion of 
MAG1 at 33°C and slightly on 30°C (Fig.32 A). Quantification of the UV sensitivity 
also shows a stronger effect for the bur1-4 ∆mag1 and bur1-7 ∆mag1 double 
mutants than deleting only MAG1 (Fig.32 B). These additive effects exclude a 
function for BUR1 in the direct reversal of alkylated sites. 
 
Figure 32: BUR1 is not epistatic with MAG1 
(A) Ten-fold serial dilutions of strains containing bur1 mutations and a deletion of MAG1 that was 
transformed either with a plasmid encoding for the wild type gene or an empty plasmid were spotted 
on plates containing different concentrations of MMS. After induction of damage by MMS the bur1-7 
and bur1-7 ∆mag1 double mutants are sicker than the deletion of MAG1. This phenotype is stronger 
at 33°C. (B) Quantification of the UV sensitivity. At 50 J/m2 the bur1-4 and bur1-7 double mutants 
become more sensitive than the deletion of MAG1 alone. Thus bur1 mutants are more sensitive to 
DNA damage than the deletion of the base excision repair factor MAG1, excluding a function of BUR1 
in BER. 
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2.5.1.10 BUR1 is not epistatic with RNR1 
To investigate a possible function of BUR1 in DNA replication, epistasis was tested 
with RNR1.  
The deletion of RNR1 does not show sensitivity to MMS, HU and Camptothecin. In 
comparison, the bur1-7 and bur1-24 as well as the double mutants with ∆rnr1 show a 
stronger sensitivity to MMS and especially to HU. The phenotype on plates 
containing MMS is visible at 33°C, semipermissive temperature, whereas on HU the 
stains containing a mutation in BUR1 show the sensitivity already at 30°C. No 
sensitivity of these strains could be observed on Camptothecin (Fig. 33 A). 
Quantification of the UV sensitivity shows, that combination of bur1 mutants with the 
deletion of RNR1 leads to an increased sensitivity of UV irradiation (Fig. 33 B). The 
quantification of the MMS sensitivity shows an additive effect for the bur1-1 and bur1-
7 mutant when combined with ∆rnr1, bur1-24 was not determined (Fig. 33 C). The 
additive effect between BUR1 and RNR1 excludes a function in DNA replication. 
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Figure 33: BUR1 is not epistatic with RNR1 
(A) Ten-fold serial dilutions of strains carrying bur1 mutants and a deletion of RNR1 that were 
transformed either with a plasmid containing the wild type gene or an empty plasmid were spotted on 
plates containing different concentrations of MMS, HU or Camptothecin. Only the bur1-7 and bur1-24 
alleles were tested because they show the strongest sensitivity. After induction of damage the bur1-7 
and bur1-7 ∆rnr1 as well as the bur1-24 and bur1-24 ∆rnr1 double mutants are sicker than the 
deletion of RNR1 alone on MMS and HU. This phenotype is stronger at 33°C. Thus, BUR1 mutants 
are more sensitive to DNA damage than the deletion of RNR1, excluding a function of BUR1 in DNA 
replication. (B) Quantification of the UV sensitivity. The bur1 ∆rnr1 double mutants are more sensitive 
to UV irradiation than the deletion of RNR1 alone showing that there is another pathway affected 
besides DNA replication and indicating that BUR1 functions in a different pathway. (C) Quantification 
of the MMS sensitivity. Mutation of BUR1 in addition to the deletion of RNR1 leads to stronger 
sensitivity and thus to an additive effect.  
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2.6. Screening for high-copy suppressors of bur1 ts mutants 
In order to find genes that have a similar function as BUR1, a high copy suppressor 
screen was performed. The principle is depicted in Fig. 34 A. Cells carrying a 
mutation that leads to a lethal phenotype, here the bur1-1 and bur1-7 temperature 
sensitive mutations grown at 37°C, are transformed with a library containing each 
yeast gene on a high copy plasmid. Genes that have a similar function as the 
mutated one compensate its function when highly expressed and therefore lead to 
growth of the cells. Transformants were grown for ten days at 37°C and the plasmids 
in the colonies that were able to grow again were isolated, checked for BUR1 or 
BUR2 as insert by restriction digest and retransformed into the bur1-7 or bur1-1 
strain to verify the suppression phenotype. If it showed the suppression again the 
plasmid was sequenced. Both, BUR1 and BUR2 were identified in the screens 
showing that the screen worked. The new high copy suppressors identified were 
involved either in cell cycle regulation, PKC1 signalling or cell wall integrity.  
The cell cycle regulatory genes are CLN2, a G1 cyclin that activates Cdc28 and 
regulates the transition from G1 to S phase (Nasmyth, 1996) and WHI3, a RNA 
binding protein that sequesters the CLN3 mRNA, which was published to suppress 
the deletion of BUR1 when hyperactive (Irie et al., 1991) and may be a upstream 
regulator of CLN1 and CLN2 (Tyers et al., 1993). It can also retain CDC28 to the 
cytoplasm and thus negatively regulates the cell cycle for the fulfilment of the critical 
cell size before transition of G1 to S phase (Wang et al., 2004). HSL1 is a protein 
kinase needed for the phosphorylation and degradation of SWE1 (McMillan et al., 
1999), a kinase that regulates G2/M transition and inhibits CDC28, was also found 
among the cell cycle regulatory suppressors.  
The second group of genes is involved in PKC1 signalling. First of all, PKC1, a 
protein kinase involved in cell wall integrity, cell cycle and cytoskeleton dynamics 
(Heinisch et al., 1999) was discovered. The other identified candidates, that are 
involved in this pathway are WCS2, a sensor of cell wall integrity and activator of the 
stress induced PKC1 pathway (Verna et al., 1997) as well as SLG1 also acting 
upstream of PKC1 (Jacoby et al., 1998). Two other suppressors, RHO2, a GTPase 
that negatively regulates ROM1, and ROM1 that is SL with ROM2, a GDP/GTP 
exchange factor could be found. RHO1 and ROM2 are also needed upstream of 
PKC1 in cell wall integrity signalling (Philip and Levin, 2001). SIA1 is an unassigned 
gene that is described to be an activator of the H+-ATPase on glucose and thus also 
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is needed for osmotic regulation (de la Fuente et al., 1997) and SKT5, an activator for 
chitin synthase III (Trilla et al., 1997). 
An involvement of BUR1 in PKC1 signalling and cell wall integrity is further 
strengthened by two observations: First, bur1-1 and bur1-4 temperature sensitivity 
can be rescued when the cells were grown on plates containing 1M sorbitol as an 
osmotic stabilizer (data not shown). Second, Bur1 might phosphorylate Ste20, a MAP 
kinase kinase kinase that is acting in Pkc1 signalling (see Bur1 substrate finding).  
 
 
Figure 34: High copy suppressor screen of bur1-7 temperature sensitive mutant 
(A) Schematic showing the principle and workflow of a high copy suppressor screen.  
(B) Overview of the suppressors found in the bur1-7 screen at 37°C. Most of the suppressors act 
either in cell cycle, PKC1 signalling or the cell wall integrity pathway. Noteworthy, those suppressors 
can not rescue the sensitivity to HU and thus might not be applicable to explain the function of BUR1 
in DNA damage or replication stress.  
 
The high copy suppressor candidates from both screens, from bur1-1 and bur1-7 
could also suppress the other mutation, respectively. Non of them was able to 
suppress the deletion of BUR1 (not shown).  
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Other cell cycle regulatory genes, like CDC28, CLB1, CLB6 and CLN3 were also 
tested in a defined way but did not suppress the bur1 mutants (data not shown). 
Screens on MMS and HU were also performed to identify DNA damage or replication 
suppressors of BUR1 mutants but did not lead to the identification of candidates.  
2.7. Screening for in vitro substrates of Bur1 kinase 
To identify the substrate of Bur1 kinase assays were performed. Two approaches 
were chosen (Fig. 35).  
In the first one, putative substrates were tested in a defined manner by TAP purifying 
them and testing with an in vitro kinase assay.  
The second one was a whole proteome approach using Protoarrays, protein arrays 
carrying 4088 yeast ORFs expressed as GST-6xHIS fusion proteins (Kung and 
Snyder, 2006) that can serve as substrates for phosphorylation.  
 
Figure 35: Two approaches for identifying substrates for Bur1 kinase 
(A) An example of an in vitro kinase assay is shown. The putative substrates, Dbf4 and Msh2 were 
TAP purified and incubated either with a mock purification, BUR, BUR and RPA or BUR, RPA and 
activated DNA. Bands marked with (x) are an example for an unspecific phosphorylation as they are 
also detectable in the first lane that was just incubated with a mock purification. Bands marked with (*) 
show the auto-phosphorylation of Bur1.   
(B) Identification of Bur1 substrates using Protoarrays. Phosphoimager scan of a Protoarray incubated 
with Bur1 and a representative cut-out from the analysis using GenePix Pro 6.0. Shown here is the 
identification of Ste20 (*) to depict the principle. 
2.7.1 Substrate finding using an in vitro kinase assay 
Putative substrates for Bur1 kinase were purified by TAP purification. Four different 
experiments were performed. First, just the substrate was incubated with a mock 
purification from an untagged wild type strain to see either auto- or unspecific 
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phosphorylation. In the second test, the possible substrate was incubated with Bur1 
kinase, prepared by a high salt wash during the purification, to wash off RPA. The 
third trial was incubated with TAP purified Bur1 bound to RPA to see if the substrate 
specificity changes when the BUR complex is bound to RPA. The fourth setup was 
incubated with BUR, RPA and activated DNA because the binding of the BUR and 
RPA complex to the substrate might be mediated via DNA. The kinase and substrate 
preparations were incubated with radioactive γ-32P-ATP, separated by SDS-PAGE 
and phosphorylation was detected by autoradiography (Fig. 35 A).  
Several possible substrates from different processes like cell cycle, checkpoint 
regulation, chromatin remodelling, DNA repair and transcription associated 
processes were tested: RPA, Rad3, Htz1, Ddc2, Dbf4, Cdh1, Ioc3, Dbp2, Dpb4, 
Msh2, Mph1, Snd1, Snf2, Mre11, Rnh1, Spt4, Hmo1, Ela1, Pho23, Cps60, Rad52, 
Rad9, Rsp5, Sir2, Sir3, Swi6 and Thp1. No substrate could be identified using this 
approach.  
2.7.2 Substrate finding using Protoarrays 
Additionally, a whole proteome approach was performed using Protoarrays. These 
arrays were incubated with TAP purified Bur1 kinase in the presence of γ-33P-
labelled ATP in TAP buffer, because Bur1 was inactive in the buffer originally coming 
with the Protoarrays. The arrays were subsequently incubated on a Phosphoimager 
and analyzed using GenePix Pro 6.0 (Fig. 35 B).  
Four putative substrates were identified using this assay:  
Ste20, a serine threonine kinase involved in MAP kinase signalling in response to 
pheromone or high osmolarity (Drogen et al., 2000) and histone H2B Ser10 
phosphorylation (Ahn et al., 2005). Ste20 can be phosphorylated by Cln2-Cdc28 (Wu 
et al., 1998). Thus, it might also just be a good substrate for cyclin dependent kinases 
and the phosphorylation could be unspecific. Furthermore, Ste20 auto- 
phosphorylates (Leberer et al., 1997) which also raises the possibility for an 
unspecific phosphorylation which has to be further investigated.  
Additionally, Ptk2, a putative serine/threonine kinase with a function in ion 
homeostasis (Erez and Kahana, 2002), together with Sky1, was identified.  
The third substrate identified is Rim11, a kinase needed for entry into meiosis 
(Mitchell and Bowdish, 1992) which could also explain the synthetic sick phenotype 
of BUR1 with RAD52 without the induction of DNA damage because RAD52 is also 
needed for meiosis. Rim11 is also important for the phosphorylation of Ume6 and the 
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complex formation of Ume6 and Ume1 (Malathi et al., 1997), a protein complex also 
needed for meiosis. Interestingly, Ume6 is also crucial for binding the URS1 
upstream regulatory sequence and recruitment of RPA to it  (Luche et al., 1993).  
Additionally, Ume6 recruits the Rpb3-Sin3 histone deacetylase complex to promoters 
(Kadosh and Struhl, 1997). This complex counteracts Bur1 (Keogh et al., 2005). 
Hence, the phosphorylation by Bur1 might offer a mechanism for regulating the 
recruitment of these factors.  
The last substrate identified is Bcy1, a regulatory subunit of the cyclic AMP-
dependent protein kinase (PKA) that is important for the cellular response to stress 
like heat shock or starvation and for sporulation (Toda et al., 1987).  
2.9 Mutation of BUR1 causes genomic instability 
We were particularly interested if the number of Rfa1 and Rad52 containing 
replication or repair foci changes depending on the bur1 mutants. For this, Bur1-GFP 
and Rfa1-RFP tagged strains were created and investigated by fluorescence 
microscopy. 
To make sure that the GFP and RFP tagged proteins still interact biochemically, a 
pulldown assay was performed. Bur1-GFP was purified and a subsequently tested for 
the interaction with RPA in a Western blot using an antibody against RFP. Untagged 
Bur1 was used as a negative control (Fig. 36). 
 
Figure 36: Bur1-GFP and Rfa1-RFP interact biochemically 
Bur1-GFP was purified using GFP-binder coupled beads. Western blotting shows an enrichment of 
Bur1-GFP in the purification. There was no unspecific binding to the resin when untagged Bur1 was 
used as a negative control. Rfa1-RFP was detected using an antibody directed against RPF. The 
tagged proteins still copurify. 
 
The whole cell extracts of the corresponding strains contained the proteins as 
expected. Detection of Bur1 in the extract of the GFP tagged strain lead to an upshift 
of the protein due to the GFP. In the IP, a lot of degraded protein is detected by the 
Bur1 antibody which is not seen in TAP purifications. Thus, this is most likely due to 
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the GFP based protein purification and degradation of the GFP tag. Rfa1-RFP can be 
detected in the IP together with Bur1-GFP but not in the control purification showing 
that the tagged proteins are still able to interact (Fig. 36).  
 
In collaboration with Susanne German and Michal Lisby the influence on genome 
stability of bur1 mutants was investigated by looking at the appearance of nuclear 
foci, DNA damage and replication factories that contain, among others, RPA (Lisby et 
al., 2004) (Fig. 37 A). The fist observation is, that in the bur1-7, bur1-24 and bur1-∆C 
mutants, the overall levels of foci is increased (Fig. 37 B), hinting to more DNA repair 
or replication ongoing in these cells, which corresponds to the sensitivity of those 
cells to DNA damage inducing agents. To further investigate if these foci are involved 
in DNA replication or repair, additionally the co-localisation of Rad52-YFP with those 
foci was examined. Foci, that contain Rad52 show ongoing homologous 
recombination, indicating that they are involved in DNA repair. The bur1-7, bur1-24 
and bur1-∆C clearly have increased levels of ongoing homologous recombination, 
indicating genome instability. Moreover, some of them also fail to suppress Rad52 
foci upon addition of hydroxyurea, which is normally seen for the wildtype. This 
mutant phenotype may be due to slow disassembly (DNA repair) of existing Rad52 
foci or a failure to suppress de novo recruitment of Rad52 to sites of DNA damage in 
the presence of HU. The first possibility is favoured because the Rad52 foci are very 
bright indicating slow repair, but further experiments are needed to un-    
ambiguously distinguish between these possibilities. Additionally, the overall 
percentage of cells containing Rad52 foci was determined in the bur1-7 mutant after 
prolonged HU treatment. This mutant shows strongly elevated levels of Rad52 foci 
after one to three hours of HU incubation. Again, this shows that in these cells more 
homologous recombination is going on (Fig. 37 C). These results show that bur1 
mutant cells are impaired in genome maintenance.    
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Figure 37: Increased formation of Rad52 foci in bur1 mutants.  
(A) Colocalizing Rfa1-RFP and Rad52-YFP foci in bur1 mutants. Wild-type and bur1 (bur1-1, bur1-4, 
bur1-7, bur1-24 and bur1-∆C) mutant strains expressing Rfa1-RFP and Rad52-YFP ectopically 
(pWJ1213) were grown in SC-His at 30 °C. The occurrence of Rfa1-RFP and Rad52-YFP was 
determined by fluorescence microscopy before and after exposure to 100 mM hydroxyurea (HU) for 1 
hour. Representative cells are shown. Selected foci are indicated by arrowheads. (B) Quantification of 
Rfa1 and Rad52 foci. For each genotype, 100-200 cells were inspected. Error-bars indicate 95% 
confidence intervals. In the absence of HU, the percentage of cells with colocalizing Rfa1 and Rad52 
foci is significantly higher than wild-type in the bur1-7, bur1-24 and bur1-∆C mutants (P=0.007, 
P=1.63×10-8, P=2.59×10-8, respectively, by Fisher’s exact test (one tailed)). The bur1-1 and bur1-4 
mutants display focus levels similar to wild-type (P=0.26 and P=0.48, respectively). (C) Rad52 foci 
accumulate in HU-treated bur1-7 cells. The experiment was performed as described for panel B, 
except that cells were examined for Rad52 foci at 0, 1,2, and 3 hours after addition of 100 mM HU. 
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2.10. Role of RPA in transcription 
2.10.1 RFA1 and TREX do not interact genetically 
Bur1 was found in our lab to be synthetic lethal with TREX. This points to a functional 
overlap between the BUR and the TREX complex. BUR copurifies with RPA, a 
protein complex essential for DNA repair and replication. As TREX also has subunits, 
HPR1 and THO2, that are important for DNA repair (Gonzalez-Barrera et al., 2002) 
synthetic lethality was also tested between TREX and RPA. No genetic interaction 
could be detected with the RPA mutants that were generated (Fig. 38). (rfa1-249, 
rfa1-6, rfa2-1-4, rfa2-26-2, rfa3-6-2, rfa3-8-2, rfa3-16-1, Clausing and Winkler, 
unpublished data) 
 
TREX subunit RPA subunit SL
HPR1 RFA1 - 
MFT1 RFA1 - 
HPR1 RFA2 - 
MFT1 RFA2 - 
HPR1 RFA3 - 
MFT1 RFA3 - 
THO2 RFA3 - 
THP2 RFA3 - 
 
Figure 38: TREX and RPA do not interact genetically 
Double mutant strains carrying deletions of TREX components and RPA subunits were tested for a 
synthetic lethal phenotype. No interaction was detected using rfa1, rfa2 or rfa3 mutants with the TREX 
deletions tested (HPR1, MFT1, THO2, THP2).  
2.10.2 A rfa1 mutant shows synthetic sickness with DST1 and RTF1 
The sensitivity of the rfa1-249 mutant to 6’-AU suggests a function of RPA in 
transcription elongation. This mutation also suppresses mutations in BUR1, which is 
crucial for efficient transcription elongation. Genetic interactions of the rfa1 mutant 
were tested with RTF1, a component of the PAF transcription elongation complex 
and thus closely related to BUR1 function, and DST1, coding for TFIIS. Interestingly 
rfa1-249 is synthetic sick with ∆rtf1 as well as ∆dst1. This phenotype can be 
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enhanced by growing the cells on media containing 6’-AU (Fig. 39). The genetic 
interaction points to a function for RPA in transcription elongation.  
 
Figure 39: RFA1 is synthetic sick with RTF1 and DST1 
RFA1 RTF1 and RFA1 DST1 double shuffle strains were transformed with RFA1, rfa1-249 and RTF1, 
DST1 or an empty plasmid, shuffled and spotted on plates selective for the plasmids and containing 
either no drug or 6’-AU. Already without the drug the rfa1-249 mutant shows a synthetic growth defect 
with deletions of RTF1 or DST1 indicating a function of RFA1 in transcription elongation. 
2.10.3 A rfa1 mutant has lower levels of histone H3 
The BUR complex was described to have a function in histone methylation and 
∆bur2 strains were shown to have lowered amounts of histone H3 (Laribee et al., 
2005). The impact of the bur1-7 and rfa1-249 mutants on histone H3 levels and 
histone modifications was tested. Cells were grown at different conditions. Control 
experiments were performed at 30°C and the influence of the temperature sensitive 
mutants was directly tested by shifting cells to 37°C for 3 hours. DNA damage was 
induced by growing the cells in 0,1% MMS for 2h, replication stress was induced by 
50 mM HU for 2 hours and transcription stress by 100 µg/ml 6’-AU for 2 hours. Cells 
were harvested, lysed and subjected to SDS-PAGE and Western blot analysis. First, 
the amount of total histone H3 in the extracts in comparison to Pgk1 was tested to 
achieve equal loading for further analysis. Interestingly, lowered levels of histone H3 
were detectable in the rfa1-249 mutant strains whereas this effect was rather low in 
the bur1-7 mutant. An impact of the mutants is not visible at 30°C. At 37°C and upon 
treatment with MMS the rfa1 mutant shows a significant lower amount of histone H3 
compared to Pgk1, used as loading control. This is not visible in the bur1-7 rfa1-249 
double mutant which might explain the suppression of their phenotypes. It is also 
possible that the histone H3 levels are simply a secondary effect of the impaired 
cellular growth. The slowest growing cells might have the lowest levels of histone H3 
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(this might also be the case for ∆bur2 in the literature as it is also impaired in growth). 
Upon treatment with HU lowered histone H3 levels can be seen in both, the rfa1-249 
mutant alone as well as in the bur1-7 rfa1-249 double mutant. The same phenotype, 
even though to a lower extent, can be detected upon treatment with 6’-AU (Fig. 40).   
 
 
Figure 40: The rfa1-249  mutant has lower levels of histone H3 upon stress 
BUR1 RFA1 double shuffle strains were transformed with BUR1, bur1-7 and RFA1 or rfa1-249. The 
cells were grown under different conditions, 30°C as control, 37°C to see the effect of the ts mutants, 
MMS to induce DNA damage, HU to induce replication stress and 6’-AU to induce transcription stress. 
Whole cell extracts of these strains were analyzed by Western Blot using an antibody directed against 
unmodified histone H3. The overall cellular levels of histone H3 are significantly lowered in cells 
containing the rfa1-249 mutation after stress. Pgk1 serves as a loading control.  
2.10.4 The rfa1-249 mutant has lower levels of histone H3 Lysine 4 
trimethylation but is not impaired in H2B ubiquitination 
The impact of the bur1 and rfa1 mutants on the methylation of histone H3K4 
trimethylation was investigated. Again the cells were grown under different conditions 
and the cell extracts were subjected to SDS-PAGE and Western blotting. Equal 
loading of histone H3 was achieved by loading three two-fold serial dilutions of every 
extract and quantification of the Western blots afterwards. For the following blots 
equal amounts of histone H3 were loaded for every sample and tested for several 
transcription associated histone modifications. Differences in methylation were 
detectable in the H3K4me3. At 30°C only a very slight defect is visible. Both the rfa1-
249 and the bur1-7 mutant are slightly impaired and the double mutant a slightly 
more (Fig. 41 A). When the cells were shifted to 37°C the rfa1 mutant alone again 
showed only a slight defect whereas the bur1-7 mutant shows a strong decrease in 
H3K4me3, which is also published for the deletion of BUR2 (Laribee et al., 2005). 
The rfa1-249 bur1-7 double mutant shows the same phenotype as the bur1-7 mutant 
(Fig. 41 B). When the cells were challenged with either 6’-AU, MMS or HU (Fig. 41 C, 
D, E) the single mutants alone were still almost unaffected whereas the double 
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mutant cells show a lower level of H3K4me3. The H3K4me and H3K4me2 were 
unaffected as well as H3K36me3 and H3K79me2 under all conditions examined. 
Detection of histone H4 Lysine 12 acetylation serves as a second loading control, 
using a different histone subunit, in addition to unmodified histone H3 (Fig. 41).  
As the H3K4me3 is dependent on the ubiquitination of histone H2B (H2Bub) (Sun 
and Allis, 2002) and ∆bur2 cells are impaired in H2Bub (Laribee et al., 2005), the 
impact of the rfa1 mutation on H2Bub was also tested. Comparison of cell extracts 
from cells carrying the rfa1-249 mutation grown either at 30°C or shifted to 37°C 
showed no significant difference in the ubiquitination of histone H2B (Fig. 41 F).   
These results show a specific impairment on H3K4me3 in the bur1-7 rfa1-249 double 
mutant strains, most likely without an impairment in H2Bub. This indicates a lowered 
level of transcription elongation, which is surprising, because these strains grow 
better than the rfa1-249 single mutant. Hence, the suppression does not depend on 
the methylation of histone H3.  
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Figure 41: bur1 and rfa1 mutants are impaired in histone H3 lysine 4 trimethylation 
BUR1 RFA1 double shuffle strains were transformed with BUR1, bur1-7 and RFA1 or rfa1-249. The 
cells were grown under different conditions, (A) 30°C as control, (B) 6’-AU to induce transcription 
stress , (C) 37°C to see the effect of the ts mutants, (D) MMS to induce DNA damage and (E) HU to 
induce replication stress. (A-E) Whole cell extracts of these cells were analyzed by Western Blot using 
antibodies directed against histone H3K4me3, H3K4me2, H3K4me, H3K36me3, H3K79me2 and 
Results 
 67
H4K12 acetylation as well as unmodified histone H3 as loading controls. The protein amount was 
calibrated to the same amount of histone H3. Three two-fold dilutions of every extract were analyzed. 
The rfa-249 mutant alone shows no or only slight impairment of H3K4me3. When grown at 37°C the 
bur1-7 mutants show lowered levels of H3K4me3 which is consistent with the literature. Interestingly, 
bur1-7 rfa1-249 double mutants show a stronger impairment in the trimethylation than the single 
mutants. This indicates a function for both proteins in histone H3 Lys4 trimethylation. (F) The rfa1-249 
mutant is not impaired in histone H2B ubiquitination.  
2.10.5 RFA1 mutants are impaired in a LacZ reporter gene expression 
The influence of mutations in either BUR1 or the RFA1 on gene expression was 
examined using a β-galactosidase reporter gene assay. This gene is rather long and 
GC rich and its activity and amount can be easily detected by measuring the 
absorbance of a ortho-nitrophenyl-β-D-galactopyranoside (ONPG) catabolization at 
420 nm (Miller, 1972). Yeast cells impaired in transcription elongation or a later step 
in gene expression might show an impairment in expressing this bacterial gene 
stronger than with a yeast gene. The bur1-1, bur1-4, bur1-7 and bur1-24 mutations 
were genomically integrated into a wild type strain, transformed with a plasmid 
containing the β-galactosidase reporter under control of the GAL1 promoter. The 
rfa1-249 mutant was tested in a ∆rfa1 strain covered with either a wild type RFA1 or 
a plasmid coding for rfa1-249 (Fig. 42).  
 
 
Figure 42: bur1 and rfa1 mutants show a decrease in β-galactosidase expression 
(A) bur1 temperature sensitive mutations were genomically integrated in a wild type strain. These 
strains were transformed with a plasmid containing a galactose inducible β-galactosidase gene. The 
reporter gene expression is decreased in bur1 mutant strains. 
(B) A RFA1 shuffle strain was transformed with RFA1 or rfa1-249, shuffled on 5’-FOA containing 
plates and transformed with the β-galactosidase reporter. The expression is also lowered in the rfa1-
249 mutant strain.  
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Cells were grown using raffinose as the carbon source, which does not affect the 
GAL1 promoter. The expression of the reporter construct was induced adding 
galactose and letting the cells grow for eight hours logarithmically. The cells were 
harvested, lysed by three freeze and thaw cycles and the β-galactosidase expression 
was tested by measuring the absorbance of ortho-nitrophenyl-β-D-galactopyranoside 
(ONPG) at 420 nm in an ELISA reader. Mutations in the BUR1 gene lead to a 
reduction to 40-50% in expression. Noteworthy, also the RFA1 mutant is impaired 
and shows a reduction to 70% showing a direct influence of RFA1 on gene 
expression (Fig. 42).  
2.10.6 Influence of the bur1-7 and rfa1-249 mutation on Rad53 
phosphorylation, RNApolII and Ctk1 levels 
To get further molecular insight into the cellular changes of strains carrying the bur1-
7 or rfa1-249 mutation or both cells were grown at 30°C or 37°C and subjected to 
DNA damage by MMS or not. First phosphorylation of the DNA damage effector 
kinase Rad53 was examined. Rad53 is not phosphorylated under normal conditions 
but when DNA damage is induced, e.g. by MMS, it becomes phosphorylated which 
can be seen by an upshift of the protein in Western analysis. No difference in Rad53 
phosphorylation is detectable when the cells were grown at permissive temperature. 
There might be a slight impairment in the phosphorylation upon shift to 37°C 
indicating a problem in checkpoint signalling dependent on the bur1 and rfa1 
mutation and strengthening the point for a function in DNA repair. The overall levels 
of RNApolII (8WG16) are reduced upon DNA damage, probably due to degradation 
of the enzyme. Phosphorylation on Serine 2 (H5) goes down in the wild type strain 
upon MMS treatment and seems to be higher when BUR1, RFA1 or both are 
mutated. The pool of RNApolII is thus shifted to the elongating form instead of the 
initiating one to avoid recruitment of additional RNApolII to the damaged DNA and 
subsequently allow DNA repair. The level of Bur1 is slightly elevated in the bur1-7 
mutant strain and does not show the higher molecular weight band that is most likely 
due to the phosphorylation by Cak1. In the strains carrying the bur1-7 mutation also 
Ctk1 is more expressed than in the strains without the mutation, indicating that Ctk1 
might take over some of the functions of Bur1. Pgk1 serves as loading control. The 
same experiments were performed with a strain carrying the BUR1 mutation and 
additionally a deletion of RAD16, needed for efficient nucleotide excision repair, as a 
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control for the specificity of the effects due to RFA1. Despite a small reduction in the 
overall levels of RNApolII (8WG16) there is no change in the protein levels examined 
(Fig. 43). 
 
 
Figure 43: Expression analysis of checkpoint and transcription associated proteins in bur1-7 
and rfa1-249 strains upon DNA damage 
BUR1 RFA1 double shuffle strains were transformed with BUR1, bur1-7 or RFA1 and rfa1-249 and 
shuffled on 5’FOA. Cells were grown at 30°C or 37°C and DNA damage was induced with 0.2% MMS 
for one hour. Afterwards, they were lysed by alkaline lysis and subjected to SDS-PAGE and Western 
blotting. Rad53 is a checkpoint effector kinase that becomes phosphorylated upon DNA damage. At 
30°C there is no impairment in Rad53 phosphorylation but upon DNA damage at 37°C there might be 
a minor impairment in the bur1-7 and rfa1-249 strains. The levels of RNApolII (8WG16) are lowered 
upon DNA damage but the level of S2 phosphorylation (H5) is higher compared to the wild type in 
relation to the RNApolII levels. This indicates less transcription initiation upon DNA damage in the 
bur1-7 and rfa1-249 mutants. The levels of Bur1 might be elevated in strains carrying the bur1-7 
mutation and loose the second higher molecular weight band. Noteworthy, also Ctk1 expression goes 
up in these strains indicating that Ctk1 might take over part of the function of Bur1. Pgk1 serves as a 
loading control. Rad16 serves as a control for an independent DNA damage protein. Here the 
phenotypes described before are not visible, showing specificity for BUR and RPA. 
2.11 Genome wide expression analysis bur1 and rfa1 mutants upon 
DNA damage 
To investigate the expression of the whole yeast genome dependent on the bur1-7 
and rfa1-249 single and double mutants upon DNA damage, microarray experiments 
were performed. Cells were grown logarithmically over night at 30°C before the 
addition of 0.1 % MMS for one hour, which was shown to have the most 
comprehensive effects on gene expression (Jelinsky and Samson, 1999). RNA was 
isolated and subjected to Affymetrix GeneChip Yeast Genome 2.0 arrays in 
collaboration with Andreas Mayer from Patrick Cramer’s laboratory and Achim 
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Tresch. Experiments were performed in triplicates with a high level of reproducibility 
which depicted in the PCA mapping, showing that the experiments with the 
corresponding strains cluster with each other (Fig.43 A) after removal of a batch 
effect due to different days of RNA extraction. One of the experiments with the 
double mutant strains was left out from the data analysis due to problems with the 
array hybridisation. However, due to the high reproducibility of the experiments this 
still lead to significant expression data.   
Compared to an isogenic wild-type strain, 41, 60 and 54 genes out of 5665 genes 
that were present on the array showed significantly altered mRNA levels in the rfa1-
249, bur1-7 and bur1-7 rfa1-249 mutant strains, respectively (Fig. 44 B). Thus, the 
regulation of only a small subset of genes was affected by the different mutations 
(0.7% in rfa1-249 and 1% in bur1-7). Although several genes were differentially 
expressed in at least two mutants the analysis revealed also genes affected in only 
one of the respective mutants. The largest overlap of significantly altered genes could 
be detected for bur1-7 and the bur1-7 rfa1-249 double mutant (22 genes), the 
smallest overlap was between bur1-7 and rfa1-249 single mutants (11 genes) (Fig. 
44 B).      
Hierarchical clustering of the expression profiles shows that the bur1-7 and the   
bur1-7 rfa1-246 double mutant strain cluster together whereas the single mutant rfa1-
249 does not. Mutation of RFA1 and BUR1 results in distinct changes of the 
transcriptome whereas the double mutation gives rise to a gene expression profile 
that is more similar to that of the bur1 mutant (Fig.43 C). This result might explain the 
suppression of these strains seen in the sensitivity to DNA damage. 
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Figure 44: Whole genome expression analysis of bur1-7 and rfa1-249 single and double mutant 
strains upon DNA damage 
(A) PCA Mapping of microarray experiments done independently in triplicates after removal of the 
batch effect. The different colours correspond to the different strains. The wild type strain is shown in 
purple, bur1-7 in blue, rfa1-249 in green and the bur1-7 rfa1-249 double mutant in red. (B) Venn 
diagram showing the numbers of differentially regulated genes in the mutants strains compared to the 
wild type. Intersections show the number of genes that are similar in the respective mutants. (C) 
Hierarchical clustering of the expression data shows that bur1-7 and the bur1-7 rfa1-249 double 
mutant cluster together whereas the rfa1-249 mutant is more distinct from these strains, which is 
depicted in the dendrogram. 
To investigate if overlapping or distinct biological networks are affected by either the 
rfa1 or the bur1 mutation, a combined approach of both explorative analysis of 
microarray data and promoter analysis was performed. 
In the case of rfa1-249 the strong transcriptional activator Swi5 was discovered to be 
the mutant-specific transcription factor (TF) that targets the largest fraction of 
significantly changed genes (20%, Fig. 45 A). All three Swi5 target genes are up-
regulated in the rfa1-249 mutant. Swi5 represents a well-studied transcription factor 
that activates transcription of target genes at the M/G1 phase boundary of the mitotic 
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cell cycle (Breeden, 2003). Additionally, expression of known Swi5 target genes was 
analyzed. Strikingly, most of the known Swi5 target genes are at least slightly up-
regulated. Since the mRNA level of SWI5 in rfa1-249 compared to wild-type yeast 
strain is not significantly changed, a post-transcriptional regulatory mechanism of 
Swi5 is most likely responsible for altered gene expression of most Swi5 target 
genes.  
In case of bur1-7, all significantly changed genes are down-regulated. Ste12 turned 
out to be the mutant-specific TF that targets the largest fraction of significantly 
changed genes (28.6%, Fig. 45 B). All four Ste12 target genes were down-regulated 
in the bur1-7 mutant. Ste12 activates genes involved in mating or 
pseudohyphal/invasive growth pathways (Herskowitz, 1995).  
Taken together, mutation of either RFA1 or BUR1 affects both overlapping as well as 
distinct potential transcription regulatory networks. In the case of rfa1-249 especially 
Swi5 target genes were at least slightly up-regulated. In the bur1-7 mutant, all 
significantly changed genes are down-regulated. Ste12 is a kind of master regulator 
targeting not only the largest fraction of differentially expressed genes but also genes 
of other transcription factors which in turn regulate other significantly changed genes 
in the bur1-7 expression profile.  
 
 
 
Figure 45: Possible transcription regulatory networks affected in rfa1-249 (A) and bur1-7 (B) 
Transcription factors and target genes are indicated as grey and white boxes, respectively. Genes 
regulated by the particular transcription factor are symbolized by an arrow. Autoregulation is 
symbolized by a curved arrow. Only transcription factors regulating at least two differentially expressed 
target genes are shown in the diagram. The regulatory diagrams were generated with YEASTRACT. 
Discussion 
 73
3. Discussion 
3.1 Bur1-2 and RPA interaction 
In order go gain further insight into the function of the Bur1-2 complex, needed for 
efficient transcription elongation, tandem affinity purifications were performed to 
purify native in vivo complexes. Interestingly, the major proteins co-purifying with 
Bur1 and Bur2 were Rfa1, Rfa2 and Rfa3, components of a well studied protein 
complex, RPA, with functions in DNA repair, replication and recombination (Iftode et 
al., 1999; Wold, 1997).  
The N-terminus of Bur1 is homologous to cyclin dependent kinase domains. The C-
terminus does not show any significant homology to known protein domains. Being 
interested in the function of those parts, truncations of Bur1 carrying just the kinase 
domain or the C-terminus were expressed in yeast cells. The kinase domain is 
sufficient for complementation of a ∆bur1 strain showing that the essential part is the 
kinase domain. The C-terminus could not complement a BUR1 deletion. However, 
tandem affinity purification of the C-terminus showed that it is sufficient for the 
binding to RPA. Other tries to express the kinase domain or C-terminal truncations of 
the full length proteins lead to low expression levels and made it impossible to purify. 
Interestingly, it was also not possible to express full length Bur1 in E. coli or a Baculo 
expression system (data not shown). These approaches lead to either insolubility or 
degradation of the protein indicating that the kinase might take over unwanted 
functions in these cells and thus has to be inactivated.  
Additionally, it was also not possible to over-express Bur1 in yeast cells showing that 
a deregulation of Bur1 kinase expression is fatal for the cell.  
Depletion experiments showed that the amount of Bur1 can be depleted to a level 
that can not be detected by Western blot anymore but gave no impairment in growth 
(data not shown). Hence, only a very small amount of protein is needed to fulfil its 
function in vivo.  
The interest was subsequently focused on the interaction of Bur1’s C-terminus and 
RPA, with the initial aim to generate a full length protein fulfilling all other functions 
like protein-protein interactions and correct folding. Just the interaction with RPA 
should be disrupted to study specifically the function of the interaction of BUR and 
RPA in vivo. 
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First, the secondary structure of the C-terminus of Bur1 was examined by computer 
predictions using PSIPRED. The C-terminal part did not show any predictable folding. 
As there was no way of guessing where the interaction with RPA might take place, 
truncations of 50 amino acids were expressed in E. coli, as the C-terminus alone 
turned out to be soluble, and were tested for their binding abilities in a GST pulldown 
experiment. Two possible binding sites could be found using this strategy but when 
they were deleted from constructs coding for C-terminal fragments the protein was 
still able to bind to RPA, suggesting that there might be more, maybe weaker sites in 
this domain that cooperate in binding. Unstructured domains having a function in 
protein-protein interactions are known to have linear motifs, small interaction sites 
that are especially found in transient and regulatory interaction domains (Fuxreiter et 
al., 2007). Additionally, this point is also strengthened by the finding that the 
BUR/RPA complex is already disrupted by 250 mM NaCl in TAP purifications (data 
not shown).  
In order to have an alternative approach for the detection of the interaction site a 
peptide mapping approach was performed in collaboration with Georg Arnold. It has 
the advantage to detect also weaker interaction sites and smaller fragments of the C-
terminus that might be important for binding of Bur1 to RPA.  
These experiments showed that many of the 15 amino acid long peptides of the C-
terminus had the ability to bind to RPA. It was thus not possible to indentify just a 
small number of residues needed for binding and to create a full length non-binding 
BUR1 mutant. Instead, a mutant carrying a deletion of the whole C-terminus was 
used. The possibility that the natively disordered domain folds upon binding to RPA 
could possibility be characterized by a structural biology approach. Binding of the two 
protein complexes via linear motifs might also explain why the human homolog, 
Cdk9, is not able to bind to RPA as these kind of interaction domains are not 
evolutionary conserved.  
The interaction of the Bur1-2 complex with RPA might provide insight into a new level 
of interconnection between transcription, chromatin modification and genome 
stability. 
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3.2 Function of Bur1 in Pkc1 signalling 
Screening for high copy suppressors of BUR1 mutations resulted in the identification 
of several genes involved in Pkc1 signalling. Pkc1 acts as a kinase upstream of the 
MAP kinase signalling pathway needed to regulate mating, sporulation and 
maintenance of cellular integrity upon response to stress due to low osmolarity as 
well as cell cycle and cytosketetal dynamics. Among the genes identified were PKC1 
as well as upstream regulators like WSC2 or SLG1 and genes needed for the 
signalling in this pathway like RHO2 or ROM1. Another group of genes identified in 
the screen is involved in cell cycle regulation, e.g. WHI3 which regulates CLN3. 
CLN3 is acting upstream of CLN1 and CLN2 in G1 phase. Hyperactive CLN3 was 
described to suppress deletion of BUR1, which was also initially indentified as a gene 
having an unspecific function in the response to mating pheromone (Irie et al., 1991). 
Another cell cycle regulator that was found to suppress the mutation of BUR1 was 
CLN2. It was originally argued that the suppression by Cln3 is based on the 
continuous expression of Cln3 whereas Cln2 (and Cln1) are expressed in waves in 
the cell cycle. In our screen Cln2 was expressed from a high copy plasmid and thus 
might also show continuous expression and could in turn suppress the bur1 mutation 
like Cln3.  Interestingly, GO analysis of microarray experiments performed with bur1-
7 mutant strains upon the addition of MMS showed enrichment of genes involved in 
mating. Additionally, Ste20, a serine threonine kinase involved in MAP kinase 
signalling in response to pheromone or high osmolarity (Drogen et al., 2000) could be 
identified as a putative substrate of Bur1 by a whole proteome approach. These data 
point to a function of Bur1 in cell cycle regulation and Pkc1 signalling.  
It is thus also possible that the sensitivity to drugs inducing DNA damage or 
replication or transcription stress of the bur1 mutants is a secondary effect of the 
impairment in cell wall integrity. However, this is considered to be unlikely because 
we could observe a role of the bur1 mutants in the formation of DNA repair foci 
making it unlikely that the damage sensitivity is simply a secondary effect of the 
impairment in cell wall integrity. This and the interaction with RPA agues for a specific 
role in DNA repair. 
The identification of the high copy suppressor genes of two bur1 mutants with roles in 
cell cycle and Pkc1 signalling suggests an additional function of Bur1 kinase in these 
processes. This might be uncoupled of the interaction with RPA and thus provides 
insight into another process Bur1 might me involved in. 
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3.3 Function of RPA in transcription 
The in vivo interaction of BUR and RPA could also suggest a function of RPA in 
transcription and chromatin modification. Sensitivity of rfa1-249 mutants to 6’AU was 
observed, arguing for a role of RPA in transcription. Additionally, the rfa1-249 mutant 
shows a genetic interaction (synthetic sickness) with DST1 and RTF1 which are both 
needed for efficient transcription elongation, by backtracking of RNA PolII or by 
facilitating histone H3 Lysine 4 trimethylation (H3K4me3), respectively. The 
combination of the bur1-7 mutant with rfa1-249 also shows impairment in H3K4me3. 
As the single mutants showed only a slight impairment in the methylation it could be 
possible that BUR and RPA act on a different pool of histones. This could be 
examined using a ChIP on Chip approach to see on a whole genome basis the levels 
of this histone modification in bur1 and rfa1 mutants. Besides the modification of 
histone H3K4me3, the overall level of histone H3 is lower in the rfa1 mutant. 
Additionally, impairment in the expression of a β-galactosidase reporter gene could 
be observed in bur1, but surprisingly also in an rfa1 mutant. This result hints to a 
more direct effect of RPA in gene expression in accordance with other studies. The 
Cooper lab showed that RPA binds specifically to regulatory sequences, e.g. URS1 
(Luche et al., 1993), needed for transcription regulation. A direct effect of RPA on 
transcription could also be observed at the metallothionein promoter in human cells 
(Tang et al., 1996). Despite this, two recent publications on Arabidopsis RPA showed 
that rfa2 mutants show a missregulation in transcriptional silencing (Elmayan et al., 
2005; Kapoor et al., 2005).  
Until today it remains elusive what the specific function of RPA on gene expression 
is. Possibly, RPA regulates transcription by binding to regulatory elements like 
promoters or upstream regulatory sequences. There, it might either recruit other 
factors needed for transcription, like Bur1-2, or prevent binding by blocking their 
binding sites. A mechanism like this could explain the suppression of the bur1 and 
rfa1 mutants, pointing to antagonistic roles of both proteins.  
One could also suspect a function RPA in the inheritance of regulatory histone 
modifications during S-phase of the cell cycle.  
Another possibility is that after mutation of BUR1 R-loops, DNA-RNA hybrids that 
often form upon impaired transcription, might occur behind the transcription bubble. It 
was shown that in a strain carrying a deletion of HPR1, a component of the TREX 
complex, R-Loops are formed co-transcriptionally (Huertas and Aguilera, 2003). Bur1 
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kinase is synthetic lethal with TREX components and might thus lead to similar 
phenotypes. The R-loops would lead to patches of ssDNA behind the transcribing 
polymerase because of the pairing of the transcribed mRNA with DNA. These ssDNA 
patches could then serve as a substrate for RPA to bind. This binding of RPA might 
even stabilize those areas and as the rfa1-249 mutant also has mutations in the DNA 
binding sites of RPA there might be a lower affinity of our mutant to ssDNA than in 
the wild type protein. This weaker binding could in turn lead to a faster dissociation of 
RPA from the DNA and the R-loop can be resolved faster. A mechanism like this 
could  also explain the suppression seen in BUR1 and RFA1 double mutants. In the 
bur1 mutant the occurrence of R-Loops is possibly higher and lower in the rfa1 
mutant. Hence, the negative effect of the bur1 mutant can be suppressed by the rfa1 
mutant. However, this mechanism can not explain why the rfa1 mutant itself is 
extremely sick. To gain a deeper insight into a possible role of RFA1 in R-loop 
formation or resolution one would need to further characterize more defined 
mutations in the DNA binding domains of RFA1 in this process. 
Another result explaining the suppression is gene expression on a whole genome 
basis. Analysis of microarray experiments performed with the bur1-7 and rfa1-249 
single and double mutants shows that the double mutant clusters together with the 
bur1-7 mutant whereas the rfa1-249 mutant does not. Thus even though the rfa1-249 
mutant is also present in the double mutant strain gene expression seems to be 
closer to wild-type or bur1-7 and this might lead to the better growth of the double 
mutant.   
The interaction of BUR and RPA provides the possibility for a role of RPA in 
transcription elongation. Results of this study, like impaired reporter gene expression 
and impairment in H3K4me3 strengthen the idea, even though the exact mechanism 
has to be investigated in future studies.  
3.4 Function of Bur1 in genome stability 
The observation that the BUR complex bind to RPA, which has functions in DNA 
replication, recombination and repair lead to the idea that BUR could also be involved 
in one of these processes. To test this possibility, temperature sensitive mutants of 
BUR1 were generated and subjected to phenotypic and genetic analysis. Mutations 
in BUR1 lead to sensitivity of the cells to MMS, UV irradiation and Hydroxyurea, 
agents that induce DNA damage or replication stress, respectively. Interestingly, 
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these sensitivities were even stronger than the sensitivity to 6’-AU which impairs 
transcription elongation. To elucidate the pathway Bur1 plays a role in, the mutant 
alleles were analysed for their epistatic behaviour with non essential deletions of 
genes involved in specific DNA repair pathways. No epistatic behaviour with any of 
these candidate genes was observed, showing that BUR1 is not a component of any 
of these pathways and most likely has a higher order role in regulating genome 
maintenance. 
Mutation of Bur1 also did not lead to a drastic reduction in Rad53 phosphorylation 
excluding a function in checkpoint signalling.  
The possibility of Bur1 having a function in post-replication repair could not be 
excluded because it was not possible to generate a BUR1 RAD6 double mutant 
strain.  
A function of Bur1 in genome stability was further investigated in collaboration with 
the Lisby lab. Using fluorescence microscopy it could be shown that some mutations 
in BUR1 lead to increased levels of homologous recombination, indicating genome 
instability. This was investigated by examining the co-localisation of the homologous 
recombination factor Rad52 with nuclear foci that form upon induction of DNA 
damage or replication. The phenotype is strong in the bur1-7, bur1-24 and bur1-∆C 
mutants, which are the most sensitive alleles to MMS, UV irradiation and 
Hydroxyurea. These mutants were also unable to suppress Rad52 foci upon addition 
of Hydroxyurea. This is normally seen in wild type cells due to the impairment on 
DNA replication (Lisby et al., 2004). This could be due to slow disassembly of 
existing Rad52 foci due to DNA repair or due to a failure to suppress de novo 
recruitment of Rad52 to sites of DNA damage. This slowing down might be a 
consequence of slow DNA repair. Furthermore, upon longer treatment with HU the 
number of cells with Rad52 foci in the bur1-7 mutant strain is significantly higher than 
in wild type cells also pointing to an impairment in genome stability due to the 
mutation of BUR1.  
In summary, a function of BUR1 in genome stability could be established, first by 
interaction with RPA, second due to sensitivity of bur1 mutants to DNA damage and 
third by the impact of bur1 mutants on the amount and persistence of DNA repair 
foci. A simple secondary effect on DNA repair due to impaired transcription could be 
excluded because the level of DNA repair annotated genes does not change in whole 
genome expression experiments.  
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4. Materials 
4.1 Consumables and chemicals  
Consumables and chemicals were purchased from the following companies:  
Acros Organics (Geel, Belgium), Applichem (Darmstadt), Applied Biosciences 
(Darmstadt), Apollo Scientific Limited (Bredbury, UK), Axon (Kaiserslautern), Becton 
Dickinson, (Heidelberg), Beckman Coulter (Krefeld), Biaffin (Kassel), Biomol 
(Hamburg), Biorad (Munich), Biozym (Hess. Oldendorf), Chemicon (Temecula, 
Canada), Fermentas (St. Leon-Rot), Formedium (Norwich, UK), GE Healthcare 
(München), Gilson (Bad Camberg), Invitrogen (Karlsruhe), Lake Placid Biologicals 
(Lake Placid, USA), Macherey & Nagel (Düren), Medac (Hamburg), Medigenomix 
(München), Membra Pure (Bodenheim), Merck Biosciences (Darmstadt), Millipore 
(Molsheim, France), Mobitec (Göttingen), MP Biomedical (Illkirch, France), NEB 
(Frankfurt), Neolab (Heidelberg), Nunc (Wiesbaden), Peske (Aindling-Arnhofen), 
Promega (Mannheim), Qiagen (Hilden), Roche (Mannheim), Roth (Karlsruhe), Santa 
Cruz (Santa Cruz, USA), Sarstedt (Nümbrecht), Semadeni (Düsseldorf), Serva 
(Heidelberg), Sigma (Taufkirchen), Stratagene (Amsterdam, The Netherlands), VWR 
(Ismaning).  
4.2 Commercially available kits  
DC Protein Assay (Biorad, München), ECL kit (Applichem, Darmstadt), Nucleobond 
AX PC100, Nucleospin Mini, Nucleospin extract (all Macherey & Nagel, Düren), 
RNeasy MinElute Cleanup Kit (Quiagen, Hilden), Protoarray Yeast PPI (Invitrogen, 
USA) 
4.3 Equipment  
Beckman DU650 spectrophotometer, L80 Ultracentrifuge, SW32 rotor (Beckman 
Coulter, Krefeld), T3 Thermocycler (Biometra, Goettingen), Gel dryer model 583, 
Mini-Protean II system (Biorad, München), DNA engine (Biozym, Hess Oldendorf), 
Lumat LB9507 (EG&G Berthold), bead mill (Fritsch, Idar-Oberstein), Thermomixer 
compact, Eppendorf centrifuge 5415D, 5415R (Eppendorf, Wesseling-Berzdorf), Äkta 
Basic System (GE Healthcare, München), Rotanda, 46R (Hettich, Tuttlingen), Ika 
Vibrax VXR basic (Ika, Staufen), Heraeus Hera Freeze (Kendro, Langenselbold), 
Kodak X-omat M35 (Kodak), Kühner ISF-1-V (Kühner AG, Switzerland), 
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Elektrophoresis Power Supply Consort E835, Heidolph shaker duomax 1030, 
Rotator, Thermostatcabinet Aqualytic, Vortex Genie (Neolab, Heidelberg), Innova 44 
shaking incubator (New Brunswick Scientific, Nürtingen), Semi-dry blotting device 
(Peqlab, Erlangen), Dissection microscope manual MSM (Singer, Somerset, UK), 
RP80AT-364, Sorvall Evolution, Sorvall RCM120Ex, SLC6000, SS34 rotor (Thermo 
Fisher Scientific), Image reader LAS-3000 (Fujifilm),  
ELISA reader 
4.4 Radioactivity  
Radioactivity was obtained from GE healthcare:  
[γ-32P]-ATP (370 MBq/ml, 10 mCi/ml), [γ-33P]-ATP (3000Ci/mmol, 10 mCi/ml) 
4.5 Enzymes  
Calf Intestine Alkaline Phosphatase (1U/µl), restriction endonucleases (BamHI, BglII, 
BsrBI, ClaI, DpnI, EcoRV, EcoRI, HindIII, HpaI, KpnI, NsiI, NcoI, NdeI, NheI, NotI, 
SphI, PstI, PvuII, SacI, SalI, SmaI, SpeI, SphI, XbaI, XhoI), Pfu and Pfu Turbo 
Polymerases (Stratagene, La Jolla, USA), T4-DNA Ligase, Taq-Polymerase for 
colony PCR and KNOP PCR, CIAP Phosphatase (all Fermentas, St. Leon-Rot), 
Micrococcal Nuclease (Roche, Mannheim), Taq Polymerase for RT-PCR (Axon, 
Kaiserslautern) TEV protease, Vent-Polymerase for KNOP-PCR (NEB, Frankfurt), 
Zymolyase 20000T / 100000T (Medac, Hamburg) 
4.6 Antibodies  
 Source Dilution Company 
Primary antibodies 
anti-actin  mouse  1:1000  Chemicon  
anti-CDK9  rabbit  1:200  Santa Cruz  
anti-Cdk9-55 rabbit 1:2500 Price lab 
PAP  rabbit  1:5000  Sigma  
anti-Pgk1 mouse 1:10000 Molecular Probes 
anti-H3 rabbit 1:2500 Lake Placid Biologicals 
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anti-H3K4me rabbit 1:500 Upstate 
anti-H3K4me2 rabbit 1:1000 Upstate 
anti-H3K4me3 rabbit 1:2500 Upstate 
anti-H3K36me3 rabbit 1:1000 Abcam 
anit-H3K79me2 rabbit 1:500 Upstate 
anti-H4K12 acetyl rabbit 1:1000 Upstate 
anti-Rfa1 rabbit 1:2000 Brill lab 
anti-Rfa2 rabbit 2:2000 Brill lab 
anti-Bur1 rabbit 1:5000 Sträßer lab 
anti-Rpb1 CTD mouse 1:500 Covance 
anti-Rpb1 S2 P mouse 1:500 Covance 
anti-Rpb1 S5 P mouse 1:500 Covance 
anti-Flag mouse 1:5000 Sigma 
anti-RFP goat 1:500 Leonhardt lab 
anti-RPA32 mouse 1:1000 Abcam 
anti-Ctk1 rabbit 1:5000 Sträßer lab 
anti Rad53 goat 1:100 Santa Cruz 
Secondary antibodies 
anti mouse IgG HRPO  goat  1:3000  Biorad  
anti rabbit IgG HRPO  goat  1:3000  Biorad  
anti goat IgG-HRPO  goat 1:5000 Sigma 
4.7 Oligonucleotides 
Name Sequence Purpose 
5'-BamHI-BUR1 
aa365-ATG 
GGGGGATCCATGTGGTTTAAAGAGGACCC
TTTACA 
Bur1-Cterm constructs starting 
from aa365 
5'-BamHI-BUR1 GGGGGATCCATGGAAAAGGGTGAATCAC Bur1-Cterm constructs starting 
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aa413-ATG CTGTCGTG from aa413 
5'-BamHI-BUR1 
aa390-ATG 
GGGGGATCCATGATTAAGAGGTACAAGGA
AGAAATGC 
Bur1-Cterm constructs starting 
from aa390 
5'-BamHI-BUR1 
aa450-ATG 
GGGGGATCCATGTCGAAAATAAGAGAACT
ACATCAAA 
Bur1-Cterm constructs starting 
from aa450 
5'-BamHI-BUR1 
aa500-ATG 
GGGGGATCCATGAGCACTGCACCCAACA
ACAGCAG 
Bur1-Cterm constructs starting 
from aa500 
5'-BamHI-BUR1 
aa510-ATG 
GGGGGATCCATGGTAAATCGATTTCATCC
TGAGACA 
Bur1-Cterm constructs starting 
from aa510 
5'-BamHI-BUR1 
aa520-ATG 
GGGGGATCCATGAGCTCTAAATATAATAA
AGTACCTT 
Bur1-Cterm constructs starting 
from aa520 
5'-BamHI-BUR1 
aa540-ATG 
GGGGGATCCATGTCAAATGAGTCCCGGTA
CAAAAAC 
Bur1-Cterm constructs starting 
from aa540 
5'-BamHI-BUR1 
aa560-ATG 
GGGGGATCCATGGTGAACAAGCCGGAAA
CCAACTTC 
Bur1-Cterm constructs starting 
from aa560 
5'-BamHI-BUR1 
aa580-ATG 
GGGGGATCCATGAATGCGCCAATCAATAA
AAATTATAA 
Bur1-Cterm constructs starting 
from aa580 
5'-BamHI-BUR1 
aa600-ATG 
GGGGGATCCATGCATCATCAAGGCTCGA
GACCTTC 
Bur1-Cterm constructs starting 
from aa600 
5'-BamHI-BUR1 
aa470-ATG 
GGGGGATCCATGAAAACTGCGATTCCACC
GCCAGC 
Bur1-Cterm constructs starting 
from aa470 
5'-BamHI-BUR1 
aa480-ATG 
GGGGGATCCATGGCAGGAGTTAATAGATA
CCGACCC 
Bur1-Cterm constructs starting 
from aa480 
5'-BamHI-BUR1 
aa490-ATG 
GGGGGATCCATGAGTTCCAGAAATAATCG
CTTCAGC 
Bur1-Cterm constructs starting 
from aa490 
3'-SalI-STOP- 
BUR1 cterm 
GGGGTCGACTTAATATAGATCTGCAATAT
CACTATTTT 
Bur1-Cterm constructs ending 
at aa657  inlcluding STOP 
3'-SalI-BUR1 
aa650-STOP 
GGGGTCGACTTAATTTTGGAACTCCTTAG
ACTCATCT 
Bur1-Cterm constructs ending 
at aa650 inlcluding STOP 
3'-SalI-BUR1 
aa630-STOP 
GGGGTCGACTTATTCTCTATTGGTTTACTC
GTAAGCT 
Bur1-Cterm constructs ending 
at aa630 inlcluding STOP 
3'-SalI-BUR1 
aa610-STOP 
GGGGTCGACTTATGGATGAGAAGGTCTCG
AGCCTT 
Bur1-Cterm constructs ending 
at aa610 inlcluding STOP 
3'-SalI-BUR1 
aa598-STOP 
GGGGTCGACTTAAGCCATATTGCGAGAAC
CGTTTG 
Bur1-Cterm constructs ending 
at aa598 inlcluding STOP 
3'-SalI-BUR1 
aa590-STOP 
GGGGTCGACTTAAGGATTATAATTTTTATT
GATTGGCG 
Bur1-Cterm constructs ending 
at aa590 inlcluding STOP 
3'-SalI-BUR1 
aa570-STOP 
GGGGTCGACTTACCTATTGAAGTTGGTTT
CCGGCTT 
Bur1-Cterm constructs ending 
at aa570 inlcluding STOP 
3'-SalI-BUR1 
aa550-STOP 
GGGGTCGACTTATGGCGAGTTTTTGTACC
GGGACTC 
Bur1-Cterm constructs ending 
at aa550 inlcluding STOP 
3’-SalI-BUR1 
aa 530-STOP 
GGGGTCGACTTATGGCAAAGGTACTTTAT
TATATTTAG 
Bur1-Cterm constructs ending 
at aa530 inlcluding STOP 
3'-SalI-BUR1 
aa500-STOP 
GGGGTCGACTTAGCTGAAGCGATTATTTC
TGGAACT 
Bur1-Cterm constructs ending 
at aa500 inlcluding STOP 
3'-SalI-BUR1 GGGGTCGACTTAATTGTTGGGTCCGTATC Bur1-Cterm constructs ending 
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aa490-STOP TATTAACT at aa 490 inlcluding STOP 
3'-SalI-BUR1 
aa480-STOP 
GGGGTCGACTTAAGGGGCTGCTGGCGGT
GGAATC 
Bur1-Cterm constructs ending 
at aa480 inlcluding STOP 
3'-SalI-BUR1 
aa470-STOP 
GGGGTCGACTTAAGCATATCCGCTGTTCA
CATGATA 
Bur1-Cterm constructs ending 
at aa470 inlcluding STOP 
3'-SalI-BUR1 
aa460-STOP 
GGGGTCGACTTAAGGATTTTGATGTAGTT
CTCTTATTT 
Bur1-Cterm constructs ending 
at aa460 inlcluding STOP 
3'-SalI-BUR1 
aa450-STOP 
GGGGTCGACTTACGGCTTAGCCAATACGT
TCTTTGATG 
Bur1-Cterm constructs ending 
at aa450 inlcluding STOP 
3'-SalI-BUR1 
aa400-STOP 
GGGGTCGACTTATGATTGGTGCATTTCTT
CCTTGTAC 
Bur1-Cterm constructs ending 
at aa400 inlcluding STOP 
3’- Bur1 Del  
490-500 
GCTGTTGTTGGGTGCAGTGCTATTGTTGG
GTCCGTATCTATTAACTCC 
5’- Bur1 Del 
 490-500 
AATAGATACGGACCCAACAATAGCACTGC
ACCCAACAACAGCAGGA 
Deletion of aa490 bis 500 in 
Bur1-Cterm construct 
3’- Bur1 Del  
480-490 
GCTGAAGCGATTATTTCTGGAAGGGGCTG
CTGGCGGTGGAATCGCAGT 
5’- Bur1 Del  
480-490 
ATTCCACCGCCAGCAGCCCCTAGTTCCAG
AAATAATCGCTTCAGCG 
Deletion of aa480 bis 490 in 
Bur1-Cterm constructs 
3’- Bur1 Del  
540-550 
TATGATATCTAGAGTCATTATTACCCTGGT
ATCTTGACTGAGGCCC 
5’- Bur1 Del  
540-550 
CAGTCAAGATACCAGGGTAATAATGACTC
TAGATATCATAACCCTA 
Deletion of aa540 bis  550 in 
Bur1-Cterm constructs 
3’- Bur1 Del  
550-560 
GGTTTCCGGCTTGTTCACTGGCGAGTTTT
TGTACCGGGACTCATT 
5’- Bur1 Del  
550-560 
TCCCGGTACAAAAACTCGCCAGTGAACAA
GCCGGAAACCAACTTC 
Deletion of aa550 bis 560 in 
Bur1-Cterm constructs 
3’-BUR1 Del  
560-570 
GGCGACTATATTTCTGTGGTTGTGGCGAG
TTTTTGTACCGGGACTCA 
5’-BUR1 Del  
560-570 
GATATCATAACCCTAGGTACCAACCACAG
AAATATAGTCGCCAAGAA 
Deletion of aa560 bis 570 in 
Bur1-Cterm constructs 
5'-NotI-BUR1 
Prom 
GGGGCGGCCGCTTTTTACCGAGAAATCAG
CCGTTGG 
cloning of the BUR1 promoter 
3'-BamHI-BUR1 
Prom 
GGGGGATCCATTATTTTACTGTTATTCTGC 
TTGACC 
cloning of the BUR1 promoter 
5'-BamHI-BUR1 –
ATG 
GGGGGATCCATGAGTGATAATGGTTCCCC
CG 
cloning of Bur1 for expression 
and complementation studies 
3'- SalI-STOP- 
BUR1 kinase 
aa372 
GGGGTCGACTTATGGTAAAGGGTCCTCTT
TAAACC 
cloning of Bur1 kinase domain 
for complementation studies 
3'- SalI-noSTOP- 
BUR1 kinase 
aa372 
GGGGTCGACTGGTAAAGGGTCCTCTTTAA
ACC 
cloning of Bur1 kinase domain 
for expression studies 
5'-BamHI-BUR1 
aa365-ATG 
GGGGGATCCATGTGGTTTAAAGAGGACCC
TTTACCA 
 
cloning of Bur1 C-terminus for 
expression and 
complementation studies 
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3'-SalI-STOP- 
BUR1 cterm 
GGGGTCGACTTATATAGATCTGCAATATC
ACTATTTTG 
 
cloning of Bur1 C-terminus 
complementation studies 
3'-SalI-noSTOP- 
BUR1 cterm 
GGGGTCGACTATAGATCTGCAATATCACT
ATTTTG 
 
cloning of Bur1 C-terminus for 
expression studies 
5’-NcoI-Oligo1-
Flag-TAP 
 
GGGTCCATGGAAAAGAGAAGAATGGACTA
CAAGGACGACGATGACAAGGATTATGATA
TTCCAACTACTGCTAGC 
 
cloning of pBS1479-Flag-TEV-
ProtA 
3’-KpnI-TAP GGGGGTACCGGGCCCATGTTTGATACATG cloning of pBS1479-Flag-TEV-
ProtA 
5'-XhoI-MSH6 
 
GGGCTCGAGAGTTTTCTGAATGGCCAACT
TTCC 
Cloning of MSH6 
3'-BamHI-MSH6  GGGGGATCCACCCCATTCTTGCCCAAGAT
GCG 
Cloning of MSH6 
5'-XhoI-POL4 
 
GGGCTCGAGTGATAATGGTCCAGCGTGG
TTACA 
Cloning of POL4 
3'-BamHI-POL4 
 
GGGGGATCCTCATTGGTGGTGGTGACACT
GCC 
Cloning of POL4 
5'-XhoI-RAD16  GGGCTCGAGGTTTTAAAGTTCGTCAGTTG
TTCC 
Cloning of RAD16 
3'-BamHI-RAD16  GGGGGATCCGACAGGTGTTGATTGGTCTA
ATGG 
Cloning of RAD16 
5'-SalI-RAD26 
 
GGGGTCGACGATCAACAGTACGAAAACTT
GTGC 
Cloning of RAD26 
3'-BamHI-RAD26  GGGGGATCCACAAAGTATGTAGGTGGCTT
CTCC 
Cloning of RAD26 
5'-BamHI-XRS2 
 
GGGGGATCCCTAGACATTCAATGGTACTC
AAGG 
Cloning of XRS2 
3'-SmaI-XRS2  GGGCCCGGGTATCAGTTGGAGTATTCAAA
GAGG 
Cloning of XRS2 
5'-XhoI-APN1  GGGCTCGAGATGGTCGCCACCAAAGGAG
AAGG 
Cloning of APN1 
3'-BamHI-APN1  GGGGGATCCAAACTTTCTATGCTTAGGAA
TAACG 
Cloning of APN1 
5' XhoI-MAG1 
 
GGGCTCGAGCCCTAATCAATAATAAGTCA
TCGG 
Cloning of MAG1 
3'-BamHI-MAG1  GGGGGATCCGCCAAGAGCTCCGATGAGA
AACG 
Cloning of MAG1 
5'-XhoI-RNR1 
 
GGGCTCGAGTACGCGTTTTATCCCATTAT
ATGG 
Cloning of RNR1 
3'-BamHI-RNR1 
 
GGGGGATCCGTGCTATTTAATTACAATTCT
TTGG 
Cloning of RNR1 
5'-SalI-CDC28 
 
GGGGTCGACGTTTACTCTAAGATTGTTAA
CTCC  
Cloning of CDC28 
3'-BamHI-CDC28 GGGGGATCCACTTTCGCGTATAACTGAAT Cloning of CDC28 
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 GTTCC 
5'-SalI-CLN3 
 
GGGGTCGACCTACTGAGTCTGCCAGTCAA
ATGG 
Cloning of CLN3 
3'-BamHI-CLN3 
 
GGGGGATCCTATAATGTGACTAGAGGAAG
TAAGG 
Cloning of CLN3 
5'-SalI-CLB1 
 
GGGGTCGACACTTCAATTTGCGTTCCGCA
TACG 
Cloning of CLN3 
3'-BamHI-CLB1 
 
GGGGGATCCCGTGTGATAATATATATGAG
ATAACC 
Cloning of CLN3 
5'-SalI-CLB6 
 
GGGGTCGACCCAAATAGCAGTTTTACGCG
TACC 
Cloning of CLB6 
3'-BamHI-CLB6 
 
GGGGGATCCATCAGGCATTCATTATTCAT
ATAACG 
Cloning of CLB6 
4.8 Plasmids 
pRS313-BUR1 
pRS314-BUR1 
pRS315-BUR1 
pRS316-BUR1 
Sträßer 
pRS313-bur1-1 
pRS314-bur1-1 
pRS315-bur1-1 
Sträßer 
pRS313-bur1-4 
pRS314-bur1-4 
pRS315-bur1-4 
Sträßer 
pRS313-bur1-7 
pRS314-bur1-7 
pRS315-bur1-7 
Sträßer 
pRS313-bur1-24 
pRS314-bur1-24 
pRS315-bur1-24 
Sträßer 
pRS314-RFA1 
pRS315-RFA1 
pRS316-RFA1 
Winkler 
pRS313-RFA1 RFA1 was cut out BamHI, XhoI from pRS314-RFA1 and cloned into the 
same sites of pRS313 
pRS315-rfa1-6 
pRS315-rfa2-1-4 
pRS315-rfa2-26-2 
pRS315-rfa3-6-1 
pRS315-rfa3-8-1 
pRS315-rfa3-16-1 
Winkler 
pRS314-rfa1-249 
 
plasmid pRS314-RFA1 was mutagenized in vitro using hydroxylamine, 
transformed into the RFA1 shuffle strain and ts phenotypes selected 
after shuffling 
pRS313-rfa1-249 
pRS315-rfa1-249 
 
rfa1-249 was cut out BamHI, XhoI from pRS314-rfa1-249 and cloned 
into the same sites of pRS313 or pRS315 
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pGEX-4T-3 GE Healthcare 
pGEX-4T-3-BUR1 
truncations 
Müller 
pRS314-RAD52 
pRS316-RAD52 
 
Winkler 
pRS315-MSH6 
pRS316-MSH6 
 
MSH6 was PCR amplified form genomic DNA using primers 5'-XhoI-
MSH6 ca. 500 bp upstream of MSH6 and 3'-BamHI-MSH6 ca. 300 bp 
downstream of MSH6 and cloned into the same sites of pRS315 or 
pRS316 
pRS315-POL4 
pRS316-POL4 
POL4 was PCR amplified from genomic DNA using primers 5'-XhoI-
POL4 ca. 500 bp upstream of POL4 and 3'-BamHI-POL4 ca. 300 bp 
downstream of POL4 and cloned into the same sites of pRS315 or 
pRS316 
pRS315-RAD16 
pRS316-RAD16 
 
 
RAD16 was PCR amplified from genomic DNA using primers 5'-XhoI-
RAD16 ca. 500 bp upstream of RAD16 and 3'-BamHI-RAD16 ca. 300 bp 
downstream of RAD16 and cloned into the same sites of pRS315 or 
pRS316 
pRS315-RAD26 
pRS316-RAD26 
 
 
RAD26 was PCR amplified from genomic DNA using primers 5'-SalI-
RAD26 ca. 500 bp upstream of RAD26 and 3'-BamHI-RAD26 ca. 300 bp 
downstream of RAD26 and cloned into the same sites of pRS315 or 
pRS316 
pRS313-XRS2 
pRS316-XRS2 
 
 
XRS2 was PCR amplified from genomic DNA using primers 5'-BamHI-
XRS2 ca. 500 bp upstream of XRS2 and 3'-SmaI-XRS2 ca. 300 bp 
downstream of XRS2 and cloned into the blunted BamHI site of pRS313 
or pRS316 
pRS313-APN1 
pRS316-APN1 
 
 
APN1 was PCR amplified from genomic DNA using primers 5'-XhoI-
APN1 ca. 500 bp upstream of APN1 and 3'-BamHI-APN1 ca. 300 bp 
downstream of APN1 and cloned into the same sites of pRS313 or 
pRS316 
pRS315-MAG1 
pRS316-MAG1 
 
 
MAG1 was PCR amplified from genomic DNA using primers 5' XhoI-
MAG1 ca. 500 bp upstream of MAG1 and 3'-BamHI-MAG1 ca. 300 bp 
downstream of MAG1 and cloned into the same sties of pRS315 or 
pRS316 
pRS315-RNR1 
 
RNR1 was PCR amplified from genomic DNA using primers 5'-XhoI-
RNR1 ca. 500 bp upstream of RNR1 and 3'-BamHI-RNR1 ca. 300 bp 
downstream of RNR1 and cloned into the same sites of pRS315 
pRS315-DST1 
pRS316-DST1 
Sträßer 
pRS315-RTF1 
pRS316-RTF1 
Sträßer 
YEplac181-CDC28 CDC28 was PCR amplified from genomic DNA using primers 5'-SalI-
CDC28 and 3'-BamHI-CDC28 and cloned into the same sites of 
YEplac181 
YEplac181-CLN3 CLN3 was PCR amplified from genomic DNA using primers 5'-SalI-
CLN3 and 3'-BamHI-CLN3 and cloned into the same sites of YEplac181 
YEplac181-CLB1 CLB1 was PCR amplified from genomic DNA using primers 5'-SalI-CLB1 
and 3'-BamHI-CLB1 and cloned into the same sites of YEplac181 
YEplac181-CLB6 CLB6 was PCR amplified from genomic DNA using primers 5'-SalI-CLB6 
and 3'-BamHI-CLB6 and cloned into the same sites of YEplac181 
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pBS1479-Flag-TEV-ProtA Flag-TEV-ProteinA was PCR amplified from pBS1479, adding the Flag 
epitope instead of CBP using primers 5’-NcoI-Oligo1-Flag-TAP and 3’-
KpnI-TAP and cloned into the same sites of pBS1479 after cutting the 
standard TAP tag using these enzymes, respectively. 
pBS-bur1-1 
pBS-bur1-4 
pBS-bur1-7 
pBS-bur1-24 
Hiechinger 
pBS-bur1-1::LEU2 The LEU2 marker was cut out of YDp-L with BamHI, blunt-ended and 
cloned in the Eco47III site of pBS-bur1-1 
pBS-bur1-4::LEU2 The LEU2 marker was cut out of YDp-L with BamHI, blunt-ended and 
cloned in the Eco47III site of pBS-bur1-4 
pBS-bur1-7::LEU2 The LEU2 marker was cut out of YDp-L with BamHI, blunt-ended and 
cloned in the Eco47III site of pBS-bur1-7 
pBS-bur1-24::LEU2 The LEU2 marker was cut out of YDp-L with BamHI, blunt-ended and 
cloned in the Eco47III site of pBS-bur1-24 
pRS315-TADH1 Röther 
pRS315-TAP-TADH1 Röther 
pRS315-BUR1 Prom-
TADH1 
 
BUR1 Promoter was PCR amplified from genomic DNA using primers 
adding NotI and BamHI sites and was cloned into the same sites of 
pRS315-TADH1 
pRS315-BUR1 Prom-TAP-
TADH1 
 
BUR1 Promoter was PCR amplified from genomic DNA using primers 
adding NotI and BamHI sites and was cloned into the same sites of 
pRS315-TAP-TADH1 
pRS315-BUR1-FL-TAP-
TADH1 
The BUR1 ORF was PCR amplified from genomic DNA using primers 
adding a 5’-BamHI site and a 3’- XhoI site and a deletion of the STOP 
codon. This PCR product was subsequently cloned into the BamHI and 
XhoI sites of pRS315-BUR1 Prom-TAP-TADH1 
pRS315-BUR1 C-
terminus-TAP-TADH1 
 
The BUR1 C-Terminus starting from amino acid 365 was PCR amplified 
from genomic DNA using primers adding a 5’-BamHI site, a 3’-XhoI site, 
an ATG and a mutation of the STOP codon. This PCR product was 
subsequently cloned into the BamHI and XhoI sites of pRS315-BUR1 
Prom-TAP-TADH1. 
pRS315- BUR1-FL-TADH1 
 
The BUR1 ORF was PCR amplified from genomic DNA using primers 
adding a 5’-BamHI site and a 3’ XhoI site. This PCR product was 
subsequently cloned into the BamHI and XhoI sites of pRS315-BUR1 
Prom-TAP-TADH1 
pRS315-bur1∆C-TADH1 
 
The BUR1 kinase domain from amino acid 1 until 372 was PCR 
amplified from genomic DNA using primers adding a 5’-BamHI site, a 3’-
XhoI site and an ATG. This PCR product was subsequently cloned into 
the BamHI and XhoI sites of pRS315-BUR1 Prom-TADH1 
pRS315-BUR1 C-
Terminus-TADH1 
 
The BUR1 C-Terminus starting from amino acid 365 was PCR amplified 
from genomic DNA using primers adding a 5’-BamHI site, a 3’-XhoI site 
and an ATG. This PCR product was subsequently cloned into the BamHI 
and XhoI sites of pRS315-BUR1 Prom-TAP-TADH1 
RPA32-GFP Leonhadt lab 
pRS313-GAL1::LacZ Breuning lab 
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The following previously described plasmids were used:  
pRS314-YRA1, pRS314-yra1-451, pRS314-yra1-635, pRS314-yra1-667 = yra1-1, 
pRS315-MFT1 (Strasser et al. 2000; Strasser and Hurt 2000; Hurt et al. 2004), 
pRS315-THO2 (A. Aguilera), pUN100-HPR1 (Joris Braspening / Jochen Baßler), 
pRS313, pRS314, pRS315, pRS316 (Sikorski and Hieter, 1989), pBSKS (+) (Alting-
Mees et al., 1992), pBS1479, pBS1539 (Puig et al., 2001). 
4.9 Strains 
E. coli strains 
 
DH5α F-, φ80dlacZ∆M15, ∆(lacZYA-argF)U169, deoR, recA1, endA1, 
hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1 
BL21 DE3 F–, ompT, hsdSB(rB-, mB-), dcm, gal, λ(DE3) 
 
S. cerevisiae stains 
 
RS453 MAT a; ade2-1; his3-11,15; ura3-52; leu2-3,112; 
trp1-1; can1-100; GAL+ 
 
BUR1 YRA1 
double shuffle 
MAT a; his3; leu2; ura3; trp1; ade2; 
YPR161c::kanMX4; YJL173c::kanMX4 
pRS316-BUR1; pRS316-YRA1 
BUR1 shuffle (spore IIIa) was 
mated YRA1 shuffle (sporeIb), 
spore Ib 
Bur1-TAP as RS453; MAT a; BUR1-CBP-TEV-
protA::TRP1-KL; 
Sträßer 
Bur2-TAP as RS453; MAT a; BUR2-CBP-TEV-
protA::TRP1-KL; 
Sträßer 
Rfa1-TAP RS453; MAT a; RFA1-CBP-TEV-protA::TRP1-
KL; 
Sträßer 
Prt1-TAP as RS453; MAT a; PRT1-CBP-TEV-
protA::TRP1-KL; 
Röther 
BUR1 shuffle BY and RS; MAT a; his3; leu2; ura3; trp1; ade2; 
YPR161c::kanMX4 
Hiechinger 
RFA1 shuffle BY and RS; MAT a; ade2; his3; ura3; leu2; trp1; 
can1-100; GAL+;YAR007c::kanMX4 
Winkler 
BUR1 RFA1 
double shuffle 
BY and RS; MAT α; his3; leu2; ura3; trp1; 
YPR161c::kanMX4YAR007c::kanMX4 
pRS316-BUR1; pRS316-RFA1 
BUR1 shuffle was mated to 
RFA1 shuffle, spore Ia 
BUR1 MSH6 
double shuffle 
BY and RS; MAT α; his3; leu2; ura3; trp1; ade2; 
YPR161c::kanMX4; YDR097c::kanMX4 
pRS316-BUR1; pRS316-MSH6 
BUR1 shuffle was mated to 
∆msh6 (spore IVc), spore Vb 
BUR1 POL4 
double shuffle 
BY and RS; MAT a; his3; leu2; ura3; trp1; ade2; 
YPR161c::kanMX4; YCR014c::kanMX4 
pRS316-BUR1; pRS316-POL4 
BUR1 shuffle was mated to 
∆pol4 (spore IId), spore Ia 
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BUR1 RAD16 
double shuffle 
BY and RS; MAT α; his3; leu2; ura3; trp1; ade2; 
YPR161c::kanMX4; YBR114w::kanMX4 
pRS316-BUR1; pRS316-RAD16 
BUR1 shuffle was mated to 
∆rad16 (spore Id), spore VIb 
BUR1 RAD26 
double shuffle 
BY and RS453; MAT α; his3; leu2; ura3; trp1 
YJR035w::kanMX4; YPR161c::kanMX4 
pRS316-BUR1; pRS316-RAD26 
BUR1 shuffle (spore Ia) was 
mated to ∆rad26 (spore IId), 
spore Ia 
BUR1 RAD16 
suffle ∆rad26 
BY and RS453; MAT α; his3; leu2; ura3; trp1 
YJR035w::kanMX4; YPR161c::kanMX4; 
YBR114w::HIS3 
pRS316-BUR1; pRS316-RAD16 
rad26 KO::HIS3 (Chanarat) was 
integrated into BUR1 ∆rad16 
bur1-7 XRS2 
shuffle 
BY; MAT a; his3; leu2; ura3; TPR1+; 
YDR369c::kanMX4; bur1-7::LEU2 
pRS316-XRS2 
bur1-7::LEU2 was integrated 
into XRS2 shuffle (spore Ia)  
BUR1 APN1 
double shuffle 
BY and RS; MAT a; his3; leu2; ura3; TRP1+; 
YPR161c::kanMX4; YKL114c::kanMX4 
pRS316-BUR1; pRS316-APN1 
BUR1 shuffle was mated to 
∆apn1 (spore Ib),  spore Ia  
BUR1 MAG1 
double shuffle 
BY and RS;MAT α; his3; leu2; ura3; trp1; 
YPR161c::kanMX4; YER142c::kanMX4 
pRS316-BUR1; pRS316-MAG1 
BUR1 shuffle was mated to 
∆mag1 (spore Id), spore VIII b 
BUR1 RNR1 
double shuffle 
BY and RS; MAT a; his3; leu2; ura3; trp1; ade2; 
YPR161c::kanMX4; YER070w::kanMX4 
pRS316-BUR1; pRS316-RNR1 
BUR1 shuffle was mated to 
∆rnr1 (spore IIa),spore IVb 
RFA1 DST1 
double shuffle 
BY and RS; MAT a; his3; leu2; ura3;  trp1; 
YAR007c::kanMX4; YGL043w::kanMX4 
pRS316-RFA1; pRS316-DST1 
RFA1 shuffle was mated to 
∆dst1 (Y136), spore IVb 
RFA1 RTF1 
double shuffle 
BY and RS; MAT a; his3; leu2; ura3; TRP1+; 
YAR007c::kanMX4; YGL244w::kanMX4 
pRS316-RFA1; pRS316-RTF1 
RFA1 shuffle (spore aIb) was 
mated to ∆rtf1 (Y110), spore 
IVa 
HPR1 RFA1 
double shuffle 
W303, RS453, BY; MAT a; ade2; his3; ura3; 
leu2; trp1; YAR007c::kanMX4; hpr1::HIS3 
pRS316-RFA1; pRS316-HPR1 
∆hpr1 (spore VId) was mated to 
RFA1 shuffle, spore IIId 
MFT1 RFA1 
double shuffle 
W303, RS453, BY; MAT α; ade2; his3; ura3; 
leu2; trp1; can1-100; mft1::kanMX4; 
YAR007c::kanMX4 
pRS316-RFA1; pRS316-MFT1 
∆mft1 (spore Ia) was mated  to 
RFA1 shuffle, spore Ib 
HPR1 RFA2 
double shuffle 
W303, RS453, BY; MAT a; ade2; his3; ura3; 
leu2; trp1; can1-100; YNL312w::kanMX4; 
hpr1::HIS3 
pRS316-RFA2; pRS316-HPR1 
∆hpr1 (spore VId) was mated to 
RFA2 shuffle (spore dId), spore 
Id 
MFT1 RFA2 
double shuffle 
W303, RS453, BY; MAT a; ade2; his3; ura3; 
leu2; trp1; can1-100; YNL312w::kanMX;  
mft1::kanMX4 
pRS316-RFA2; pRS316-MFT1 
Sträßer 
HPR1 RFA3 
double shuffle 
W303, RS453, BY; MAT α; ade2; his3; ura3; 
leu2; trp1; can1-100; YJL173c::kanMX4; 
hpr1::HIS3 
pRS316-RFA3; pRS316-HPR1 
∆hpr1 (spore VId) was mated to 
RFA3 shuffle (spore IVb), spore 
Id 
MFT1 RFA3 
double shuffle 
W303, RS453, BY; MAT α; ade2; his3; ura3; 
leu2; trp1; can1-100; YJL173c::kanMX4; 
mft1::kanMX4 
pRS316-RFA3; pRS316-MFT1 
∆mft1 (spore Ia) was mated  to 
RFA3 shuffle (spore IVb), spore 
Vb 
Materials 
 90
THO2 RFA3 
double shuffle 
W303, RS453, BY; MAT a; ade2; his3; ura3; 
leu2; trp1; can1-100; YJL173c::kanMX4; 
tho2::kanMX4 
pRS316-RFA3; pRS316-THO2 
Sträßer 
THP2 RFA3 
double shuffle 
RS and BY; MAT a; his3; leu2; ura3; trp1; 
ADE2; YJL173c::kanMX4; thp2::kanMX4 
pRS316-RFA3; pRS316-THP2 
Sträßer 
bur1-1::LEU2 MAT a; ade2-1; his3-11,15; ura3-52; 3,112; 
trp1-1; can1-100; GAL+; bur1-1::LEU2 
bur1-1 was integrated into 
RS453 using the NotI, SalI 
fragment from pBS-bur1-
1::LEU2 
bur1-4::LEU2 MAT a; ade2-1; his3-11,15; ura3-52; 3,112; 
trp1-1; can1-100; GAL+; bur1-4::LEU2 
bur1-4 was integrated into 
RS453 using the NotI, SalI 
fragment from pBS-bur1-
4::LEU2 
bur1-7::LEU2 MAT a; ade2-1; his3-11,15; ura3-52; 3,112; 
trp1-1; can1-100; GAL+; bur1-7::LEU2 
bur1-7 was integrated into 
RS453 using the NotI, SalI 
fragment from pBS-bur1-
7::LEU2 
bur1-24::LEU2 MAT a; ade2-1; his3-11,15; ura3-52; 3,112; 
trp1-1; can1-100; GAL+; bur1-7::LEU2 
bur1-24 was integrated into 
RS453 using the NotI, SalI 
fragment from pBS-bur1-
24::LEU2 
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5. Methods  
5.1 Standard methods  
Cloning procedures such as restriction digest, dephosphorylation of fragments, 
ligations, and transformation of newly generated vectors in Escherichia coli and 
separation of DNA in agarose gels were done according to Sambrook and Russell, 
CSHL Press, 2001. Commercial available kits were used according to manufacturer’s 
instructions.  
Amplification of yeast genes or TAP-tags was usually done in a 50-100 µl KNOP-
PCR reaction using 0.5 µM primer1, 0.5 µM primer2, 0.2 mM of each dNTP, 1 x 
KNOP buffer (50 mM Tris-HCl, pH 9.2, 16 mM (NH4)2SO4, 2.25 mM MgCl2), 0.3 µl 
genomic DNA or 1 µl 1:20 diluted plasmid Midi prep and 1 µl KNOP polymerase (2U 
Taq, 0.56 U Vent). In general, the following amplification protocol was used: 2 min 
94°C, [1 min 94°C, 30 s at the respective °C, 1 min / 1000 bp 68°C], 35 cycles, 10 
min 68°C.  
To check for the correct integration of the disruption cassette, colony PCR was 
performed. A 25 µl reaction was assembled, containing 1 µM primer1, 1 µM primer2, 
62.5 µM of each dNTP, 750 µM MgCl2 and 1x Taq buffer (Fermentas, St. Leon-Rot). 
Freshly growing cells were picked with a yellow tip and added to the reaction. The 
PCR reaction was boiled for 15 min, before 1.5 U Taq polymerase (Fermentas, St. 
Leon-Rot) were added. Amplification was performed using the following protocol: [30 
s 95°C, 30 s 45°C, 60 s 72°C] 25 cycles, 2 min 72°C.  
Point mutations were inserted by quick change mutagenesis using Pfu or Pfu Turbo 
polymerase (Stratagene). The PCR product was then digested with 10 U DpnI for 2 
hours at 37°C. 50 µl of the reaction were then transformed into E. coli DH5α. Point 
mutations or plasmids were sent for sequencing to Medigenomix (Munich).  
Fusion PCR for deletion mutants were also perfomed using Pfu polymerse. 
5.2 Yeast-specific techniques  
5.2.1 Culture of S. cerevisiae  
Yeast strains were cultured in either full-medium or synthetic complete (SC) medium. 
Full-medium contained 1% yeast extract (Becton Dickinson, Heidelberg), 2% Bacto-
Peptone (Becton Dickinson, Heidelberg) and either 2% glucose (YPD) or 2% 
galactose (YPG). Synthetic complete media contained 0.67% yeast nitrogen base 
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(Formedium, Norwich, UK), 0.06% complete synthetic mix (including all essential 
amino acids except the four amino acids used as auxotrophy markers, i.e. leucine, 
tryptophane, histidine, uracil and adenine) and either 2% glucose (SDC) or 2% 
galactose (SGC). 5-FOA was added to a final concentration of 0.1%.  
5.2.2 Transformation of yeast cells  
50 ml of yeast were grown to an optical density of 0.5 to 0.8 and harvested by 
centrifugation for 3 min at 3600 rpm using a Rotanda 46R centrifuge. After washing 
with 10 ml H2O, the pellet was resuspended in 500 µl of solution I (10 mM Tris-HCl, 
pH 7.5, 1 mM EDTA, 100 mM Li-acetate). After centrifugation, the pellet was 
resuspended in 250 µl solution I. 1 µl of Midi-prep DNA or 5 µl of Mini-Prep DNA was 
provided in a tube, 5 µl of single strand carrier DNA (DNA of salmon or herring testis, 
2 mg/ml), 50 µl of cells in solution I and 300 µl of solution II (10 mM Tris-HCl, pH 7.5, 
1 mM EDTA, 100 mM Li-acetate, 40% PEG-4000) was added and the mixture was 
incubated for 30 min on a turning wheel at room temperature. Transformations were 
then heat-shocked for 10 min at 42°C, followed by 3 min incubation on ice. 1 ml of 
H2O was added and centrifuged. The pellet was resuspended in 50-µl H2O and 
plated on selective plates. For genomic integrations of a galactose promoter, a TAP-
tag or a disruption cassette, the pellets were resuspended in 1 ml YPD or YPG and 
incubated for 1 h at room temperature on a turning wheel prior to plating. To 
transform yeast cells grown on plate, 1 loop of freshly restreaked yeast cells was 
resuspended in 100 mM Li-acetate and vortexed. DNA, carrier DNA and solution II 
were added as described above. After incubation for 30 min on a turning wheel at 
RT, 35 µl DMSO were added prior to heat shock and transformations were then 
treated as described above.  
5.2.3 Preparation of genomic DNA  
10 ml of an overnight RS453 culture with an OD600nm > 1 were centrifuged (3 min, 
3600 rpm) and washed with 10 ml H2O. The cells were resuspended in 500 µl H2O 
and 200 µl lysis buffer (2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris-HCl, 
pH 8.0, 1 mM EDTA). 300 µl glass beads and 300 µl 
phenol:chloroform:isoamylalcohol (25:24:1) were added and the mixture was 
vortexed for 3 min. After a centrifugation for 10 min at 16,000 g the upper phase was 
removed and extracted with an equal volume of chloroform. Genomic DNA was 
precipitated using 1.2 ml 100% ethanol and incubation of the solution for 10 min at -
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20°C. After a centrifugation for 30 min at 4°C and 16,000 g, the pellet was dried and 
resuspended in 400 µl TE (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, pH 8.0). To destroy 
RNA, 20 µl RNaseA (10 mg/ml) were added and incubated for 40 min at 37°C. 
Genomic DNA was precipitated by addition of 40 µl 3 M Na-acetate, pH 5.2 and 800 
µl 100% ethanol and incubation of the mixture for 10 min at – 20°C. After 
centrifugation (16,000 g, 4°C, 30 min) the pellet was washed with 80% ethanol, dried 
and resuspended in 30 µl TE.  
5.2.4 Genomic integration of a TAP (tandem-affinity-purification) tag  
The genomic integration of the TAP-tag is achieved by homologous recombination of 
the C-terminal region of the respective gene with a transformed PCR-product 
containing the TAP-tag and an auxotrophy marker. For C-terminal tagging, the 5’ 
primer consisted of 50 nucleotides of yeast genomic sequence flanking the 
integration site before the stop codon plus 5’-tccatggaaaagagaag-3’ (YXZ-oligo1), 
which hybridizes at the 5’ end of the CBP coding sequence. The 3’ primer consisted 
of 50 nucleotides in the 3’ UTR region, 30 nt downstream of the stop codon (-30 to -
80) plus 5’-tacgactcactataggg-3’, which anneals downstream of the selection marker 
(XYZ-oligo2). These primers were used to amplify the TAP-tag using pBS1539 
(URA3) or pBS1479 (TRP1) as template (Puig et al. 2001), following the Knop-PCR 
protocol. The PCR-product was then purified via phenol chloroform extraction. 100 µl 
PCR-product was mixed with 60 µl phenol:chloroform:isoamylalcohol (25:24:1). After 
10 min centrifugation at 16,000 g, the upper phase was removed, mixed with an 
equal volume of chloroform and centrifuged for 5 min at 16,000 g. The upper phase 
was removed, mixed with 1 / 10 volume of 3 M Na-acetate and 2 volumes of 100% 
ethanol. After incubation for 1 h at -20°C, the DNA was precipitated and washed with 
70% ethanol. The pellet was dried and resuspended in 10 µl TE. The DNA was then 
transformed into the yeast cells (5.2.2) to achieve integration into the genome by 
homologous recombination. Transformants were then tested for the presence of the 
tag by Western Blotting (5.13). 
5.2.5 Crossings of yeast strains to test for synthetic lethality and 
Epistasis  
Synthetic lethality can be assessed by either combining the deletion of two non-
essential genes or by analyzing combinations between different allelic mutations in 
case of essential genes. Thus, double knockout shuffle strains of the genes of 
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interest needed to be created. Haploid parental strains carrying opposite mating 
types were mixed onto YPD plates. After several hours, the characteristic diploid cells 
were selected using a dissection microscope onto YPD plates. As soon as these cells 
formed colonies, they were first transferred to the respective plates (either YPD or 
SDC-ura) and on the following day transferred to a sporulation plate. On these plates, 
the diploid cells undergo meiosis and the genetic information is divided in four 
haploid spores, enclosed in a tetrad. The outer cell wall of the tetrad was destroyed 
by incubating 1 loop of cells in 10 µl Zymolyase 20 T (50 mg/ml, 1.2 M sorbitol, 10 
mM Tris-HCl, pH 8.0, 1 mM EDTA, pH 8.0). The destruction was stopped by addition 
of 30 µl of 10 mM Tris-HCl, pH 8.0, 0.5 mM EDTA, and the spores could be dissected 
using the dissection microscope. Tetrads with 4 growing spores were then restreaked 
onto YPD and the respective drop-out plates. Correct double knockout strains were 
selected by checking for the correct 2:2 auxotrophy marker distribution. Two spores 
with the opposite mating type were chosen to test for synthetic lethality. 
5.2.6 Dot spots and drug sensitivity 
1 loop of freshly growing cells was resuspended in 1 ml water. After performing five 
10-fold serial dilutions, 10-15 µl of the cell suspensions were spotted onto the 
corresponding plate (YPD, SDC-X with or without the addition of drugs). Plates with 
dot spots that were treated with DNA damage inducing agents were incubated in the 
dark to prevent photorepair. 
5.2.7 Quantification of MMS and UV survival 
Quantification of MMS and UV survival rates was tested by growing yeast cells to 
logarithmic phase in selective liquid medium (SDC-X), counting them and plating 
defined amounts onto plates. For the MMS survival rates, the liquid cultures were 
treated with different amounts of MMS for 30 minutes, the MMS was neutralized with 
sodiumthiolulfate and defined amounts of cells were plated out. For the UV survival 
rates, defined amounts of cells were first plated out, the plates were dried by waiting 
for 30-60 minutes and subsequently irradiated with defined doses of UV irradiation 
using a Spectroline UV crosslinker. Plates were immediately wrapped with aluminium 
foil and incubated in the dark for 3-4 days before counting the surviving colonies.  
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5.2.8 Generation of temperature sensitive alleles  
20 µg of pLEU2-RFA1 plasmid DNA was incubated in 500 µl of 2 M hydroxylamine 
buffer for 20 h at 55 °C. The RFA1 shuffle strain was transformed with the 
mutagenized plasmid and cells were streaked on plates containing selection medium 
lacking leucine for 3 days at 30 °C in the dark. About 3800 single colonies were 
picked and streaked on 5-fluoroorotic acid-containing plates at 30 °C.  
Those plates were replica plated onto YPD plates and incubated at 30°C and 37°C. 
One rfa1-ts mutant (rfa1-249) was derived from this screen, recovered and 
reintroduced into RFA1 shuffle to verify the ts phenotype.  
5.2.9 β-galactosidase reporter gene expression 
Cells were grown in synthetic medium containing 2% raffinose before either 2% 
galactose or 2% glucose were added. Cells were harvested after 8 h of logarithmic 
growth, washed twice with Z-buffer, and frozen in liquid nitrogen. Cells were lysed in 
Z-buffer by three freeze and thaw cycles, and the hydrolysis of Onitrophenyl-
galactopyranoside was assayed as described (Miller, 1972). β-galactosidase activity 
was calculated from six independent experiments and glucose values were 
substracted from the galactose values. 
5.3 Cell culture  
HeLa cells were maintained in DMEM high glucose (Invitrogen, Karlsruhe), 
supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml penicilline, 100 
µg/ml streptomycine (all Invitrogen, Karlsruhe). Cells were splitted every other day to 
maintain a proliferating culture.  
Transfections were performed using Lipofectamine 2000 as in the manufacturer’s 
protocol. 
5.4 Tandem affinity purification (TAP)  
TAP allows a rapid and clean purification of native protein complexes using a 
combination of two different tags, Protein A and calmodulin binding protein (CBP), 
separated by a TEV-cleavage site.  
5.4.1 Cell harvest and lysis  
For purification of native protein complexes of S. cerevisiae (Puig et al. 2001), a 2 l 
culture of an optical density of 3-4 was harvested (2 min, 5000 rpm). Cells were first 
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washed with water, followed by a second washing step with 25 ml TAP-buffer (100 
mM NaCl, 50 mM Tris-HCl, pH 7.5, 1.5 mM MgCl2, 0.15% NP-40) plus protease 
inhibitors (1.3 µg/ml pepstatin A, 0.28 µg/ml leupeptin, 170 µg/ml PMSF, 330 µg/ml 
benzamidine). Cells were then flash-frozen in liquid nitrogen. An equal volume of 
TAP-Buffer (containing 1 mM DTT, protease inhibitors) and a double volume of glass 
beads were mixed with the cells in a bead mill (Fritsch, Idar-Oberstein), and lysed by 
the following milling protocol: 3 x [4 min, 500 rpm, 2 min break]. The glass beads 
were removed and washed once with buffer, so that the lysate comprised 25 ml. After 
centrifugation for 10 min at 4°C and 4000 rpm (Hettich Rotanda, Germany), the 
supernatant was subjected to a 1 h 100,000 g ultracentrifugation at 4°C using an 
SW32 rotor.  
The top fatty phase was removed by aspiration and the clear lysate was collected. 
For storage, glycerol was added to the lysate up to a final concentration of 5% and 
the lysate was flash-frozen in liquid nitrogen.  
5.4.2 Purification and TCA precipitation  
0.4 ml IgG-sepharose were washed 3 x in TAP-buffer (2 min, 1800 rpm, 4°C) and 
added to the lysate. After incubation for 1 h on a turning wheel at 4°C, the beads 
were centrifuged down and transferred to a mobicol column, containing a 35 µm filter. 
The beads were washed with 10 ml TAP-Buffer containing 0.5 mM DTT by gravity 
flow.  
To cleave-off the protein complex 6 µl TEV protease were added in 150 µl TAP-buffer 
plus 0.5 mM DTT and incubated for 1 h 20 min on a turning wheel at 19°C. For 
elution, the mobicol was centrifuged in a table top centrifuge for 1 min at 2000 rpm.  
During the TEV cleavage, 0.5 ml calmodulin beads were washed 3 x with TAP-buffer 
containing 1 mM DTT and 2 mM CaCl2. After removal of surplus buffer, the beads 
were incubated with 150 µl TAP-buffer containing 1 mM DTT and 2 mM CaCl2 on ice. 
For calmodulin binding the 150 µl TEV eluate were added, incubated for 1 h on a 
turning wheel at 4°C and washed with 7.5 ml of TAP-buffer plus 1 mM DTT and 2 
mM CaCl2.  
To elute the protein complex, the beads were incubated in a thermomixer at 37°C for 
2 x 7.5 min in 10 mM Tris-HCl, pH 8.0 and 5 mM EGTA. The eluate was obtained by 
centrifugation for 1 min at 2000 rpm.  
To concentrate the samples, TCA was added to a final concentration of 10% and the 
samples were incubated for 20 min on ice. After 20 min centrifugation at 16,000 g 
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and 4°C, the pellet was resuspended in 60 µl 1 x SB (62.5 mM Tris-HCl, pH 6.8, 
2.3% SDS, 10% glycerol, 0.05% bromophenolblue, 25 mM DTT), the resulting 
solution neutralized by the addition of Tris-Base, denatured and subjected to SDS-
PAGE. 
5.4.3 Purification of proteins for in vitro kinase assays  
For in vitro kinase assays cells from 2 l cultures of either wt or Bur1-TAP cells were 
lysed and the tagged protein was purified. After the IgG binding step the beads were 
washed with 10 ml TAP-buffer containing 1 M NaCl for the purification of the BUR 
complex without RPA, followed by a 5 ml wash with TAP-buffer. The BUR/RPA 
complex was purified as in the normal protocol. For the subsequent assays TEV 
eluates were used. 
5.4.4 Purification of Rfa1-Flag-TEV-ProtA for peptide mapping 
For peptide mapping a 2 l culture of Rfa1-Flag-TEV-ProtA cells was lysed and the 
tagged protein was purified in three TAP purifications (one purification according to 
666 ml of cell suspension). After the IgG binding step the beads were washed with 10 
ml TAP-buffer containing 1 M NaCl, followed by a 5 ml wash with standard TAP-
buffer. For the assay the TEV eluate was used. 
5.4.4 Purification of proteins using GFP binder 
Protein purifications using GFP binder were done as described in the manufacturer’s 
protocol, except for using TAP buffer after establishing the method. 
5.5 In vitro kinase assay  
For in vitro kinase assays 5 µl of each kinase and/or substrate were incubated in the 
presence of 0.5 mM ATP, 1 mM DTT, 100 mM Tris-HCl, pH 7.5, 1 mM MgCl2, 1 mM 
EGTA and 1 Ci [γ-32P]-ATP at 30°C for 30 min. Reactions were separated by 15% 
SDS-PAGE, followed by autoradiography.  
5.6 Protoarrays 
The Protoarray Yeast PPI Kit (Invitrogen, USA) was used as in the manufacturer’s 
protocol except for exchanging the buffer for TAP buffer (see 5.4.1) (Bur1 kinase was 
inactive in the buffer coming with the kit.)  
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5.7 Whole cell extracts (WCE)  
Analytical WCE were used to test for the correct integration of the TAP-tag. A 2 ml 
culture was inoculated with one loop of freshly grown cells and grown over night to 
saturation. Cells were harvested (3 min 3600 rpm), resuspended in 96°C 100 µl 1 x 
SB and vortexed with 100-µl glass beads as following: 3 x [1 min vortexing, 3 min 
96°C]. After 5 min 16,000 g, 5-µl of this extract were subjected to SDS-PAGE and 
Western blotting and the presence of the TAP-tag was assessed using the PAP 
antibody.  
For native WCE, cells were grown to mid-log phase and 10 OD600nm were 
harvested and washed with 1 ml TAP-buffer. The pellet was resuspended in an equal 
volume of TAP-buffer and lysed with the double volume of glass beads (4 x 2 min 
vortex, 2 min ice). After a low spin (3 min 1500 g, 4°C), the supernatant was 
centrifuged for 30 min at 16,000 g, 4°C. The protein concentration was determined 
using the DC Protein Assay kit (Biorad, München) and 0.2 A750 were loaded onto 
SDS-PAGE and subsequent Western blotting.  
5.8 SDS-PAGE and Western Blotting  
SDS-PAGE was performed according to Laemmli using the Mini-Protean II system 
(Biorad, München). Proteins were transferred onto nitrocellulose membrane using a 
semi-dry blotting machine (Peqlab, Erlangen). After transfer, the membrane was 
blocked with blocking buffer (2% milk-powder in PBS) and incubated overnight at 4°C 
with the first antibody dissolved in blocking buffer. Excess of first antibody was 
removed by washing the membrane 3 times for 15 min with blocking buffer at RT. 
The membrane was incubated with secondary antibodies diluted in blocking buffer for 
2 h at RT. Visualization of immunodecorated proteins was performed using either an 
ECL-Kit (Applichem), followed by exposure of the membrane to light-sensitive films 
and subsequent developing using a Kodak X omat M35 developing machine, or by 
incubating the membrane with 0.3 mg/ml chloronaphthol, 10% methanol, 0.03% H2O2 
in PBS. For quantification of the signal, the intensity was measured using a Fujifilm 
Image Reader LAS-3000 system. 
5.9 Cell extracts and blots for the detection of histone modifications 
Cells were inoculated from a saturated pre-cultures in the evening to have them 
growing logarithmically in the morning. They were at least grown from an OD600 of 0.1 
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to 0.8-1.0. Cells were harvested by centrifugation, washed with 10 ml of water, 
washed with water containing protease inhibitors once and transferred to a reaction 
tube and frozen in liquid nitrogen. The cell pellets were kept at -80°C until use. For 
the extracts the cell pellets were resuspended in lysis buffer (200 mM Tris-HCl pH 
8.0, 320 mM ammonium-sulphate, 5 mM MgCl2, 10 mM EGTA pH 8.0, 20 mM EDTA 
pH 8.0, 20% glycerol and freshly added 1mM DTT, 10 mM NaF, 5 mM sodium-
phosphate and protease inhibitors). Lysis was performed by vortexing with 200 µl 
acid washed glass beads four times 2 minutes with 2 minutes breaks on ice in 
between. The lysate was spun down in a tabletop centrifuge for 20 min at 13000 rpm 
at 4°C. The supernatant was transferred to a new tube and mixed with sample buffer 
(62.5 mM Tris-HCl, pH 6.8, 2.3% SDS, 10% Glycerin, 0.05% bromophenol-blue, 25 
mM DTT). The amount of protein was adjusted either using A280 measurement or if 
the mutant used had an impact on the overall levels of histone H3 by quantification of 
the H3 intensities by quantitative western blotting. Two fold dilutions of every sample 
were loaded on a 15% PAA gel with 1 mm spacer plates. Gels were run at 120 V for 
approximately 2 hours in SDS running buffer (15.1 g/l Tris, 72 g/l Glycin, 3.72 g/l 
EDTA, 5 g/l SDS) and blotted on PVDF membranes in semidry blotting buffer (5.85 
g/l Tris, 9.92 g/l Glycin, 0.37 g/l SDS, 10% Methanol) at 1.5 V/cm2 for 90 minutes and 
blocked in 5% milk in TBS for at least one hour. Antibodies detecting histone 
modifications were incubated in 2.5% milk-TBS over night. Blots were then washed 
three times with 5% milk-TBS and the secondary antibody was incubated for 2h at 
RT and the membrane was washed three times for 5 min with TBST (Kizer et al., 
2006) before detection by X-ray film or quantification. 
5.10 GST pulldown and binding assay 
5.10.1 Expression and purification of Bur1 C-terminal fragments 
Fragments of the Bur1 C-terminus were PCR amplified from a plasmid containing the 
BUR1 ORF adding a 5’ BamHI site and a 3’ SalI site. The PCR products were cloned 
into the same sites of pGEX-4T3 to express them with a N-terminal GST tag. Those 
constructs were transformed into BL21 E. coli strains. Those strains were inoculated 
in 20 ml LB media and grown at 37°C until an OD600 of 0.5 was reached. Expression 
of the protein was induced by adding 0.5 mM IPTG for 4 hours at 37°C. Cells were 
harvested and washed once in TAP buffer with the addition of protease inhibitors and 
frozen in liquid nitrogen. For lysis the cells were thawed and resuspended in TAP 
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buffer with 0,5 mM DTT and protease inhibitors and sonified for 6 min (30% duty 
cycle, 10% output). The lysate was centrifuged in a SS34 rotor for 15 min at 15000 
rpm. The supernatant was transferred to a 15 ml tube and incubated with 400 µl of 
slurry buffer equilibrated Glutathione sepharose. After an incubation of 1h at 4°C, the 
beads were transferred to a mobicol and washed with 50 ml TAP buffer containing 1 
M NaCl and 0,5 mM DTT and with 3ml TAP buffer containing 100 mM NaCl. The 
settled beads were resuspended in 300 µl TAP buffer and 10 µl of those beads 
containing the immobilized GST-Bur1-C-terminus fragments were subjected to the 
binding reaction with TAP purified Rfa1. 
5.10.2 Bur1-Rfa1 binding assay 
The immobilized Bur1 fragments served as bait proteins for the binding assay with 
TAP purified Rfa1. For the assay 10 µl of slurry Glutatione beads were mixed with 50 
µl of 1 M NaCl washed Rfa1-TEV eluates and 140 µl of TAP buffer. The negative 
controls contained either no Rfa1-TEV eluate or just expressed and immobilized 
GST. Binding was performed for 1 h at 4°C followed by 3 washing steps with 500 µl 
TAP buffer with 0.5 mM DTT and protease inhibitors. Elution was performed with 45 
µl TAP buffer and 15 µl 4 x SB, boiling for 2 min at 96°C. Of this eluate 17 µl were 
subjected to SDS-PAGE analysis.  
5.11 Genome-wide expression profiling 
5.11.1 RNA isolation 
For genome-wide gene expression profiling, cells were inoculated from a saturated 
pre-culture and grown logarithmically over night at 30°C without diluting them. MMS 
was added to a concentration of 0,1% for one hour to the logarithmically growing 
cells. For the isolation of RNA, fifteen OD600 of cells were harvested, washed in 1 ml 
of ice cold TE buffer,  and resuspended in 500 µl RNA cross buffer 1 (0.3 M NaCl, 10 
mM Tris pH 7.5, 1 mM EDTA,  0.2% SDS). Cells were lysed using 200 µl of acid 
washed glass beads, 400 µl phenole-chloroforme for RNA isolation (Roth) on a 
Vibrax, for 10 minutes at 4°C. The lysate was spun down 5 min at 13000 rpm at 4°C 
in a tabletop centrifuge. From the supernatant 400 µl were taken off and mixed with 1 
ml of cold 100% ethanol. The RNA was precipitated at -20°C for 1 hour with 
subsequent centrifugation (15 min, 13000 rpm, 4°C). The pellet was dried for 3 
minutes at 65°C and resuspended in 78 µl of DEPC-treated water with heating at 
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65°C for 5 minutes. The solubilised RNA was incubated with 10 µl DNaseI buffer and 
10 µl DNaseI (Fermentas) and 2 µl RNasin (Promega) for 15 minutes at room 
temperature. The reaction was stopped by adding 11 µl 25 mM EDTA and heat 
inactivation of the DNaseI at 65°C for 10 minutes. The RNA concentration was 
determined (2 µl RNA in 98 µl water). Afterwards 45 µg of the RNA were loaded onto 
a Quiagen RNeasy MinElute coloumn and cleaned up according to the 
manufacturer’s protocol. The quality of the RNA was determined by agarose gel 
electrophoresis and staining with ethidium bromide.  
5.11.2 Microarray hybridization 
Yeast RNA was hybridized to Affymetrix GeneChipYeast Genome 2.0 Arrays 
(Affymetrix, Santa Clara, CA) as described in the users manual (Affymetrix GeneChip 
Expression Analysis Technical Manual, 2005), using the GeneChip Expression 3’ 
Amplification One-Cycle Target Labeling and Control Reagents kit. Briefly, 700 ng 
total RNA was reverse transcribed to cDNA using a T7-oligo (dt) primer. Following 
second-strand cDNA synthesis, the double-stranded cDNA was purified as a 
template for the subsequent in vitro transcription (IVT) reaction. Linearly amplified 
biotin-labeled complementary RNA (cRNA) was synthesized in the presence of a 
biotinylated nucleotide analogue. The labelled cRNA was purified and the quantity of 
each cRNA sample measured via a ND-1000 Spectrophotometer (NanoDrop 
Technologies). Yields were above 50 µg for all samples. 15 µg of each cRNA sample 
were fragmented by metal-ion catalyzed hydrolysis. cRNA fragmentation was 
evaluated by 4% agarose gel electrophoresis (ready-to-use gels from Invitrogen). 5 
µg of the labelled and fragmented cRNA was then hybridized to the arrays at 45°C 
for 16 hours with constant rotational mixing at 60 rpm in a GeneChip Hybridization 
Oven 640 (Affymetrix, Santa Clara, CA). Washing and staining of the arrays was 
performed using the FS450_0003 script of the Affymetrix GeneChip Fluidics Station 
450. The arrays were scanned using an Affymetrix GeneChip Scanner 3000 7G.  
Biological triplicate measurements were performed for the wild-type strain, bur1-7 
and rfa1-249. Biological duplicate measurements were done for the bur1-7 rfa1-249 
double mutant strain, since one sample was identified to be an outlier (see below).      
5.11.3 Data analysis 
Raw signal intensities for each probe set as they are contained in the .CEL files were 
analyzed using PARTEK GENOMICS SUITE version 6.3 software (Partek Inc., St 
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Louis, MO). As part of the import process of all .CEL files into the software package, 
data was filtered by application of a modified mask-file that was based on the 
s_cerevisiae.msk file of Affymetrix. This allowed us not only to mask all the S. pombe 
probe sets that are also part of the Affymetrix GeneChipYeast Genome 2.0 Array but 
also to mask unspecific probe sets as well as outdated replicate probe sets of S. 
cerevisiae. The RMA (robust multiarray average) normalization method (Irizarry et al., 
2003) was used for RMA background correction, quantile normalization and 
medianpolish probe set summarization. Expression values were log2 transformed 
before statistical analysis.  
During analysis, one bur1-7 rfa1-249 sample was identified to be an outlier showing 
an unusual expression pattern with respect to all other samples. This sample was 
therefore excluded from the analysis. Since the microarray experiments were 
performed on different days, a batch effect (“scan day”) could be observed via 
principal components analysis (PCA). This batch effect was removed by application 
of the “Remove Batch Effect” tool that is part of the PARTEK GENOMICS SUITE 
software package.    
After exclusion of the outlier sample and batch-remove a 1-way ANOVA was 
performed, to detect genes that were differentially expressed between wild-type and 
mutant yeast strains. Within the ANOVA model, a linear contrast was used to 
compare mutant samples with baseline wild-type samples (mutant versus wild-type). 
The P-values of the mutant versus wild-type comparison were then corrected using a 
step-up false discovery rate (FDR) value of 5% (Benjamini et al., 2001) to produce a 
list of significantly differentially expressed genes. This list of statistically significant 
genes was further filtered to include only genes that demonstrated two fold or greater 
up- or downregulation.  
5.11.4 Hierarchical cluster and correlation analysis 
Hierarchical cluster analysis was performed with microarray data of bur1-7, rfa1-249 
and bur1-7 rfa1-249 mutant yeast strains. In total the hierarchical cluster analysis 
was performed for 115 significantly altered genes. Hierarchical cluster analysis was 
calculated using TIGR MeV application (Saeed et al., 2003), choosing average 
linkage as the linkage method and Euclidean distance as distance metric. 
Pearson’s correlation was calculated in Microsoft Excel. The respective correlation 
coefficient (r-value) was calculated for each pair of mutant strains and was based on 
the respective lists of significantly altered genes. 
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5.11.5 Gene Ontology (GO) analysis. 
Overrepresented biological processes for genes with significant expression changes 
were determined using the Gene Ontology Enrichment Analysis Software Toolkit 
(Zheng and Wang, 2008) that is based on GO database (Ashburner et al., 2000) and 
annotation files of Affymetrix GeneChip system. Affymetrix probe set IDs served as 
gene identifiers. Therefore a list of Affymetrix probe set IDs of differentially expressed 
genes could be directly uploaded into GOEAST. Additionally this provided a list of all 
genes present on the Affymetrix GeneChipYeast Genome 2.0 Array as the 
corresponding genomic background. The statistical method used by GOEAST to 
identify significantly enriched GO terms (p-value < 0.05) among the given list of 
genes was hypergeometric test.   
5.11.6 Explorative and promoter analysis 
Explorative data analysis was performed with PARTEK GENOMICS SUITE software 
package. Genes with a fold change > 1.7 or < -1.7 and a p-value ≤ 0.05 were 
considered to be significantly changed. Genes with a fold change between -1.3 and 
1.3 were regarded as not changed. In the resulting final gene lists, open-reading-
frames (ORFs) with the associated gene title “putative protein of unknown function” 
were not considered in further analysis.   
Promoter analysis was conducted with YEASTRACT (Yeast Search for 
Transcriptional Regulators And Consensus Tracking; www.yeastract.com), an open-
source and web-based database of regulatory associations between transcription 
factors (TFs) and target genes in Saccharomyces cerevisiae (Teixeira et al., 2006). 
The “Group Genes by TF”-tool was used to reveal transcription factors that target the 
corresponding genes in the lists. Only documented associations with direct evidence 
code (most stringent search query available in that database) were considered. The 
“Search for Potential Transcription Factors (TFs)”-tool was applied to detect potential 
binding sites of Swi5 in the promoter region of the genes of interest.     
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7. Abbreviations 
 
 
°C  degree centigrade 
5-FOA  5-Fluoroorotic acid  
aa  amino acid 
ATP  adenosine triphosphate 
bp  basepair 
d  day  
Da  dalton 
DNA deoxyribonucleic acid 
dNTP  deoxyribonucleosid triphosphate 
E. coli Escherichia coli 
ECL enhanced chemoluminiscence 
g  gram 
GFP  green fluorescence protein  
GST  glutathione S-transferase 
h  hours  
HU Hydroxyurea 
l  litre 
m  milli 
M  molar 
min  minute  
mRNA  messenger ribonucleic acid  
mRNP  messenger ribonucleoprotein  
nt  nucleotide 
OD  optical density 
ORF  open reading frame 
PAGE  polyacrylamide gelelectrophoresis 
PCR  polymerase chain reaction 
pH  potential of hydrogen 
RNA  ribonucleic acid 
rpm revolutions per minute 
RT  room temperature 
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SDS  sodium dodecyle sulphate 
sec  second 
ts  temperature sensitive 
UV ultraviolet 
µ  micro 
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